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0.5 Abstract
This dissertation is divided into five chapters. Chapter One consists of an introduction to
radical cyclisation and rearrangement reactions. Chapter Two investigates the reactions
of substituted arylsulfonamides 278a-l with copper bromide and an amine ligand-TPA.
This reaction involves an alkyl radical generated from the copper (I) bromide/TPA
complex, which can then undergo a 1,5- ipso attack onto the sulfonamide leading to a
cyclohexadienyl radical intermediate. Re-aromatisation and extrusion of sulfur dioxide
leads to an amidyl radical intermediate. This can undergo either cyclisation back onto
the aromatic ring to give the 6-substituted oxindole 336, or reduction from H-atom
abstraction by the solvent leading to rearranged amides. A minor product identified as a
5-substituted oxindole 333 may be formed from direct radical cyclisation onto the
sulfonamide followed by extrusion of sulfur dioxide. An unambiguous synthesis of 333
was obtained through the Stollé method in order to rigorously identify this product. For
completion, the rearranged amide 280e was also unambiguously synthesised from
known literature sources. It has been shown that the selectivity towards either
rearrangement or cyclisation is dependent upon the solvent used and temperature. For
example, toluene induces excellent selectivity towards cyclisation (to furnish oxindoles),
while using dichloromethane (DCM) induces a greater selectivity towards rearranged
amides. Chapter Three explores the effects of varying the alkyl chain length on the
nitrogen atom on selectivity, while keeping both the aryl group and initiator the same. It
has been shown that selectivity towards the rearrangement (or decrease in cyclisation)
occurred when the alkyl chain was increased from N-butyl to N-dodecyl. In addition a
similar solvent effect on selectivity was observed as discussed in Chapter 3, notably
relatively more rearranged amide was produced with DCM and oxindoles with toluene.
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Chapter four involves investigating the copper-mediated radical cyclisation of halo-
amides to give oxindoles directly. The final chapter consists of the experimental.
Chapter One
18
CHAPTER ONE
LITERATURE REVIEW
Chapter One
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1.0 Introduction to radical chemistry
Radicals are defined as chemical species that contain one or more unpaired electrons.
Amongst the several types of radicals known to the chemist, it is the carbon-centred
radical, which has received the most attention. This has been particularly the case in
reactions involving the formation of new C—C bonds, such as polymerisation
reactions,1 and the construction of cyclic compounds.2-4 The use of nitrogen,5
phosphorus6 or sulfur-based7-8 radicals are less common in synthesis, yet there has been
extensive research in these areas.
The majority of carbon based alkyl radicals (eg. •CH3) are trigonal planar in structure
(similar to carbocations), although some exceptions are possible. When hydrogen atoms
on a methyl radical are replaced by an σ-attractor, π-donor component or group
(halogen, OH, NH2) this leads to pyramidalization of the radical. In the case of •CF3, this
results in a tetrahedral structure.9 The sp2-hybridized atom is electron deficient, and as
such, the stability of the radical is increased with substitution of alkyl groups, hence
tertiary alkyl radicals are stabilized more than secondary ones. Resonance is also a
contributing factor in radical stability.2
1.1 Classes of radical reactions
Radicals can undergo a range of reactions, for example abstraction (eq. 1)10
intermolecular addition (eq. 2)11 intramolecular addition (eq. 3)12 rearrangement (eq. 4)13
and radical-radical reaction (eq. 5)14 as outlined in Scheme 1.
Chapter One
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1) A-X + B
heat or hv
A + B-X
2)
R
+ Y Y
R
3)
+
4)
R
A B A B
R
5) A + B A B
Scheme 1 Possible radical reactions
1.2 Radical abstraction reactions
An early example of radical abstraction reactions were those involving the reaction
between an alkyl radical and an alkyl halide. Much work was done during the 1960’s on
these types of reactions. King and Swinbourne15 investigated the abstraction of halogen
atoms by methyl radicals. Thermal homolytic dissociation of di-tert-butylperoxide 1
gives two molecules of tert-butyl peroxide radical 2.16 The tert-butyl peroxide radical 2
formed can then undergo a β-fragmentation to give a methyl radical 3 and acetone. A
high temperature (>150ºC) is required to produce the methyl radical 3, since the
activation energy is between 6-8 kcal/mol higher for β-fragmentation than that of
hydrogen abstraction by tert-butyl peroxide radical 2. Reaction of a methyl radical 3 and
ethyl chloride 4 yield both methane 5 and the 1-chloroethyl radical 6 as shown in
Scheme 2.
Chapter One
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CH3 C2H5Cl CH4 C2H4Cl
O
O
+ +
1 2 3
4 5
O2 x
>150 oC O
+CH3
63
ß-fragmentation
Scheme 2 Hydrogen atom abstraction by methyl radical15
Whilst the majority of reactions involve abstraction of hydrogen atoms from alkanes, it
is also possible to get abstraction of other atoms attached to an alkyl group. These
include radical leaving groups such as PhS,9 PhSe,17 Barton esters18 and xanthates19
(which are popular ways to achieve de-oxygenation of alcohols).20 Abstraction of atoms
other than hydrogen (e.g. halogens) have also been reported.21 In this case tributyltin
radical abstracts an iodine atom from iodobenzene 7 to give an aryl radical 8 and
tributyltin iodide as depicted in Scheme 3.
I
SnBu3 + ISnBu3
7 8
Scheme 3 Halogen abstraction from an aromatic ring
1.3 Radical addition reactions
Radicals can add to unsaturated substrates, (such as alkenes, alkynes and aromatic
groups) in an inter- and intramolecular fashion.
1.3.1 Intermolecular addition
In 1933 a series of reactions by Kharasch, McCabe and Mayo22 on the addition of
hydrogen bromide 11 to propylene 12 were studied. Homolytic dissociation of di-
benzoyl peroxide 9 at room temperature gave two molecules of benzoyl peroxide radical
10. In the presence of a benzoyl peroxide radical 10, rapid abstraction of the hydrogen
Chapter One
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atom from hydrogen bromide 11 led to the bromine radical, which could then add to
propylene 12. This was followed by formation of a secondary alkyl radical intermediate
13, which underwent hydrogen atom transfer to furnish the anti-Markovikov product 1-
bromopropane 14 in 87% at room temperature, as illustrated in Scheme 4. The
regiochemistry of addition in the presence of anti-oxidants was reversed and the
Markovnikov product, (iso-propyl bromide, not shown) formed via an ionic
(electrophilic) addition resulted.
Br
H BrBr Br
13 14
11
O
O
O
O
87%
heat
OO
H Br -PhCOOH
Br
12
12
9 10
2 x
Scheme 4 Radical bromination of an alkene22
1.4 Intramolecular addition reactions (cyclisations)23-26
With the exception of radical polymerisation reactions, intramolecular radical reactions
have probably received the most attention. Baldwin’s rules27 generally govern the
regiochemical outcomes of these cyclisations, hence, the 5-hexenyl radical 15
preferentially cyclises to give the 5-exo product 16 via a chair-like transition state.28 The
reactions are normally under kinetic control and as such the major product is the five
membered ring in the ratio of 98:2 (16:17) at room temperature for the all carbon case as
illustrated in Scheme 5. Cyclisation onto alkynes29 and aromatics are also possible (see
Section 2.0).
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Scheme 5 5-Hexenyl radical cyclisation
1.5 Radical rearrangements
A range of radical rearrangement (or migration) reactions has been reported where either
atoms or groups of atoms, can undergo migration. A classic example is the 1,2-phenyl
migration 30 of radical 18 (Scheme 6). The migration is thought to occur via 3-ipso-exo
cyclisation onto the aromatic ring to furnish the spirocyclised radical intermediate 19
followed by reversible ring opening via cleavage of the alternative C/C bond to yield the
iso-butyl benzyl radical 20 .
1,2-shi ft
18 19 20
Scheme 6 Possible radical rearrangement reaction
1.5.1 Group transfer reactions
Urry and Kharasch explored neophyl rearrangements in 1944.31 These are 1,2-
migrations32 typified by the reaction shown in Scheme 7. Groups that undergo this type
of migration include nitrates33 22, phosphate,34 ester35 and sulfonate derivatives.33 The
driving force for such reactions is often the formation of a more stable radical (i.e. the
primary radical 21 was transformed to the secondary benzylic radical 22 as depicted in
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Scheme 7. O-Neophyl rearrangement of 1,1-diarylalkoxyl radicals have also been
reported.36 These sorts of migration can also occur in vivo, normally mediated by
vitamin B12 and cobalt dependent enzymes.37
Ph
O
N
O
O
O
N
O
O
Ph
21 22
1,2-aryl migration
Scheme 7 An 1,2-aryl migration
1.5.2 Hydrogen abstraction reaction
Other rearrangement can occur via hydrogen abstractions. A range of H-abstraction
reactions have been reported (eg. 1,2-;38 1,4-;38 1,5-;39 1,6-,40 1,7-;)41 However the
commonest are 1,5-H abstraction which occur via a chair-like transition state. For
example, peroxide-initiated radical abstraction of the iodo compound 23 (Scheme 8)
yielded the alkyl radical intermediate 24. This then underwent a 1,5-H abstraction, to
give 25 which was terminated by abstraction of an iodine atom to furnish the
iodosulfone 26 in 94% yield.39
PhO2S PhO2S
H
H
Bz2O2
PhO2S
H
I
I
24 25 26
PhO2S
H
I
1,5-H abstracti on
23
8
Scheme 8 An 1,5-H abstraction from alkyl iodide
Hydrogen abstractions can also occur from aromatics.42 Irradiation of an
iodobenzophenone 27 (Scheme 9) in tert-butanol furnished the aryl radical intermediate
28, which then underwent 1,5-hydrogen abstraction to give the new radical 29.
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Scheme 9 An 1,5-H abstraction from an iodo aromatic compound42
In another example, Curran43 has treated an ortho-halo-aromatic 30 (Scheme 10) with
tributyltin hydride/AIBN to form the aryl radical intermediate 31, which underwent an
1,5-H atom abstraction to furnish the alkyl radical intermediate 32.
Ph O
H
Ph O
H
Ph O
H
X
Bu3SnH
AIBN
1,5-H
30 31 32
Scheme 10 An 1,5-H abstraction from an aryl radical to form an alkyl radical
1.6 Radical-radical reactions3, 9
The process in which two radical species interact to form non-radical products is called
chain termination. Two processes are possible: (1) radical coupling and (2)
disproportionation. In the following example, the methyl radical 3 and ethyl radical 33
re-combine to give the radical coupled product propane 34 or through disproportionation
to furnish methane 5 and ethylene 35 as depicted in Scheme 11 When two of the same
radical fragments re-combine, this is called dimerisation. A classic example is the
Kolbe44 aniodic oxidation of carboxylic acid salts.
CH3 + C2H5
CH3CH2CH3
CH4 + CH2CH2
radical coupling
disproportionation
3 33
34
5 35
Scheme 11 Possible radical coupling and disproportionation reaction
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2.0 Aromatic radical reactions-Addition to aromatic ring.
Intermolecular addition onto an aromatic ring45-47 can go through three possible
mechanistic pathways. These include; (1) aromatic nucleophilic substitution45-an attack
by a nucleophile (Nu-), giving an anionic σ-complex, and loss of an anion; (2) aromatic
electrophilic substitution46-an attack by an electrophile (E+), giving a cationic σ-
complex, and loss of a cation; and (3) aromatic homolytic substitution47-an attack by a
radical (R•), giving a radicalσ-complex and loss of a leaving group (which is normally
hydrogen, H•). An early example of an intramolecular homolytic aromatic substitution
involves the Pschorr reaction48-50 as illustrated in Scheme 12. In this example, the radical
precursor 36 when treated with copper (I) chloride furnished the aryl radical 37 through
loss of nitrogen gas. This aryl radical can then add into the aromatic ring to give the
cyclohexadienyl radical intermediate 38 followed by re-aromatisation to the tetracyclic
product 39.
NMe
N2X
NMe NMe
H
NMe
36 37 38 39
[O]
Scheme 12 The Pschorr reaction (1900)50
2.1 Introduction 51-55
The primary objectives of this thesis were to investigate the cyclisation of radicals into
aryl rings. Due to the nature of the cyclisation systems involved (discussed in Chapters
2-4) rearrangement reactions compete with the desired cyclisations. Therefore, the
remainder of the introduction will focus both on radical cyclisation into aryl rings and
radical rearrangement reactions.
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2.2 Mechanistic aspects of aromatic homolytic substitution reactions
Historically, homolytic aromatic substitutions have resulted in poor yields and product
mixtures. A prime example of this is the Gomberg reaction,56 that not only gives every
possible regioisomer, but also radical-radical coupling by-products as shown in Scheme
13. In this example, the aryl diazonium salt 40 when treated with a base ( OˉH), furnishes
the aryl radical 41 through loss of nitrogen gas and the generation of a hydroxide radical.
The aryl radical 41 can then add into another aromatic ring 42, which if substituted (Z)
could lead to several regioisomers-namely para 43, meta 44 and ortho 45 radical
intermediates, followed by re-aromatisation to give para 46, meta 47 and ortho 48
biaryls. The aryl radical 41 could also recombine with another aryl radical 41 to give the
dimerised product 49.
N
N
OH N N
OH -N2 + OH
Z
40 41 42
H Ph
Z
H Ph H Ph
Z
Z
Ph
Z
Ph
Z
Ph
Z
H
Ph
Ph
H
Z Z
43 44 45
46 47 48
49
para meta ortho
dimerisation
+
Scheme 13 The Gomberg reaction
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A far more useful variant of this reaction involves intramolecular homolytic aromatic
substitution, which will be illustrated later in the thesis. The mechanism of re-
aromatisation (oxidation) in these substitution reactions is somewhat curious. The first
step of the reaction appears logical and straightforward, in that a radical R• attacks the
aryl ring (see Scheme 14) to produce a sigma complex (or cyclohexadienyl radical when
the aryl ring is benzene). This intermediate then has to undergo what is formally an
oxidation reaction to give the fully aromatic product. The strange feature of the
mechanism lies in this re-aromatisation step, since typically these reactions are
conducted using Bu3SnH as the radical mediator (see Scheme 15), formally a reducing
agent. Therefore, it would appear that oxidation is taking place in the presence of a
redundant! Several hypotheses have been forwarded to explain this dichotomy over the
years.
This process has been extensively reviewed by Bowman and Storey.47 The
intermolecular reaction proceeds via a sigma (σ) complex intermediate 50 as illustrated
in Scheme 14, followed by extraction of the leaving group and re-aromatisation.57 The
mechanism for the re-aromatisation will depend upon the reaction conditions employed,
and the leaving group X.
X
R
X
R
-X
sigma
complex
R
50
Scheme 14 Homolytic aromatic substitution-mechanistic outline
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Intermolecular addition reactions of the type outline in Scheme 14 have been previously
investigated. Traynham58 has conducted mechanistic studies on the effects of
substituents on the aromatic ring (ipso substitution).
2.3 Alkyl radical cyclisation onto aromatics
While cyclisation of alkyl radicals onto unsaturated systems (e.g. alkenes, see Section
1.4), abound in the literature, there are relatively few examples of cyclisation of such
radicals onto aromatic rings (Scheme 15). In these reactions, there is direct attack onto
the aromatic ring, from the nucleophilic alkyl radical followed by re-aromatisation. The
mechanism of this re-aromatisation will depend upon the reaction conditions.
I
[O]Bu3SnH
AIBN
H
Scheme 15 General mechanism for intramolecular cyclisation
The uses of aryl halides59-60 as substrates to initiate cyclisations onto monoaromatics
have also been investigated. Beckwith and Storey60 has shown that the precursor 51
when treated with tributyltin hydride and AIBN in toluene led to the aryl radical 52 that
could undergo an 1,5-hydrogen atom transfer to furnish the newly stabilised tertiary
radical 53. This was followed by aromatic homolytic substitution leading to the
cyclohexadienyl radical intermediate 54 to give the oxindole 55 in 81% yield as depicted
in Scheme 16.
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Scheme 16 Synthesis of a spirocyclic oxindole60
Three possible mechanisms for re-aromatisation have been postulated; (1) oxidation of
54 by AIBN as mentioned by Curran.61 (2) disproportionation of 56 followed by
oxidation of the cyclohexadienyl radical intermediate during work-up. In this illustrative
example (Scheme 17); the re-aromatisation process occurs as follows; one molecule of
the aryl radical intermediate 56 abstracts a hydrogen atom from another molecule of the
aryl radical intermediate 56 leading to the re-aromatised product 58 and the
cyclohexadienyl radical intermediate 57, which upon oxidation would furnish the
bicyclic product 58.
R
H
R
H
R
R
H
R
H
oxidation on work-up
56
58
57 58
Scheme 17 Disproportion reaction
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The third possibility invokes a mechanism involving the intervention of the initiator
fragments, and later proven by Beckwith, Storey and Bowman as illustrated in Scheme
18. By using the fully deuterated aromatic substrate 59 the production of the deuterated
initiator fragment 60 was proven. However, it would appear, at least in the system
investigated that other mechanistic pathways were operating at the same time.
D
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D
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D
O
Br
Bu3SnH
AIBN
D
D
N
D
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NC NC D
59
60
D
D
N
D
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Scheme 18 Investigation of re-aromatisation using deuterated arenes.
Until recently the mechanism proposed by Bowman62 was generally accepted as an
adequate explanation for oxidation in Bu3SnH mediated reactions. This involved
Bu3SnH acting as a hydride donor and radical 61 acting as a protic acid to give the arene
radical anion 62. This is then postulated to undergo a single electron transfer (SET) to
the starting halide to maintain the chain process as shown in Scheme 19.
H
R R
R
R
61 62
SET
ArRBr
+ Bu3Sn
Bu3SnH
H H+
+ Br
Scheme 19 Bowman’s hypothetic mechanism for re-aromatisation
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More recently a thorough investigation of the mechanism of general re-aromatisation
under different conditions has been published.57 Each mechanistic possibility has been
investigated and it would appear that the radical initiator is the key to determining the
mechanism.
Two parallel mechanistic pathways were proposed. The first, involving an initiator
fragment (resulting from AIBN homolysis) as outlined below. Under the conditions of
the reaction investigated this would appear to be the minor mechanism. The major
mechanism appears to involve the initiator acting as an oxidising agent prior to
homolysis. These two competing mechanistic pathways are illustrated in Scheme 20.
It would appear from the results presented that the postulation of each pathway is highly
dependent upon the substrate, initiator, radical mediator and other reaction conditions.
R
Br
R R
R
CN
NC
N
N
CN
CNH
NC
N
N
CN
NC
N
N
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N
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Bu3Sn
Bu3SnBr
Minor Pathway
H
H
H
H
cyclisation
Major Pathway
Scheme 20 Bowman and Storey proposed mechanism for re-aromatisation
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Storey has applied this methodology to the synthesis of aza-oxindoles63 In addition to
tributyltin hydride as a radical carrier or radical mediator, other reagents have also been
employed to furnish carbocyclic and heterocyclic compounds. These cyclisations can be
carried out with a combination of TTMSS/AIBN. Further evidence suggesting the role
of the initiators involvement in re-aromatisation can be seen in the synthesis of
methoxybenzene derivatives as well as with other reagents.64
2.3.1 Cyclisation of xanthates
(S)-Aryl ether xanthates 63 was treated with dilauroyl peroxide, and the alkyl radical
64 was produced (Scheme 21 ).65 This then cyclised to give a mixture of products.
Interestingly, radical cyclisation via path A predominates leading to the (S) 3-
aminochromane with the substituent in the 5-position 66. Radical cyclisation via the
cyclohexadienyl radical intermediate 67 (path B) led to the (S) 3-aminochromane with
the ketone substituent in the 7-position 68. Re-aromatisation under these xanthate-
mediated conditions was postulated to go through a single electron transfer-SET process
as described by Zard,66 however, it would seem feasible, that the lauroyl radical could
abstract the hydrogen atom from intermediate 65 or 66 to produce re-aromatisation.
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Scheme 21 Guillaumet synthesis of aminochromane65
However, several inconsistencies in this work were observed. It was stated that the iodo
compound 63a gave the best overall yield (37% for 66); yet, it is evident that it is the
xanthate compound 63b that has the highest yields (69%) for the aminochromanes 66.
Similarly, α-tetralone derivative 73 have also been synthesised using an alkyl radical
cyclisation (48%). Zard67 investigated the radical addition of acetophenone xanthate 69
onto vinyl pivalate 70 in the presence of dilauroyl peroxide (DLP) to give the radical
adduct 71 (scheme 22). This alkyl radical 71 then underwent cyclisation onto the
aromatic ring leading to 73 (48%), after re-aromatisation of 72.68-70 No mechanistic
hypothesis was presented for re-aromatisation, but again, the initiator, dilauroyl peroxide
is required in stoichiometric quantities in order to obtain reasonable yields of product.
This would strongly suggest that the initiator is involved with the re-aromatisation
process as previously discussed.
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Scheme 22 Zard’s synthesis ofα-tetralone67
2.4 Sequential intermolecular/intramolecular radical cyclisation onto aromatics
The use of an initial intermolecular addition to generate a new radical that is suitable for
cyclisation into aromatics has been achieved. This methodology has been used in the
synthesis of heterocycles and provides an elegant method for the generation of a
cyclisation precursor radical. N-allyl-anilides 74 were treated with the ‘Tordo
alkoxyamine’ 75.71-73 Thermal homolysis of 75 led to the formation of an alkyl radical
76 and a nitroxyl radical (“SG1”) 77. Radical addition of 76 to the alkene generated the
more stable radical intermediate 78, followed by intramolecular addition onto the
aromatic ring to furnish the cyclohexadienyl radical intermediate 79, which upon re-
aromatisation furnished the indole product 80 in 63% yield as shown in Scheme 23. No
evidence of products produced from the trapping of the radical intermediate 79 was
observed. It was assumed that re-aromatisation arose either from H-atom abstraction by
the nitroxide radical or because of its initial re-combination with SG1 77 followed by
elimination to furnish 80. No mechanistic evidence is presented for either pathway.
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Scheme 23 Tordo’s synthesis of indole71
The same method was used in synthesising oxindole 82. The nitroxide radical74
(“SG1”)-tethered substrate 81 underwent aromatic homolytic substitution and re-
aromatisation to furnish 82 in 63% yield as depicted in Scheme 24.
N O
O
Bu3OH 80
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81 82 63%
N
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Scheme 24 Synthesis of N-methyl-3,3-dimethyloxindole
Carbocycles can also be produced via intramolecular addition (Scheme 25). Addition of
a tosyl radical 84 onto the terminal alkene 83 furnished the more stable secondary alkyl
radical intermediate 85, which could undergo cyclisation onto the aromatic ring leading
to the cyclohexadienyl radical intermediate 86. Oxidation of 86 by subsequent reaction
with copper acetate furnished the tetrahydronaphthalene 87 in 90% yield.75 In this case
the oxidation by Cu2+ gives the cyclohexadienyl cation (not shown), which loses a
proton generating acetic acid and CuI. When the reactions were carried out under acidic
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conditions (acetic acid), high yields were obtained (90%, 48h), when formic acid was
used, the reaction was accelerated 82%, (9h).
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90%
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Scheme 25 Synthesis of carbocyclics75
A less common sequential approach to heteroaromatics via cyclisation onto an aryl
group is the intermolecular-intramolecular reactions of benzylideneamines. Thermal
homolytic dissociation of diisopropyl peroxydicarbonate (DPDC)9 (2 equivalents) 88 in
benzene at 60 ºC gave the isopropyloxycarbonyl radical 89 which could then abstract a
hydrogen atom from N-benzylidineamine 90.24 Addition of this radical to the alkyne, 91
was maintained until complete consumption of the radical initiator 89. This then gave
the vinyl radical intermediate 93 which subsequently underwent cyclisation into the aryl
ring to yield the quinoline derivatives 94 as depicted in Scheme 26. Similar approaches
to Luotenin A47 have shown that re-aromatisation occurred from hydrogen abstraction of
the intermediate cyclohexadienyl radical intermediate by a methyl radical generated
from the breakdown of Me3Sn• radicals or tert-butoxyl radicals. In this example, a high
concentration of hexamethylditin was required (14 equivalents) to furnish the product.
This could explain how the step from 93 to 94 was achieved. In that case it would be
from the homolysis of DPDC and subsequent hydrogen abstraction during the re-
aromatisation stage.
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Scheme 26 Synthesis of quinoline derivative24
A similar class of reactions were used by Bowman in the synthesis of Camptothecin,76-80
mappicine, luotonin76 and Zanardi’s synthesis of phenanthridine 98 (Scheme 27).77 The
key step in these reactions was a 6-endo attack of an aryl radical 96 onto the imine, to
give the aminyl radical intermediate 97. This was followed by re-aromatisation to
furnish phenanthridine 98 in 19% yield. The mechanism of re-aromatisation for this
reaction involves extrusion of the tert-Bu group.77 Reactions involving re-aromatisation
from extrusion of an alkyl group have been reviewed by Bowman et al.78-79
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Scheme 27 Zanardi’s synthesis of phenanthridine77
2.5 Aromatic radical cyclisation onto aromatics
Over the last decade, the synthesis of polyaromatics by cyclisation of aryl radicals onto
aromatic rings has become popular. The synthesis of phenanthrene derivatives from cis-
stilbenes have recently been used in the synthesis of steganone.81 The aryl radical 99
generated from homolysis of the corresponding bromo aromatic compound with Bu3SnH
(not shown) cyclised onto the second aromatic ring leading to intermediate 100. Re-
aromatisation presumably occurs by hydrogen abstraction of the cyclohexadienyl
intermediate by the initiator (AIBN) as discussed previously, no evidence to the contrary
has been presented by Harrowven et al.82 Phenanthrene 101 was furnished in 32%,
which showed that disproportionation may possibly be responsible for the oxidation
process (Scheme 28).81
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Scheme 28 Narasimhan synthesis of phenanthrene81
In addition to the above example, this methodology has been used to synthesise a range
of polyaromatic natural products e.g. β-copaena, β-ylangene, lemnalol,83-84
seychellene,85 and towards the synthesis of vitamin D3.86 In a related reaction,
Harrowven,82 used cis-stilbene (Scheme 29). In this case, the accepting aromatic ring
was not electron rich but electron poor. Cis-4-cyano stilbene 102 was treated under
classical radical conditions (tributyltin hydride, AIBN) to generate the aryl radical
intermediate 103, which could add via an intramolecular exo/endo-trig cyclisation to
give the cyclohexadienyl radical intermediate 104. Re-aromatisation of the radical
intermediate 105 probably occurs as described above, involving the initiator either
homolysed or intact to give phenanthrene in 85% yield. Disproportionation can be ruled
out as a mechanistic possibility. This reaction was repeated for the electron rich cis-3-
methoxy stilbene 106, under similar conditions to furnish regioisomers 107 and 108 in
high yield (82%). This should be compared to results from cis-3-cyano stilbene that gave
similar regioisomers at slightly lower yields (78%) (not shown).
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Scheme 29 Harrowven’s synthesis of phenanthridines82
Harrowven87 has also shown that the cis stilbene 109 (Scheme 30) when treated with
tributyltin hydride furnished the aryl radical intermediate 110. This radical then added
onto to the aromatic ring to give the cyclohexadienyl radical intermediate 111.
Re-aromatisation furnished the helicene 112 in 52% yield. Alternatively, the radical
intermediate 110 can undergo addition onto C-7, leading through re-aromatisation to
furnish dibenzo[a,h]anthracene 113 in 17% yield. Preference for the C-5 over C-7 attack
was evident. The reason for this selectivity is not clear, but is most likely to occur
because of a more favourable SOMO-LUMO interaction with C-5. Possible re-
aromatisation mechanisms were not mentioned.
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Scheme 30 Harrowven’s synthesis of helicene-187
An alternative approach by Harrowven88 to furnish [5]-helicene 112 is the use of (Z,Z)-
1,4-bis-iodo stilbenes. Treatment of the bis-iodo substrate (not shown) under classical
radical conditions (tributyltin hydride, AIBN) furnished the di-radical intermediate 114,
which underwent radical coupling to furnish the [5]-helicene 112 in 35% yield and the
by-product dibenzo[a,h]anthracene 113 in 27% yield (Scheme 31). Since aryl radical
formation is relatively fast compared to homolytic aromatic substitution it is indeed
likely that a biaryl intermediate like 114 actually is formed, rather than the formation of
one radical followed by the formation of another. There is however no evidence for
radical-radical coupling, which is a fast process. In this reaction a fourfold excess of
tributyltin hydride was used to push the reaction towards bicyclisation. Harrowven
stated that the driving force for re-aromatisation overcame the energy barrier caused by
the lack of planarity on helicene.
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Scheme 31 Harrowven’s synthesis of helicene and phenanthrene88
2.6 Alkyl radical cyclisation onto heteroaromatics
Cyclisation of radicals into heteroaromatics is a relatively new process. The first
example of this involves cyclisation of an alkyl radical into a protonated pyridinium
salt.89 Intermolecular and intramolecular aromatic homolytic substitutions into
heterocycles are relatively well researched. An example of an intermolecular addition
into an heteroaromatic was first demonstrated by Minisci,90 whereby the nucleophilic
alkyl radical (R•) can add intermolecularly into the protonated pyridinium salt 115 to
give the radical cationic species 116. Loss of a proton yields the radicalαto the nitrogen
atom 117. Re-aromatisation under oxidative conditions leads to the fully aromatic
product 118 as depicted in Scheme 32.
N
H
N
H
N
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R R R
115 116 117 118
R -H
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Scheme 32 Murphy’s reaction of protonated pyridinium salts
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An intramolecular version of this reaction was accomplished by Murphy.91-92 In this
example (Scheme 33), treatment of the 2-iodoalkyl pyridinium salt 119 with tributyltin
hydride (1.3 eq.) and AIBN (1.2 eq.) gave the nucleophilic alkyl radical 120 which could
add into the pyridinium ring to furnish the tetrahydroquinolizinium salt 121 in 60%
yield.
N
H
N
119 I
N
H I
Bu3SnH, AIBN oxidation
120 121 60%
Scheme 33 Murphy’s intramolecular addition into pyridinium salt
2.6.1 Radical cyclisation onto pyrazoles
Intramolecular cyclisation onto pyrazoles have been accomplished to give 4-phenyl
pyrazole derivatives 125.93 Reaction of a 4-phenylpyrazole phenylselenyl precursor 122
with tributyltin hydride (1.3 eq.) and ACCN (1.5 eq.) gave the alkyl radical intermediate
123 (Scheme 34), which underwent a 6-exo cyclisation to give the intermediate π-radical
124 followed by oxidation to furnish 4-phenylpyrazole 125 in 63% yield. For
cyclisations involving a 5-exo or 7-exo cyclisation, there was a considerable amount of
reduced product 126 formed. There was no product pertaining to the other regioisomer
127.
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Scheme 34 Intramolecular cyclisation of pyrazine93
The reaction was repeated using the ester93 [COOEt] on C-3 of the pyrazole (Scheme
35). Treatment of the radical precursor 128 with tris(trimethylsilyl)silane (1.3 eq.) and
triethylborane (Et3B) (1.5 eq.) as the radical initiator in refluxing toluene under an aerial
atmosphere furnished the alkyl radical 129 which underwent 6-exo cyclisation to furnish
the cyclic radical intermediate 130 followed by oxidation to give the bicyclic product
131 in 36% yield. Both 5-exo and 7-exo cyclisations were disfavoured, and only the
reduced product 132 was isolated, due to faster H-abstraction of hydrogen by the
intermediate radical 129. In addition, none of the regioisomeric cyclised product 133
was observed, which indicated the regioselectivity was more favourable towards C-5
than C-2 (the nitrogen atom adjacent to the alkyl chain).
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Scheme 35 Reaction of pyrazole (ester) on radical cyclisation93
The mechanism for the oxidative step 130 to 131 is not clear, but it is reported that the
stability of the π-radical intermediate 131 is crucial (to aromatisation).94-98 The re-
aromatisation could occur from H-abstraction by the ethyl radical formed during the
oxygen-generated breakdown of Et3B that was used as the initiator. With ACCN as
initiator, more than one equivalent of initiator was required, which indicated that
involvement of ACCN or its breakdown products (1-cyanocyclohex-1-yl radical) was
involved in re-aromatisation. 57, 94-103
2.6.2 Radical cyclisation onto imidazoles
Further studies were conducted involving cyclisation onto imidazoles94 (Scheme 36). In
these reactions the alkyl bromide radical precursor 134 when treated with tributyltin
hydride (1.5 eq.) and AIBN (0.25 eq.) generated the nucleophilic alkyl radical
intermediate 135, which underwent cyclisation at the electrophilic C-2 position of the
imidazole, leading to theπ-radical intermediate 136 followed by oxidation to the product
137. Again, it was observed that 6-exo cyclisation was more selective (no reduced
product) than that concerning the 5-exo and 7-exo cyclisation (both generating the
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reduced product 138). There was no regioisomer 139 resulting from cyclisation onto the
C-5 position.
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Key: a) n = 1, 137 = 42%; 138 = 10% b) n = 2, 137 = 49%; 138 = 0% c) n = 3, 137 = 14%; 138 = 8%.
Scheme 36 Intramolecular cyclisation of imidazole94
In order to explore the regioselectivity of this reaction, the reaction was repeated,
blocking the C-5 of the imidazole with a methyl group 140 (Scheme 37). The result was
complete selectivity towards C-2 cyclisation leading to the bicyclic product 141 in 75%
yield. Furthermore, regioselectivity was investigated, whereby C-2 of the imidazole was
blocked with a methyl group 142. This resulted in only reduced product 143 being
isolated in 46% yield. The regioselectivity would appear to be determined by
nucleophilic alkyl radical addition onto the electrophilic β-position of the imidazole.
This reaction was also investigated with tributylgeranium hydride.104
N
N
OHC
Br
N
NOHC
N
N
OHC
Br
N
N
OHC
Bu3SnH Bu3SnH
AIBN AIBN
140 141 142 14375% 46%
Scheme 37 Blocking of the C-2 and C-5 with methyl group94
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In addition, a carbaldehyde in the α-position of the imidazole 144 gave good yields of
the 6-membered ring product 145 in 53% yield (Scheme 38). However, attempts to
mediate 5-exo cyclisation from the radical precursor 146 failed leading to the reduced
product 147.
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Br
Bu3SnH
AIBN
N
144 145
2 2
CHO CHO
N
N
PhSe
Bu3SnH
AIBN
N
N
146 147
2 2
CHO CHO
55% 53%
Scheme 38 Intramolecular cyclisation of pyrrole and imidazole99
In this paper, there is no specific proposed mechanism to explain the oxidative radical
cyclisation of these substrates with Bu3SnH. There are three putative mechanisms
proposed in the earlier papers: (1) formation of a dihydro product and subsequent air
oxidation to achieve re-aromatisation. However this is unlikely since reactions are
performed under an inert atmosphere; (2) H-abstraction by AIBN and/or 2-cyanoprop-2-
yl radicals;105 although Lobo, Prabhaker et.al,106 conducted experimental work on
similar oxidative cyclisation, which showed that the hydrogen that is lost, is not
abstracted by 2-cyanoprop-2-yl radicals. (3) a pseudo-SRN1 mechanism.94
2.7 Ipso-substitution and extrusion of a good radical leaving groups
The reaction of radical precursor 148 (Scheme 39)107 when treated with tributyltin
hydride and AIBN led to the alkyl radical intermediate 149. The intermediate radical is
weakly nucleophilic and adds to the electrophilic C-2 carbon leading to the π-radical
intermediate 150. Elimination of the leaving group furnished the product 151. In the
previous section cyclisation occurred at sites substituted by an H-atom and not at sites
blocked by substituents (e.g. COOEt). However, if the substituent (e.g. Z, 148) is a good
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radical leaving group, ipso substitution with loss of this group can occur. Caddick has
used this methodology to furnish [1,2-a] indoles using sulfone, sulfide and sulfoxide
groups as leaving groups in substituted indoles.108 Highest yields were obtained from 6-
exo attack onto sulfoxides (tosyl group).
N
NN
N Z
Z
-Z
N
N
149 150 151
N
N Z
SePh
ipso substitution
Bu3SnH, AIBN
n n
n n
148
Z = Ts, n = 1; 151a = 52%, n = 2; 151b = 48%, n = 3; 151c = 63%, Z = PhSO2, n = 1; 151a = 51%, Z =
PhS, n = 1; 151a = 16%.
Scheme 39 Intramolecular ipso cyclisation of imidazoles107
There was no noticeable change in yield for n = 1 on varying the tosyl leaving group
151a in 52% yield and the phenylsulfonyl leaving group 151a in 51% yield. The low
yield for the phenylsulfanyl group 151a (16%) is attributed to this leaving group not
being sufficiently electron withdrawing to facilitate complete attack at C-2 by the
weakly nucleophilic alkyl radical. The same approach can be used to prepare [1,2-α]-
fused benzimidazole 152 as depicted in Scheme 40.108-110 The radical precursor 152 was
treated with tributyltin hydride and AIBN to give the alkyl radical intermediate 153.
This underwent an attack on the electrophilic C-2 carbon of the benzimidazole to give
the π-radical intermediate 154, and elimination of the phenylsulfanyl group to give the
product 155.
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Scheme 40 Intramolecular ipso cyclisation of benzimidazole110
The 5-exo cyclisation to 155a (n =1) proceeded in a higher yield to that of the analogous
imidazole reaction in 16% yield as depicted in Scheme 39. The yields for the
benzimidazole were reasonably good, with the 6-exo cyclisation providing higher yields
(54%) than the 5- and 7- exo cyclisations. This was explained because the imidazole ring
in benzimidazole has less aromatic character than in imidazole, and that addition of the
alkyl radical was more facile, and also because the weakly electron withdrawing
(phenylsulfanyl) group facilitates cyclisation over reduction.
2.8 Cyclisation of pyrroles
Related work by Bowman94 on pyrroles has shown similar selectivities with respect to
the 6-exo cyclisation (no reduced product observed). In this case the bromo alkyl radical
precursor 156 was treated with tributyltin hydride (1.5 eq.) and AIBN (0.25%), which
generated the alkyl radical intermediate 157 followed by addition onto the electrophilic
C-2 to yield the π-radical intermediate 158, which after oxidation furnished the product
159 as depicted in Scheme 41. Again, both the 5-exo and 7-exo cyclisations were
accompanied by small amounts of reduced products 160.
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Scheme 41 Intramolecular cyclisation of pyrrole-294
Several cyclisations onto the C-2 position of imidazoles proceed by reductive cyclisation
and not aromatic homolytic substitution48 that indicates that reduction of the
intermediate radical by Bu3SnH is faster than re-aromatisation. However, when an
electron-withdrawing group is present in the C-3 position, normal aromatic homolytic
substitution is largely favoured.111-116
2.9 Acyl radical cyclisation on pyrroles
Acyl radicals also undergo addition reactions.97 In this example, treatment of the
phenylselenyl radical precursor 161 with tributyltin hydride and AIBN furnished the
acyl radical intermediate 162 as illustrated in Scheme 42. This was followed by exo
attack onto the pyrrole to give the π-radical intermediate 163, followed by oxidation to
the product 164a (n = 1) in 31% yield and 164b (n = 2) in 20% yield. No reduced
product 165 was isolated. An alternative product can be formed from the intermediate
166. Decarbonylation gave the alkyl radical 166 that could add in an exo-fashion onto
the pyrrole to give the π-radical intermediate 167, followed by oxidation to the product
168a (n = 1) in 0% yield and 168b (n = 2) in 13%. Only the reduced product 169a (n =
1) was isolated in 34% yield.
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Scheme 42 Intramolecular cyclisation of pyrroles using acyl radicals97
It should be noted that decarbonylation is an exothermic process. The rate of CO loss
(approximately 2 x 102 M-1 s-1) at 80 ºC to generate a primary alkyl radical, is much
slower than CO addition (6.3 x 105 M-1 s-1) at 80 ºC for primary alkyl radicals.117 In
order to facilitate the synthesis of 164 this reaction was conducted under a CO
atmosphere. Furthermore, this methodology has been applied towards tetracyclic
heterocycles119 from 2-indolylacyl radicals. The mechanism for re-aromatisation98 in this
reaction is still unclear. In the Bu3SnH mediated oxidative cyclisation, more than one
equivalent of AIBN is required, which would suggest that AIBN is involved in an H-
abstraction mechanism for this step (see Scheme 20).
Azo compounds can act as oxidants, and as such would give dihydro-AIBN 172
(Scheme 43) as the expected product. Subsequently, experimental studies using AIBMe
170 as the radical initiator with radical precursor 161b furnished the cyclised product
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164b and dihydro-AIBN 171 indicating that AIBMe 170 was responsible for the
oxidative step.
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Scheme 43 Mechanism indicating AIBN involvement in re-aromatisation
2.10 Aryl radical cyclisation onto heteroaromatics
A popular approach to polyheteroaromatics119-120 is the addition of an aryl radical onto
another heteroaromatic such as quinoline (Scheme 44). Radical intermediates 173a and
173b are produced from homolysis of the corresponding C-X bonds with Bu3SnH (not
shown). The use of iodo aromatics is superior in terms of yield to the bromo analogues.
The stilbene radical intermediate 173a, underwent 6-exo/endo-trig cyclisation to furnish
the two regioisomers resulting from attack at C-2, 174a in 57% yield and C-4, 175a in
38% yield.119 When the reaction was repeated without the alkene bridge (e.g. an ethyl
bridge between the aromatic and the quinoline 173b), yields were slightly less for the C-
2 analogue 174b in 51% yield and C-4, 175b in 23% yield. The low yield from the
bromo precursor was due to several intractable products. The use of the iodide precursor
proved more effective. Again, it was shown that the product from C-4 addition occurred
in higher yields. The mechanism for re-aromatisation was postulated to go through two
mechanistic pathways as described by Harrowven et al.119 Similar methodology using
cobalt (II)-salophen was used in the synthesis of Toddaquinoline.121
Chapter One
54
N
O
O
N
O
O
N
O
O
+
+
N
N
O
O
173a
173b
174a
174b
6-exo/endo-trig
175a
175b
2
3
45
6
7
8
N
O
O
2
3
45
6
7
8
O
O
23
4
5
6 7
8
4
5
6 7
8
23
6-exo/endo-trig
Key: Bromo precursor Bu3SnH, 0.9 eq. AIBN, PhMe, 80ºC; 1747a = 24%, 175a = 46%; 174b = 18%,
175b = 15%; Iodo precursor Bu3SnH, 0.1 eq. AIBN, PhMe, 80ºC; 174a = 38%, 175a = 57%; 174b = 23%,
175b = 51%.
Scheme 44 Harrowven’s synthesis of polyheteroaromatics119
Cyclisations onto indoles have been explored by Harrowven122 using halo N-benzyl
indoles derivative 176. In this case the aryl radical 177 generated from tributyltin
hydride mediated homolysis of the aryl iodide underwent a 5-exo trig cyclisation to
furnish the radical intermediate 178. Hydrogen abstraction from another molecule of
tributyltin hydride furnished the tetracycle 179 in 80% yield and the reduced product
180 in <5% yields as depicted in Scheme 45.
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Scheme 45 Intramolecular cyclisation of indoles
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Further developments of this reaction were employed in the synthesis of several
heterocycles namely-deoxyvascinone, mackinazoline, luotinin A, tryptanthrin.123
The Jones’ group has developed cyclisation onto pyrroles further.124-126 An ortho bromo
anilide derivative 181 when treated with tributyltin hydride (0.02M) and sub-
stoichiometric amount of AIBN furnished the aryl radical intermediate 182 as illustrated
in Scheme 46. This could undergo three reactive pathways. The radical intermediate 182
could undergo 6-endo cyclisation via the radical intermediate 183 onto the pyrrole to
furnish the product 186. It could undergo 6-exo cyclisation via the radical intermediate
184 onto the pyrrole to give the regioisomeric product 187. Finally, it could undergo 5-
exo cyclisation via the radical intermediate 185 to furnish the spirocyclised product 188.
It is important to note the effects of substituents on the nitrogen atom of the pyrrole ring
in controlling the reaction. If unsubstituted groups (R2 = H), then regioisomeric products
186a (R1 = Me, R2 = H, 37%) and 187a (R1 = Me, R2 = H, 15%) dominated. Conversely,
cyclisation using N-t-Boc group led predominately to the spirocyclised product 188b (R1
= Me, R2 = Boc) in 31% yield, with the regioisomers as minor products (186b/187b =
18%/1%). If an electron-withdrawing group was attached to the nitrogen atom of the
pyrrole, only 186c (R1 = SEM, R2 = Me) was furnished in 43% yield. The
regioselectivity was unaffected when substitutents were on the aromatic ring. The
reasons for the differences in the reactivity between the varying groups on the nitrogen
atom of the pyrrole is not entirely clear nor is the mode of re-aromatisation given that
sub-stoichiometric amounts of initiator are reported to have been used.
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Scheme 46 Intramolecular cyclisation onto pyrroles125
2.11 Trapping of the cyclohexadienyl radical intermediate
Recent developments in radical chemistry have led to many possible routes to form
spirocyclised natural products through in-situ trapping of the cyclohexadienyl radical
intermediate. Zard’s method has shown that spirolactams127 can be prepared from N-
benzyl trichloroacetamides using nickel powder/acetic acid. Furthermore, Jones’ has
used this methodology towards the spirooxindole natural products-horsfiline, (Scheme
47) elacomine, alstonisine and spirotryprostatin A.128
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Scheme 47 An example of spirocyclisation128
Spirodienones have been synthesised via intermolecular ipso substitution from N-
methoxy-(4)-(halogeneophenyl) amides and hydroxyl (tosyloxy) iodobenzene
(HTIB)/trifluoroethanol (TFEA). This methodology was developed for the synthesis of
1-azaspiro-[4,5]-decane-mediated natural products-TAN1251A-D, FR901483I,
lepadiformine and cylindricine A-F.129 Furthermore, this methodology has been used by
Curran and de Turiso in the synthesis of spirocyclohexadienone intermediates, which
could be applied to synthesis of SR121463A and aza-galanthamine.130
2.12 Spirocyclisation followed by rearrangement reactions
In cases where there is a good radical leaving group α to the intermediate
cyclohexadienyl radical, it can undergo re-aromatisation with extrusion of the radical
leaving group; this can result in rearrangement as shown in this example Scheme 48.
Azacoumarins 194131 have been prepared by a unique double ipso substitution from aryl
benzoate 189. The reaction goes via an initial 1,5-ipso attack at the 2-position of the
pyridine 190 to generate the spirocyclised intermediate 191 followed by re-aromatisation
and fragmentation of the carbon-oxygen bond to furnish the carbonyloxy radical
intermediate 192. The aromatic carbonyloxy radical (k = 104-105 s-1) is considerably
slower than alkyl carbonyloxy radical (k = 108-1010 s-1), and allows the radical
intermediate 192 time to undergo a second 1,6-ipso attack at the methoxy position
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leading to the aryl radical intermediate 193. This is followed by extrusion of the
methoxy group to furnish the azacoumarin 194. It should be noted that the use of the
methoxy group was crucial to the whole rearrangement process.
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Scheme 48 Complex double ipso cyclisation to form azacoumarins131
3.0 Aryl migration
Aryl groups can undergo migration reactions132-134 generally via the intermediacy of a
spirocyclohexadienyl system followed by re-aromatisation and cleavage of the
appropriate bonds. Wieland135 first reported radical aryl migration reactions in 1911.
There has been an extensive investigation of 1,2-ipso aryl migrations, however, there are
currently no literature reports concerning 1,3-aryl migrations, though numerous
examples regarding 1,4-aryl migrations have been reported. The most frequent type of
aryl migrations are 1,5-migrations. In the example illustrated in Scheme 49,136
tributyltin-mediated radical abstraction of the iodo group in 195 generated the aryl
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radical intermediate 196, which underwent an initial 5-exo-trig cyclisation resulting in
the spirocyclic intermediate 197. Re-aromatisation and fragmentation gave the radical
intermediate 198. There were three possible pathways observed that can occur in this
system. The radical intermediate 198 can (A), undergo hydrogen atom abstraction from
tributyltin hydride to give the methyl ether 199 (6%); (B) undergo the slower 6-
endo/exo-trig cyclisation leading to the benzo[c]chromene radical intermediate 200
followed by re-aromatisation to the product 201 (27%); or (C) via a fragmentation
process leading to the phenol 202 (46%). This last step was not rationalised by
Harrowven and is currently under further investigation.
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Scheme 49 Harrowven’s intramolecular cyclisation of an aryl ether136
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Harrowven136 synthesised the natural product isoauparin 203 through the same
methodology as described above (Figure 1).
OH OMe
OMe
203
Figure 1 Structure of isoaucuparin
Under similar conditions, tributyltin hydride-mediated radical abstraction of the ortho
halo-compound 204 furnished the aryl radical 205 which underwent a 1-5-ipso attack to
give the spirocyclised radical intermediate 206 as depicted in Scheme 50. Re-
aromatisation to give 207 followed by possible hydrogen abstraction from another
molecule of tributyltin hydride resulted in the biaryl 208 via an aryl migration.98
Alternatively, the radical intermediate 206 underwent a neophyl rearrangement to give
theσ-complex 209 which upon oxidation (re-aromatisation) led to the benzo[c]chromane
210 (Me = 36%, OMe = 21%). In this reaction, the cyclisation via the neophyl
rearrangement was faster than the ipso substitution followed by fragmentation.
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Scheme 50 Intramolecular cyclisation of benzyl ethers
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Synthesis of biaryls can be achieved by nitrogen to carbon aryl migration. For example,
N-methanesulfonamide 211 is converted to the N-(3-arylpropyl) amide 214.139 Formation
of radical 212 by homolysis of the corresponding C-Br bond using tributyltin hydride
and AIBN led to a 1,5-ipso attack to furnish the spirocyclohexadienyl radical
intermediate 213, re-aromatisation followed by homolytic cleavage of the C-N bond
furnished the sulfonamide 214 in 72% yield as depicted in Scheme 51. The reaction
proceeds through a captodatively-stabilised spirocyclised radical intermediate 213. It is
noted that varying the type of substituent on the nitrogen atom, affects the outcome for
the rearranged product, as such, methanesulfonamide is more efficient (in furnishing the
rearranged product) than the methyl ester or p-toluenesulfonyl group. The same authors
used this approach for oxygen to carbon aryl migrations.138
N
O
O O
NH
O
O O
S
O
O
S OO
N
O
O
O
S
O
O
1,5-ipso
213
N
O
O O
S
O
O
Br
Bu3SnH/AIBN
211 212 214 72%
Scheme 51 Nitrogen to carbon aryl migration137
It is rarer but also possible to get migrations occurring in a 1,4-139-140 and 1,6- fashion.141
For example, treatment of the xanthate 215 with dilauroyl peroxide gave the radical
intermediate 216 which could then undergo a 1,4-ipso139 cyclisation leading to a
spiroazetidinone radical intermediate 217 as illustrated in Scheme 52. This was followed
by re-aromatisation and cleavage of the carbon-nitrogen bond, which gives an amidyl
radical intermediate 218. This can then abstract a hydrogen atom presumably from the
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solvent to furnish the rearranged product 219 in 71% yield. Radical 216 was hindered
from cyclisation onto the aromatic ring, due to steric effects when R = tert-butyl.
However if the nitrogen substituent is changed from the tert-butyl group to a methyl
group, then only the cyclised product 220 is observed in 39% yield.
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Scheme 52 Smiles rearrangement
An example of 1,6-migration is illustrated in Scheme 53. Tributyltin hydride-mediated
radical formation from the bromo compound 221 generated the aryl radical 222, which
underwent an 1,6-ipso attack onto one of the three phenyl rings attached to the silyl
group to give the spirocyclohexadienyl radical intermediate 223.142-143 Re-aromatisation
followed by homolytic cleavage of the carbon-silicon bond led to the silyl radical
intermediate 224. Extrusion of the silyl group furnished the biaryl alcohol 225 in 71%
yield. Phenyl migration from other groups was investigated. When the trimethyltin
(Me3Sn-) substrate was used, it did not form the expected rearranged product, but
instead the aryl radical intermediate 226 underwent a SH1 type of reaction to furnish the
bicyclic silylated product 227. Ring opening of the cyclic silyl ether with methyllithium
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furnished the silylated benzyl alcohol 228 in 84% yield. The use of a phenyl or methyl
group gave exclusively the rearranged product.
O
Si
OH
O
Si1-6-ipso
Ph
Ph
O
Si
Ph Ph
222 223 224
225
Ph
Ph
O
Si
RPh
Ph
221
Br
O Si
Ph
Ph Si
HO
O
Si
SnPh
Ph
71%228227226
a) R = Ph
b) R = SnMe3
Bu3SnH
AIBN
Bu3SnH
AIBN
SH
1
84%
Ph Me
H
Scheme 53 Silicon to carbon aryl migration142
Struder has extensively investigated aryl migrations of sulfur to carbon.132-133 The thia-
neophyl type 1,2-phenyl migration from sulfur to carbon is known144 however, there is
no radical 1,3-aryl migration of sulfur to carbon to date. The majority of sulfur to carbon
reactions involve 1,4-, 1,5- and 1,6 aryl migration. In the following example, Studer et
al.133 investigated radical 1,5-aryl migration from sulfur in sulfonates to secondary C-
radicals for stereoselective bond formations (Scheme 54). Starting from the iodide 229,
tributyltin hydride and AIBN generated the secondary alkyl radical 230 that could
undergo a 1,5-ipso attack into the phenyl ring to form the cyclohexadienyl radical
intermediate 231. Re-aromatisation fromβ-elimination gave the alkoxysulfonyl radical
intermediate 232. Extrusion of SO2 furnished the alkoxy radical 233 followed by H-
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abstraction to yield the product 234 in good yield (76%) and high selectivity (dr = 13:1)
for the unsubstituted aryl group.
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Scheme 54 1.6-ipso aryl migration134
3.1. Radical cyclisation and rearrangement reactions of aryl sulfonamides
The further reactions and discussions in this thesis focus on the reactions of
sulfonamides thus the following section comprises aromatic homolytic substitution and
rearrangement reactions of aryl sulfonamides.
3.2 Alkyl radical cyclisation and rearrangements from aryl sulfonamides
Speckamp and Köhler145 reported that sulfonamide 235 (Scheme 55) when suitably
substituted, could undergo a radical cyclisation reaction to give 236, if treated with
azobisisobutyronitrile (AIBN) and tributyltin hydride (TBTH). However in addition to
the cyclised products 236a-d, f, the rearranged products146 237a-f and reduced products
238a-f were also detected.
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Scheme 55 Speckamp sulfonamide reactions 1145
The effect of substituents 235a-f on the rate of reaction and ratios of all three products
was determined. While cyclised products 236a-d,f arise via cyclisation into the aromatic
nucleus (see Section 2.5) the rearranged product 237a-f were obtained by the attack of
the initial alkyl radical 239 (Scheme 56) into the aryl ring in an ipso 1,5 fashion,
resulting in a spirocyclised intermediate 240. Re-aromatisation and cleavage of the C-S
bond furnishes the sulfur centred radical 241 that upon elimination of SO2 furnished the
observed product via the aminyl radical 242. The cyclised product 236 (Scheme 55) was
formed from a 1,6 addition onto the aryl ring, while the reduced product 238a-f occurs
via reduction by TBTH of 239 prior to cyclisation.
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Scheme 56 Mechanism for rearranged amine 237
When the tosyl substrate 235a was dissolved in anisole at 22 °C for 24hrs, the cyclised
product 236a predominated (68%). Conversely, with diphenylether as the solvent
(190 °C/30min) the rearranged product 237a predominated (64%). This showed that
increasing the temperature alters the product distribution. Of course, if the ortho aryl
positions were blocked, as with the mesitylene derivative 236e, only the rearranged
product 237e was isolated. Further studies investigated the effects of changing the
initiating halogen on the product outcome.147 While the iodo-nitro derivative 235f as
depicted in Scheme 57 gave the rearranged product 237f in 56% yield.
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Scheme 57 Rearranged amide from nitro compound147
The corresponding bromide 243 furnished only the dimeric azo sulfonamide 244 in 51%
yield (Scheme 58). This indicated that azo formation was faster than the C-Br
homolysis. Therefore, only iodides were used in further investigations.
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Scheme 58 Dimerisation from nitro compound
In order to broaden the scope of their reaction, Speckamp and Köhler investigated
further changes to the aryl substituent. Heteroaryl sulfonamides were also tolerated, thus
a pyridyl sulfonamide 245, (Scheme 49) gave the expected rearranged product 246 in
30% yield, and the reduced product 247 in 28% yield, but no cyclised product was
observed.
N
SN
I
PhH, reflux
N
N
H
245 246 247
AIBN, Bu3SnH
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Scheme 59 Synthesis of rearranged amine from pyridyl sulfonamide
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When a 1-naphthyl sulfonamide 248, (Scheme 60) was treated under the standard
conditions described above, a novel dihydronaphthalene cyclised product 250 was
formed in 81% yield instead of rearrangement or oxidative cyclisation. The explanation
given was that the “orbital interaction between the allylic radical 249 and the extended
furtherπ-system is favourable”.147
S N
I
PhH, reflux
NS
H
H
248 250
AIBN, Bu3SnH
249
NS
H
H
H
O
O
O
O
OO
81%
Scheme 60 Cyclisation of 1-naphthyl sulfonamide
However, when the 2-naphthyl sulfonamide 251 (Scheme 61) was used, it led to the
cyclised product 252 in 28% yield and the reduced product 253 in 14% yield, with no
dihydronaphthalene derivative being isolated.
S
N
I
PhH, reflux
251 252 253
AIBN, Bu3SnH
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28% 14%
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N O
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Scheme 61 Cyclisation from 2 substituted naphthalene
3.3 Aryl radical cyclisation and rearrangement of aryl sulfonamides
While Speckamp investigated the addition of alkyl radicals onto aryl sulfonamides,
Motherwell has investigated aryl radical additions onto similar substrates. The two main
reaction modes (cyclisation and rearrangement) were also observed. This reaction has
been used as a new method of Ar-Ar coupling148 (Scheme 62). This has been achieved
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by reacting biaryl sulfonamides 254a-b with AIBN and tributyltin hydride. When
substituents are on the ortho position of the sulfonamide 255a (R1 = Me, R2 = H), they
undergo a 1,5 addition onto the second aryl ring which leads to the rearranged product
256a via the analogous pathway described earlier in Scheme 56. When the substitutents
are in the para position of the sulfonamide 254b they undergo a 1,6- addition leading to
a 1:1 ratio of cyclised 255b and rearranged product 256b.
N S
R1
R2
PhH, reflux
S
N
R1
R2
NH
R2
254a-b 255a-b 256a-b
AIBN, Bu3SnH
R1
O
O O O
I
+
a) R1 = CH3 , R
2 = H; b) R1 = H, R2 = CH3
Scheme 62 Motherwell’s synthesis of biaryls and cyclic sulfonamides
Similarly, to the Speckamp studies varying the type of substitutents on the ortho and
meta position of the aryl sulfonamide was investigated.149 Inclusion of a methylene
group between the aryl ring and the sulfonyl group 257 led predominately to cyclised
products 258 with no rearranged products detected by the 1,6 ipso mode. A number of
heteroaromatic sulfonamides were tested (Scheme 64)150 including thiophenes 259 and
quinolines 261 to furnish the cyclic sulfonamides 260 and 262 respectively.
I
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O
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Scheme 63 Examples of 1,7-ipso cyclisation reactions150
Inserting a further carbon between the aryl groups (but incorporating an alkene, i.e.
unsymmetrical stilbenes) led to loss of SO2 but via a different mechanism to that
previously discussed.151 Reaction of phenyl allyl sulfonamides 263 (Scheme 64) under
standard radical conditions (AIBN, TBTH) led to an intermediate 264 via a 5-exo radical
cyclisation onto the alkene. Elimination of sulfur dioxide subsequently yielded the
rearranged product 265.
S
N
I S
N
NH
R1
R2
263 264 265
R2
R1 OO
O
O
R1
R2
Bu3SnH
AIBN
Scheme 64 Motherwell’s stilbene synthesis
3.4 Related work
Speckamp has previously shown that the use of alkyl iodides was essential for
cyclisation/rearrangement with the use of bromides leading to alternative reactions i.e.
azo formation in the case of p-nitroaryl substrates 243 (see Scheme 58). In related work,
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bromoaryl)-benzenesulfonamides152 266 (Scheme 65) if treated with (Ph2HSi)2 instead
of TBTH could successfully be used to make the spirocyclised intermediate 267 which
went on to yield rearranged biaryl products 268 in 61% yield, following re-
aromatisation,
N
S
O
Br
SN
O
NH
O
266 267 268
1,5-ipso attack (-SO2)
OO
O
O
61%
Scheme 65 Togo’s synthesis of biaryls
Similarly, when sulfonamide xanthate 269 (Scheme 66) are treated with dilauroyl
peroxide (DLP), the ensuring alkyl radical 270 can undergo a 1,5-ipso addition to give
the spirocyclohexadienyl radical intermediate 271. Re-aromatisation led to the
amidosulfonyl radical 272 which upon extrusion of sulfur dioxide furnished the amidyl
radical 273 which gets reduced by 2-propanol to the rearranged amide product 274 in
81% yield.153
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Scheme 66 Zard’s rearrangement reaction of sulfonamides
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3.5 Clark’s work
While the majority of this previous work has involved the use of toxic Bu3SnH, work by
Clark154 has investigated whether similar reactions can be mediated by copper (I)
complexes.155 It was found that the tosyl amide 275 when treated with Cu(I)Cl and an
amine ligand led to a 1,5 addition into the aromatic ring forming an initial spiro-
compound 276, After re-aromatisation and loss of sulfur dioxide a novel rearranged
product 277 was formed in 30% yield as illustrated in Scheme 67. No 6-endo cyclisation
of 275 was observed.
CCl3
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S
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Cl
275 276 277
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O
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Tren
30%
Scheme 67 Clark’s synthesis of rearranged amides
Thus, the use of Bu3SnH is not essential to mediate these types of reactions. The
tremendous advantage of copper reagents is that the salts are inexpensive, and have a
long shelf life. They are also non-toxic and the workup at the end of the reaction is easy
to accomplish since purification consists of filtration using a small silica plug, and
flushing the compound with ethyl acetate. In contrast, the disadvantages of the tin
reagents are well known (eg toxicity, expense, the great difficulties encountered during
purification and workup) but they tend to lead to reduced products as well in these types
of reactions. This lowers the yield of the desired cyclised or rearranged product. The
copper salts do not suffer from this disadvantage.
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CHAPTER TWO
RADICAL REACTIONS OF N-BUTYL-
(SUBSTITUTED)-ARYL SULFONAMIDES
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1.0 Introduction
In light of the previous work discussed in Scheme 67, where substrate 275154 was
observed to undergo rearrangement to form the rearranged amide 277 under ATRC
conditions (see Scheme 68). It was decided to investigate this type of reaction
further. The product 277 was tentatively assigned from the crude NMR spectra, and
was not isolated pure, in addition, according to Wongtap,156 the product 277 was
contaminated with an uncharacterized product, tentatively assigned as the reduced
product (10:90), nor was an alternative synthesis to authenticate this product
proposed. The mechanism hypothesized for the rearranged amide was plausible,
according to Speckamp’s work. As has been previously shown that it is possible to
mediate conventional atom transfer radical cyclisation (ATRC)157-160 reaction of
unactivated bromides using copper bromide/TPA161-162 279.
CCl3
O
C
O
HNS
Cl
Cl
275 277
NO
O
CuCl
TREN +
CCl2
O
S N
O
O
H
reduced
Scheme 68 Clark’s synthesis of rearranged amides
The Clark group explored the rearrangement of unactivated bromide R = H 278 to
amide 281.163 In order not to complicate the analysis of these reactions due to
competitive cyclisation, the nitrogen group was changed from alkenyl 275 to N-butyl
278 as depicted in Scheme 69.
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Scheme 69 Murphy’s synthesis of rearranged amides
1.1 Aims and Objectives
The initial aim of this thesis was to determine the scope and limitation of this latter
reaction (Scheme 69) by investigating the effects of the aryl substituent (R) on the
efficiency of this rearrangement. Later chapters will investigate the effects of N-
substitution and the acyl group. During this work, the effects of temperature and
solvent will be investigated to determine whether this can influence the efficiency of
the rearrangement. In addition, it was anticipated that it might be possible to obtain
cyclised products by 6-exo cyclisation, into the aromatic ring and this was to be
investigated.
2.0 Synthesis and use of sulfonamide starting materials
In order to develop a synthesis towards compounds 278, a preparation of the N-butyl
substituted arylsulfonamides 283 was required. An initial synthesis of these classes
of compounds is shown below (Scheme 70). A range of commercially available
arylsulfonyl chlorides 281a-m as illustrated in Table 1 were carefully selected for
this study, as it was necessary to have an array of electron withdrawing and electron
donating substituents for kinetic studies.
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Scheme 70 Synthesis of starting sulfonamides
The Clark (Fullaway) group163 had previously developed a process towards substrate
278e, thus arylsulfonyl chlorides 281a, e-f (1.0 eq.) were treated with n-butylamine
282 (1.0 eq., pKa ≈11)164 and triethylamine (TEA) in dichloromethane (DCM),
followed by acidic work-up to furnish the arylsulfonamides 283a-l. A similar method
developed by Miyaka’s165 involved equimolar amounts of the arylsulfonyl chloride
281, n-butylamine 282 and triethylamine Method A followed by aqueous work-up
that was successful in the majority of cases. An alternative approach utilised n-
butylamine 282 (3.0 eq.) alone in diethyl ether Method B. Arylsulfonamides 283a-l
were purified either by recrystallization166 (using diethyl ether/hexane), or by flash
chromatography.167 Method B gave higher yields for most substrates, as little
purification was required. Purification of 283g using flash chromatography (petrol
ether/ethyl acetate 6:1) furnished low yield (26%). In addition, purification of the 2-
cyano substrate 283m using column chromatography failed. In light of these results,
either Fullaway’s method or Method B furnished excellent yields of
arylsulfonamides 283.
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281 283
Entry Substrate Method Entry Substrate Yield (%)
281a H B 283a H 99168
281b 4-F B 283b 4-F 90169
281c 4-Br B 283c 4-Br 77170
281d 4-I B 283d 4-I 86171
281e 4-CH3 B 283e 4-CH3 89
172
281f 2,4,6-CH3 A 283f 2,4,6-CH3 a
281g 2-Naph. A 283g 2-Naph. 26173
281h 4-OMe A 283h 4-OMe 90174
281i 4-CN B 283i 4-CN 80175
281j 4-NO2 B 283j 4-NO2 87176
281k 4-CF3 B 283k 4-CF3 92
281l 3,5-CF3 A 283l 3,5-CF3 62
281m 2-CN A 283m 2-CN 0177
a Gift from D. Fullaway.
Table 1 Synthesis of N-butyl-arylsulfonamides 283a-m.
2.1 Synthesis and use of the radical precursor 278
With a range of sulfonamides 283a-l in hand, the next goal was to react these with
the appropriate acid bromide 284, to prepare a range of radical precursors 278a-l
suitable for investigation (Scheme 71).
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Scheme 71 Synthesis of radical precursors 278
The primary method involved reacting sulfonamides 281b-c,j with 2 equivalents of
1.6M n-butyllithium (pKa≈48) in anhydrous THF, followed by addition of the acid
bromide 284. Unfortunately, upon scrutiny, this approach gave numerous
unidentifiable products that could have been due to the concentration of n-
butyllithium and consequently an improved procedure was required. Fullaway163
devised a good method toward the radical precursors 278 using equimolar quantities
of 1.6M butyllithium, the acid bromide 284 and starting sulfonamide 283. The
highest yield was for the p-tosyl compound 278e in 79% yield, followed by the
phenyl compound 278a in 48% yield. However, there was negligible yield obtained
for the mestylene compound 278f (7%), which could be attributed to steric effects
from the two ortho methyl groups. The reaction conditions were modified (according
to Fullaway’s method) so that only 1 equivalent of 1.6M n-butyllithium (1.0 eq.)
Method A was used in the reactions. This significantly enhanced the reaction yields
though considerable quantities of the eliminated acrylamides178 286a-l (see Figure 2)
were isolated (tentatively assigned by NMR). However, good yields for the 4-bromo
derivative 278c in 70% yield, 4-trifluoromethyl derivative 278k in 70% yield and 4-
CN derivative 278i in 56% yield were achieved. To confirm the identify of 286a-l,
the parent 286a was prepared unambiguously as below and its NMR spectra was
compared to that obtained using Method A (Scheme 72).
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Scheme 72 Synthesis of eliminated product 286a
Due to the formation of unwanted elimination product 286a, an alternative method
was used for the majority of the rest of the precursors. This involved changing from
n-buytllithium to triethylamine (2.0 eq., pKa ≈11) Method B as a base. For the
majority of reactions, this procedure produced poor (<32%) 278e-g,j to fair (<58%)
278a-b,d,h yields of the desired products. In the case of the 4-nitro derivative 278j
even with one equivalent of triethylamine, a small amount of the eliminated
acrylamide 286j was detected. In order to resolve this problem, a hindered base
(N,N-diisopropylethylamine, Hünig’s base, 1.3 eq.) Method C was used to hinder
competing E2 elimination. Although no elimination occurred, the reaction was
significantly impeded, so that unreacted 284 was hydrolysed to the corresponding
acid upon work-up. However, in the case of 3,5-trifluoromethyl derivative 278l this
approach was successful. All products were purified by flash chromatography to give
sufficiently pure products that could be used for further studies (see Table 2).
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Entry Substrate Meth Method Yield (%)
278a H B 58 (48)163
278b 4-F B 52
278c 4-Br A 70
278d 4-I B 43
278e 4-CH3 B 22 (79)
163
278f 2,4,6-CH3 B 22 (7)163
278g 2-Naphthalene B 18
278h 4-OMe B 48
278i 4-CN A 56
278j 4-NO2 B 32
278k 4-CF3 A 70
278l 3,5-CF3 C 67
Table 2 Synthesis of the N-butyl-arylsulfonamides radical precursors
278a-l.
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Figure 2 Structure of eliminated product 286
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3.0 Synthesis of the amine ligand-TPA 279
One of the most important reagents involved in these radical reactions is tris(2-
pyridylmethyl)amine (TPA). As will be explained shortly, the amine can interact
with copper salts to form a soluble copper-amine ligand complex. The synthesis of
TPA 279 was relatively straightforward using Geden’s method.162
3.1 Reaction of parent compound 278a with copper (I) salt/ TPA complex
As previously mentioned in Scheme 67 initial work on substituted arylsulfonamides
278 using copper (I) salts and tren154 showed that a rearrangement to 277 could take
place. Later work using copper (I) salts and TPA 279 as ligand (instead of tren)
improved yields. Consequently, a series of experiments were conducted using the
phenyl substrate 278a as depicted in Scheme 73. Heating a mixture of sulfonamide
278a (1.0 eq.) with equimolar amounts of copper (I) bromide (1.2 eq.) and TPA 279
(1.2 eq.) in refluxing toluene for 48 hours, led to complete disappearance of starting
material. Analysis of the crude NMR (see Appendix 1) showed two products in a
ratio of 1:5. The minor component was identified as the rearranged amide 280a. The
structure for 280a was determined by 1H NMR as shown in Figure 3.
S
O N
O O
Br
CuBr/TPA
Toluene, reflux
O
HN
278a 280a
Scheme 73 Reaction of radical precursor with CuBr and TPA 279
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Figure 3 1H NMR assignment of phenyl rearranged amide
Analysis of the phenyl rearranged amide 280a was made by 1H NMR. Characteristic
data involved a multiplex 7.4-7.25 (5H) for aromatics. A singlet at 1.55 for the
dimethyl groups (6H), and peaks characteristic of the n-butyl group (2.92 (t), 1.46-
1.39 (quintet), 1.33-1.23 (sextet), 0.80 (t,). The N-H group appeared as a broad
singlet at 5.41ppm. The major product Figure 4 showed four distinct aromatics
peaks indicative of a cyclised product which was tentatively assigned as 287.
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Figure 4 Structure of the proposed cyclic sulfonamide 287
Mechanistically this would arise from cyclisation of the radical 288 into the aromatic
ring to give 289 followed by re-aromatisation to furnish the cyclic sulfonamide 287
as depicted in scheme 74.
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Scheme 74
Proposed mechanism for the formation of the cyclic sulfonamide 287
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3.2 Purification of the radical products
The reaction of the phenyl derivative 278a was monitored by TLC, which showed
two products tentatively identified as the cyclised product 287 and the rearranged
amide 280a. Due to the close proximity in Rf values between the starting material
278a and the cyclic sulfonamide 287, determining the end point of the reaction was
very difficult. Further difficulty involved visualisation of the products, which were
present in minor quantities. Isolation of the cyclised and rearranged products was
achieved using careful flash chromatograph and 1H NMR analysis of individual
column fractions.
3.3 Characterisation of cyclised material 287
While full characterisation data for 287 and 280a was obtained, the mass spectra (EI
or LSIMS-FAB) was lacking an M+ for 287 (RMM = 281.1086) and instead M+-SO2
was observed (RMM = 217.1459). The extrusion of SO2 in mass spectrometry of
cyclic sulfonamides is well known and examples where an M+ cannot be found are
present in the literature. Instead M+-SO2 was observed and reported.179 However,
while there was precedent for the extrusion of SO2 in mass spectrometry, in order to
be certain of the assignment of 287 a sulfur analysis was obtained. Theoretically, this
should be 11.4%, instead only 0.43% was detected indicating minimal sulfur. A
CHN analysis was also obtained. Theoretically this should be C, 64.2; H, 7.2; N, 17.2
for 287 instead the values obtained were C, 74.2; H, 8.6; N, 6.0. Thus it was very
likely that no SO2 was present in the product 287, and that the M+ peak at 217 is not
M+-SO2 , but the correct mass for the molecular ion. Another technique to determine
the presence of sulfur may be the use of 33S NMR.180-181 However this was not
attempted. The major disadvantage being the small gyromagnetic ratio (1/13 that of
1H) and low natural abundance (0.75%), that makes determining the small quantity
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of sulfur in the product 287 very difficult. An alternative approach for determining
the sulfur analysis would be either ICP-Emission, at minimum of 50μg/L of sulfur or
ICP-MS, at minimum of 500μg/L.182 Other techniques not used but might be useful
for analysis are 15N NMR183, 184 or the use of 17O NMR185 which might show a
change in the carbonyl group. For amides, this is typically around 300ppm when
using dioxane as the NMR standard. The difficulty with 17O NMR is again associated
with low natural abundance (0.037%) and sensitivity 105 less than a proton. A
literature search suggested that the 13C NMR186 data for the current compound
matched that for the known oxindole 290 (Figure 5). Based on these results, it would
appear that the cyclised material was 290 and not 287 (see Appendix 2).
N
O
290
Figure 5 Structure of the oxindole 290
Whilst this was not the expected result, it was clear that further work would be
required in order to obtain the cyclic sulfonamides if they were needed for the future.
These compounds are pharmacologically important. They have well-known diuretic,
antihypertensive, and anticonvulsive properties.187 Although the cyclised sulfur
compound 287 is not known, the related compound 302 has been reported in the
literature.187 Treatment of o-nitrotoluene 291 (Scheme 75), with diethyl oxalate 292
in sodium ethoxide (generated in-situ from sodium metal and ethanol), led to o-
nitrophenylpyruvic acid ethyl ester 293. Hydrolysis of the ester led to the o-
nitropyruvic acid derivative 294. Treatment of 294 with hydroxylamine
hydrochloride 295 furnished the o-nitropyruvic acid oxime 296. Hydrolysis and
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decarboxylation of the oxime 296 with acetic anhydride yield the o-
nitrobenzylcyanide 297. Hydrogenation of 297 with palladium on charcoal in
absolute ethanol, and hydrogen gas at 50Ib/psi atmosphere furnished the o-
aminobenzylcyanide 298.188 Diazoniation of 298 from sodium nitrite and
hydrochloric acid, followed by addition of sulfur dioxide and copper(II)chloride led
to the o-sulfonyl chloride derivative 299. Treatment of 299 with n-butylamine 282
furnished the arylsulfonamide derivative 300. Hydrolysis of the nitrile group gave
the acid derivative 301, and this was followed by acid-induced cyclisation to give the
cyclic sulfonamide 302.189
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Scheme 75 Synthesis of the cyclic sulfonamide precursor
Theoretically it should be possible to methylate 302 to the cyclic sulfonamide 287 as
depicted in Scheme 76, which would allow Clark and Murphy to unambiguously
determine if this product was presenting the crude NMR of 290. This synthetic
approach however proved too lengthy (nine steps)187-189 and was not undertaken.
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Consequently, the structure of the oxindole 290 has been confirmed by comparison
to the literature data.190
N
S
O O
O
N
S
O O
O
NaH, MeI
302 287
Scheme 76 Methylation of the sulfur precursor 287
3.4 Potential mechanism for oxindole formation
Other groups have noted extrusion of SO2151 during cyclisation of sulfonamides. In
the following example, vinylic sulfonamide 303 (Scheme 77) when treated with
tributyltin hydride and AIBN furnished the aryl radical intermediate 304. This could
undergo a 1,6-exo attack onto the alkene to form the cyclic radical intermediate 305.
Ring opening followed by extrusion of sulfur dioxide led to the amidyl radical
intermediate 306. Addition of the amidyl radical via 1,5-exo attack onto the alkene
gave the oxindole radical intermediate 307, which followed by H-abstraction of
tributyltin hydride formed the oxindole derivative 308.
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Scheme 77 Motherwell’s synthesis of an oxindole from sulfonamide
Motherwell has shown that radical cyclisation of vinylic sulfonate 309 (scheme 78)
occurs similarly to give the 6-exo-product 311 in 70% yield, along with a minor
amount of the ring contracted ether 310 in 5% yield via extrusion of SO2.152
However, no analogous pathway to these observations is available in the current
reaction to give oxindole 290.
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Scheme 78 Motherwell’s cyclic ether synthesis via SO2 extrusion
Alternatively, the oxindole 290 may be formed by direct cyclisation of the amidyl
radical.191 In the following example, xanthate 312 (Scheme 79) when treated with
dilauroyl peroxide generated the alkyl radical 313, which underwent an
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intermolecular attack onto the alkenyl group of the N-allylsulfonylamide 314. This
was followed by formation of the N-amidosulfonyl radical intermediate 315 and
extrusion of sulfur dioxide to give the amidyl radical intermediate 316 followed by
rapid 5-exo cyclisation onto the terminal alkene to furnish the lactam radical
intermediate 317. The radical intermediate 317 can undergo addition to another
molecule of 312 to give the lactam 318 and regenerating the radical 313, which could
undergo the whole radical process described above.
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Scheme 79 Zard’s synthesis of pyrrolidines through sulfonamides
Consequently in the current reaction, the oxindole 290 (Scheme 80) may be formed
by cyclisation of the amidyl radical 322 generated from the tertiary radical 319 via
1,5-ipso cyclisation and re-aromatisation to give 321 followed by loss of SO2.
Addition of the amidyl radical onto the aromatic ring followed by oxidation
(presumably via Cu(II)Br2) would yield the oxindole 290.
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Scheme 80 proposed synthetic approach to oxindole
Alternatively, it may be possible that oxindole 290 forms via extrusion of SO2
directly from the cyclic sulfonamide 287 as depicted in scheme 81.
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Scheme 81 Proposed synthetic approach to oxindole
It should be possible to determine which of these two mechanisms is operating if a
substitutent is appended to the aromatic ring. This is because both mechanisms lead
to different regioisomeric oxindoles (Scheme 82).
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Scheme 82 Proposed mechanisms for regioisomers
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The final solution would be to complete an unambiguous synthesis of each of the
regioisomers themselves. However, before this mechanistic curiosity could be
addressed, it was necessary to a) determine if this was a general reaction, b) optimise
the reaction conditions to increase the yield of the reaction, and c) observe if it was
possible to alter the ratio of the two products under different conditions.
An investigation towards the reaction of the phenyl derivative 278a (Scheme 83)
under two experimental constraints were made. The first was to investigate the
amount of copper (I) bromide and TPA 279 required to give complete conversion of
the radical precursor 278a to products, and establish the effect on product outcome.
Secondly, the role of using different temperatures to determine product outcome was
studied as depicted in Table 3. For these experiments, both toluene and
dichloromethane were used as these solvents are common solvents in ATRC. Typical
experimental conditions are as follows: To a small three-necked flask was added the
radical precursor 278a (1.0 eq.), copper (I) bromide (1.2 eq.) and TPA 279 (1.2 eq.).
Toluene or dichloromethane was added via syringe. The reaction mixture was heated
under a nitrogen atmosphere at reflux for a specified time. The reaction was
quenched with ethyl acetate and the solvent evaporated in-vacuo to yield a brown or
green crystalline solid. The crude product was obtained using ethyl acetate as the
eluent and filtered through a silica plug to remove the inorganic copper residue.
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Scheme 83 Phenyl sulfonamide radical reaction
Entry
278a
Reaction conditions Conversion
%
Mass
balance %
Ratio
280a:290
I PhMe, rt, 96h 0 100 0:0
II DCM, rt, 168h 33 65 1:0
III PhMe, 50 °C, 18h 12 83 1:1
IV DCM, 37 °C, 18h 100 78 1.4:1
V PhMe, 110 ºC, 12h 100 72 0.3:1
VI PhMe, 110 ºC, 48h 100 66 0.2:1
Key: Mass balance is defined here as the mass of the crude product isolated, divided by the mass of
radical precursor 278a used, expressed as a percentage. Conversion is defined here as the amount of
[cyclised:rearranged] product obtained in the reaction minus the radical precursor, i.e. no radical
precursor in NMR = 100% conversion to products.
Table 3 Table for the parent substrate 278a in solvents at varying temperature
[I]: At room temperature, the CuBr/TPA ligand complex was insoluble in toluene
and that the temperature was insufficient to generate a reaction. Consequently, only
starting material was re-isolated (100%).
[II]: In order to determine if a more polar solvent such as dichloromethane (DCM)
would increase the solubility of the CuBr/TPA complex ligand (L) and thus facilitate
the reaction at room temperature, the solvent was changed for this reaction. Notably
under these conditions it was possible to mediate the reaction, however, it was
relatively slow [67% starting material remained after 168h]. Moreover, only the
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product assigned as the rearranged amide 280a was detected, no oxindole 290 was
isolated. The increase in solubilization of the CuBr/TPA ligand complex (L)192 is
important in facilitating this reaction. The solvent can also change the redox potential
of Cu(I)/Cu(II) salts,193 and by participating in bonding to the copper ligand complex
geometry.194 Thus in DCM there may be a change in redox potential which helps to
facilitate carbon-bromide bond homolysis. This eventually leads to the rearranged
product 280 (and cyclised product). Electrochemical studies195 using cyclic
voltammetry have provided proof that a change in redox potential occurs with
different solvents.
[III]: Heating in PhMe for 18h at 50 °C did facilitate the reaction although it
proceeded slowly, with only a small amount (12% conversion) of two products being
produced in roughly 1:1 ratio, although the inaccuracy of this measurement is large
due to small amounts of material in the crude NMR and the errors in integration of
1H NMR signals. The formation of an equal amount of the cyclised product 280 and
the rearranged amide 290 would indicate that the CuBr/TPA ligand complex was
more active than in experiment I. This is presumably due to the increased
temperature at which the reaction was conducted leading to better solubility of the
Cu complex.
[IV] Having observed that the reaction proceeded, and a possible selectivity for the
rearranged product 280a in DCM at RT, the next task was to increase the
temperature, in order to force the reaction to completion. Thus heating at 37 ºC for
18h allowed the reaction to go to completion, although now the major product was
the rearranged 280a instead of the cyclised 290 product. In this reaction, the increase
in temperature has improved the solubilisation of the ligand complex and also the
rate of reaction. The selectivity towards the rearranged amide, might be due to more
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efficient H-abstraction of the amidyl radical intermediate 322 from dichloromethane
of higher temperatures. This hypothesis could be tested by using a poor hydrogen
donor as the solvent under the same conditions (i.e. tert-BuOH) or increasing the
temperature further.
[V]: The previous reactions with toluene [I] and [III] showed very poor turnover and
solubility of the ligand complex. When the reaction was repeated in refluxing toluene
for 12 hours the reaction proceeded to completion, but now the cyclised product 290
predominated. The reaction was shown to be complete (100% conversion) producing
the two compounds 280a/290 in a 0.3/1 ratio. The increase in temperature has
improved the rate of reaction as expected. However contrary to the reaction in
toluene the oxindole now predominates indicating that the rate of cyclisation is
greater than H-abstraction in toluene at higher temperature
[VI]: In order to determine whether an increase in time would alter the product
distribution (i.e. to determine if the reaction was under kinetic or thermodynamic
control), the reaction was repeated in refluxing toluene for 48 hrs instead of 12 hrs.
However, heating for 48 hours (four times the length as in entry V) furnished only a
similar yield and ratio of products, 0.2/1 (within the level of accuracy of
measurement by NMR). This would indicate that increasing the time does not change
the outcome in terms of either selectivity or overall yield. This suggests either the
reaction is under kinetic control or the reaction has reached its thermodynamic
equilibrium after 12 hrs. Experimental work should be conducted to determine the
precise time taken for complete conversion to products.
Summary:
The results indicate that CH2Cl2 is a superior solvent with respect to the
rate/conversion of the reaction than toluene is at the same temperature. This is
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presumably due to the improved solubility of the CuBr/TPA complex in this solvent.
Conducting the reaction at higher temperatures appears to increase the proportion of
cyclic material with DCM at 37 ºC, preferentially giving rearranged amide 280a
while toluene at 110 ºC preferentially furnished oxindole 290. This was interesting
since similar work by Speckamp145 on related systems has shown that lower
temperatures generally led to cyclised products (anisole, RT, 24h), while rearranged
amides were furnished with elevated temperatures (diphenylether, 190 °C, 0.5h).
Having shown that the product ratio was sensitive to temperature the following
experimental work involved investigating the effect of five further solvents, notably
methanol, THF, MeCN, H2O, BMIM BF4 (a common ionic liquid), all at the same
temperature (Table 4).
S N
O Br
N
O
+
O
HN
278a 290280a
CuBr, TPA 282
O
O
Entry
278a
Reaction
Conditions
Conversion
%
Mass
balance
Ratio
280a:290:X a
VII MeOH, 50 ºC, 18h 69 66 2:1:3
VIII THF, 50 ºC, 18h 88 54 2:1:0
IX H2O, 50 ºC, 18h 100 51 2:1:0.2
X MeCN, 50 ºC, 18h 100 74 1:0:6
XI BMIM BF4, 50 ºC, 18h 100 13 0.1:1:0.2
a Significant amounts of uncharacterised by-product.
Table 4: Effects of solvent on product distribution.
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Brief observations:
[VII]: The solubility of the copper ligand complex (L) was improved relative to both
toluene and DCM using methanol but NMR analysis showed that the reaction had
only gone to 66% completion after 18 hours and that it showed significant amounts
of uncharacterised by-products.
[VIII]: In the copper ligand complex (L) was readily solubilised. The reaction was
faster than in MeOH, with analysis showing the reaction had gone to 88%
completion after 18 hours. It was also cleaner than in MeOH with no by-products
detected.
[X]: In this experiment deionised water was degassed with nitrogen for fifteen
minutes. Excellent solubility was observed with the copper ligand complex (L).
There was complete conversion to products. However minor amounts of similar by-
products to those detected in MeOH were produced.
[IX]: Acetonitrile readily solubilised the copper ligand complex (L). Acetonitrile is
often the choice solvent for ATRC reactions, however the reaction was not clean
giving significant amounts of unidentifiable products which precluded all efforts to
separate them in order to glean spectroscopic information.
[XI]: N-butyl-N-methyl imidazolium tetrafluoroborate was used as an ionic liquid in
order to investigate the effects of a polar environment. There was complete
conversion to products under these conditions and this was selective towards the
cyclised material 290 although the low mass balance was disappointing and was due
to difficulty in extracting the products from the ionic liquid.
While all these solvents were able to facilitate the reaction to a certain extent, the
reactions were messy with numerous compounds being produced in addition to the
compounds of interest (Appendix 3). Ligand complex solubility was markedly
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improved in all the solvents compared relative to toluene; however, they did not
enhance the selectivity for either of the products 280a/290 to a synthetically useful
level. The exception was THF, which was cleaner and gave the ratio of 280a/290 as
2/1 although only to 88% conversion. There were some difficulties with extraction of
the crude products from some of the solvents. With highly solubilised ligand
complex, the light green copper (II) bromide is sometimes present along with the
crude products. This is evident from the 1H NMR which shows peak broadening due
to paramagnetic Cu2+ ions ([Ar]3d9).196
Although not fully characterised, it seems that the minor components
(uncharacterised by-product) consist of 286a, the corresponding sulfonamide 283a
and the reduced178 product 323 (Figure 6). It became clear that the cleanest reactions
with the best mass balance involved using either DCM or toluene.
N
H
O
S
O
O
323
Figure 6 Phenyl reduced product 323
The most probable explanation for the formation of the reduced product 323 from
some of the reactions would be H-abstraction from the solvent by radical 319
(Scheme 84). An alterative mechanism would be via an initial intramolecular 1,5-H
abstraction 319 to 324 followed by reduction of 324 by the solvent.
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Scheme 84 Potential mechanism for the reduced product 323
Other reactions that could come from the secondary alkyl radical intermediate 324
could give further products that may be contained in the uncharacterised mixture of
products. Thus a 1,5-ipso attack of 324 to furnish the cyclohexadienyl radical
intermediate 325, followed by re-aromatisation and extrusion of sulfur dioxide to
give the amidyl radical intermediate 326 could occur (Scheme 85). At this juncture,
the amidyl radical intermediate 326 can be quenched via the solvent to give the
rearranged amide 327 or undergoes cyclisation into the aromatic ring, followed by
oxidation to the oxindole 328. Alternatively, the alkyl radical intermediate can
undergo direct addition into the aromatic ring to furnish the cyclic sulfonamide 329,
followed by loss of sulfur dioxide and subsequent amidyl radical addition into the
aromatic ring to furnish 328.
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Scheme 85 Proposed mechanism based on 1-5 ipso and direct cyclisation
4.0 Use of tosyl sulfonamide 278e and mechanistic insights into oxindole
formation
Having investigated the effects of the copper (I) bromide-TPA ligand on the neutral
phenyl derivative 278a, and determining that under certain solvent conditions, that it
was possible to obtain either the rearranged amide 280a or the cyclised product 290,
attention was turned to substrates with varying groups on the sulfonamide aromatic
ring. The purpose was to determine the effect of the copper (I) bromide-TPA and
solvent effects on product outcome. The first substrate investigated was the tosyl
derivative 278e (Figure 7).
S
O
O
N
O
Br
Figure 7 Structure of the tosyl radical precursor 278e
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4.1 Introduction
Early work by Clark and Fullaway163 showed reacting 278e CuBr and various amine
ligands could furnish the rearranged amide 280e and a cyclised product initially
proposed as the cyclic sulfonamide 332. A series of amine ligands were used in
conjunction with Cu(I)Br to form the ligand complex (L). The first experiment
involved reaction of 278e, bipyridine (2.0 eq.) and CuBr (2.0 eq.) in dichloromethane
to furnish exclusively the rearranged amide 280e but only in 26% yield. The
following reaction involved using pentyl-pyridin-2-ylmethyleneamine 330 (3.0 eq.)
and CuBr (2.0 eq.) in dichloromethane. Again only the rearranged amide was
isolated in poor yield (21%). Further work involved using [1,10]-phenanthroline 331
(2.4 eq.) and CuBr (1.2 eq.) in dichloromethane gave no reaction. The reaction
conditions were improved when equimolar amounts of tris(2-pyridinylmethyl) amine
(TPA) and CuBr in dichloromethane (30 mL) were used. In this case, the rearranged
amide was produced in good yield (56%). Remarkably, when the reaction was
repeated with equimolar amounts of TPA and CuBr in dichloromethane (5 mL) this
led to a cyclic product that was believed to be the cyclic sulfonamide 332 and the
rearranged amide 280e in 54% yield. The only difference in reaction conditions
being one of concentration.
N N
N N
S
O
O
N
O
Br Amine CuBr
DCM
H
NO
S
OO
N
O
+
N
N
N
NAmine =
278e 280e 332
330 331279
Scheme 86 Fullaway’s synthesis of rearranged amide and cyclic product
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Mass Spectrometry of the cyclic compound 332 showed an M+ (RMM = 231), which
was contrary to the expected M+ (RMM = 295). This could only occur from M-SO2,
indicating that it was most likely the oxindole 333 (Figure 8) and that the Clark
group165 had wrongly assigned the cyclic compound as 332 and not as oxindole 333.
No elemental analysis was done, nor an unambiguous synthesis of the sulfur
compound 332 or oxindole 333 to adequately prove the structure of the cyclic
compound. Consequently, the next step was to re-investigate this reaction.
N
H
H
H
O
333
Figure 8 Structure of oxindole 333
In the previous section, it was postulated that there were two possible mechanisms
(Scheme 82) for the formation of the oxindole product 290 and that carrying out the
reaction would allow determining which of these two mechanisms is operational.
Thus the reaction of the tosyl analogue 278e CuBr/TPA was further investigated. The
presence of the para-methyl substituent would give a structural handle to determine
how the reaction proceeds. If the mechanism goes via extrusion of SO2 from the
cyclised compound, 334 then oxindole190 isomer 333 would be produced, if the
oxindole occurs from cyclisation of the amidyl radical 335, the alternative oxindole
isomer 336 should be detected.
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Scheme 87 Proposed mechanisms for the oxindoles 333 and 336
Reacting bromide 278e with copper bromide/TPA in PhMe at reflux for 24h [I]
furnished three products in a combined 94% overall yield. Chromatography of the
mixture separated the rearranged amide 280e but the other two compounds eluted
together. These two inseparable compounds were tentatively identified as the two
possible oxindole regioisomers 333:336 in a 0.03:1 ratio.
4.2 Proposed methods for separation of regioisomers
In order to unambiguously assign the structures of the cyclised products it was
necessary to separate them. However, several problems were encountered with
separating these products, due to the close proximity of the Rf valves of the radical
precursor 278e and both the desired cyclic compound(s) 333 or 336. The use of flash
chromatography to isolate the products pure through individual column fractions was
not sufficient to separate the regioisomers. Several methods have been used to prove
regioisomeric oxindole structure and there has been some success in separating
oxindole mixtures (by other researchers).
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Structure determination.
 NMR spectroscopic techniques197 for determining regioisomeric oxindoles:
(1) NOE198 (2) HMBC198 (3) HETCOR199 (4) INEPT199 (5) COSY199
INADEQUATE.200
 (1) X-Ray Diffraction,201 X-Ray Crystallography202
Separation
 Separation techniques for isolating regioisomeric oxindoles: (1) Reverse-
Phase Column Chromatography,203 (2) HPLC-UV detector203 (3) Reverse-
Phase HPLC,204 (4) GLC204 (5) MPLC.205
 Capillary Electrophoresis206
However while the methods could have been used to separate the products,
ultimately an unambiguous synthesis of both of them was required.
a) Preparative TLC was used for small quantity of products (<100mg),
unfortunately, the products could not be separated because the Rf values were
too close.
b) Preparative HPLC was available at Warwick, although due to high demand, it
was not possible to use this method continuously.
c) GLC was available at Warwick, but again due to high demand, it was not
possible to use this method continuously.
One main problem with the separation and identification of the regioisomeric
oxindoles was the low yield that they were isolated in. The maximum obtained was
50mg. An INADEQUATE experiment was attempted, but failed to provide good
spectra, due to insufficient products.
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4.3 Radical reaction of tosyl precursor 278e
The identification of the major cyclised compound was accomplished by
synthesising the oxindole 333 unambigiously. This was achieved using a
modification of the Stollé synthesis (Scheme 88). In the original method, Stollé207, 208
had reacted α-chlorocarboxylic acid chlorides with alkylated anilides to furnish
precursors 337 for intramolecular Friedel-Craft alkylation reactions. The
intramolecular Friedel-Craft alkylation was mediated using aluminium chloride to
furnish the oxindoles 338.
N
R1
O
Cl
R
N
R1
O
R
AlCl3
Stolle
337 338
Scheme 88 Stollé synthesis
For 333 a variation to this approach was used,209-212 namely preparing the related
bromo-analogue 341 as outlined in Scheme 89.
NH2
a
NH
b
N
O Br
N
O
c
+NH
339 340 341]
333340
Key: (a) (i) NaH, DMF, (ii) n-BuI, RT, 24h; (b) TEA, 284, RT, 3h; (c) AlCl3 Anh. 50ºC at 10 min.
then 160ºC at 60 min.
Scheme 89 Synthetic route toward the oxindole 333
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This approach was used to prepare a sample of the oxindole 333 although some
hydrolysis of the amide bond in 341 occurred under the reaction conditions. With
333 in hand, it was possible to determine that this oxindole was the minor component
of the two cyclised products (1:0.03) obtained in the copper-mediated reaction of
278e.
4.4 Attempted synthesis of the major oxindole 336
In order to be certain that the major cyclised product resulting from the copper-
mediated reaction was the regiomeric oxindole 336 it was necessary to make an
authentic sample of this compound as well. The outline of the synthesis is shown in
Scheme 90. The oxindole 336 was prepared using the same procedure as used for the
minor product 333. Although two regioisomers 346 and 336 were obtained (again
inseparable), the proton NMR spectra obtained from this crude mixture, tentatively
shows the product from the copper reaction to be the oxindole 336, (see Appendix
4). Whilst it cannot be said with 100% certainty, it is likely that the major cyclised
product is the oxindole 336 due to these spectral similarities. This would have been
formed via the amidyl radical intermediate 335 cyclising onto the aryl ring (335 to
336 as depicted in Scheme 87. Due to time constraints, it was not possible to repeat
this experiment. The methyl analogue of oxindole 336 has been synthesised by
Nishio’s178 group (Figure 9) and NMR was consistent with assignment of 336.
N
O
H
H
Hd
d
d
d = doublet
342
Figure 9 Structure of Nishio oxindole 342
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Key: (a) (i) NaH, DMF, (ii) n-BuI, RT, 24h; (b) TEA, 284, RT, 3h; (c) AlCl3 Anh. 50ºC at 10 min.
then 160ºC at 60 min.
Scheme 90 Synthesis of oxindole 336
4.5 Authentic synthesis of the rearranged amide 280e
Having proven the identity of the two oxindoles 333 and 336 the next step was to
prepare an authentic sample of the rearranged amide 280e for comparison with that
obtained from the reaction of 278e. This approach involved the dialkylation of the
known ester 347.213-216
O
O
O
O
O
O
H
Method A-C
Method D-E
O
O
O
O
347 348 349
+
Scheme 91 Synthesis of the di-methylated product 348
The first method for dialkylation investigated involved treating the ester 347 with
sodium hydride (2.2 eq.) in anhydrous THF followed by iodomethane (2.2 eq.) at
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room temperature for 48 hours (Method A).216-217 Analysis of the crude reaction
mixture by NMR showed that the reaction had failed to provide 348, and that only a
monomethylated product 349 had been formed. In order to push the reaction to
completion, the monomethylated product 349 was re-exposed to the reaction
conditions (i.e. treated with sodium hydride (1.2 eq.) and iodomethane (2.0 eq.) at
RT for 24 hours). The crude NMR analysis again showed only the monomethylated
product 349. This indicated that the second alkylation was slow presumably due to
alkylation of a tertiary carbon. The next step involved modifying the reaction so the
ester 347 was treated with sodium metal chips (3.0 eq) in anhydrous ethanol (95%),
and iodomethane (3.0 eq.) at RT for 48 hours (Method B). The crude NMR again
showed only the monomethylated product 349. Thus, it seems that the second
alkylation was particularly slow under these conditions as well. In light of these
problems, a stronger base was used. The ester 347 was treated with n-butyllithium
(1.6M) (2.2 eq.) in anhydrous THF, followed by iodomethane (2.2 eq.) (Method C).
While successful in part (both 348 and 349 were produced as indicated by NMR data
of the crude reaction mixture) the reaction did not provide enough 349 to continue.
An alternative procedure to Method A was next used. The ester 347 was treated
sodium hydride (3.6 eq.) in anhydrous DMF and iodomethane (3.6 eq.) (Method D).
Distillation of the crude product gave a mixture of 348 and 349. Further purification
using flash chromatography separated the desired dialkylated ester, albeit in low
yields (6%). The reaction was repeated using sodium hydride (3.0 eq.) in the more
polar DMF and iodomethane (3.0 eq.). The ester 347 was added dropwise to the
suspension over one hour (Method E).219 Again chromatography was required after
initial distillation and gave the dialkylated product 347 in slightly better yield (20%).
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The gem methylated ester 348 was next subjected to hydrolysis with ethanolic
potassium hydroxide solution to give the acid 350220 in 74%. This was followed by
conversion to the acid chloride 351 in 31% yield using excess oxalyl chloride. The
amide 280e in 84% was then prepared from the acid chloride 351 221-222 with excess
butylamine 282. The spectroscopic details matched those of the product isolated
from the copper mediated reaction (Scheme 87).
O
O
O
OH
O
Cl
O
NH
[a] [b]
[c]
348 350 351
280e
74% 31%
84%
Key: (a) (i) KOH, Anh. EtOH refluxed 6d (ii) acidified with 2M HCl; (b) (COCl)2 DCM 40 ºC 24h;
(c) nBuNH2 (3.0 eq.), RT, 2d.
Scheme 92 Synthesis of the rearranged amide 280e
4.6 Reaction of tosyl substrate 278e in various solvents
As is the case from the previous reaction of the phenyl radical precursor 278a,
evidence of both cyclised products and rearranged amide was presented. The next
step was to determine the effects of solvent on the substrate 278e and see if it was
similar to that observed with 278a. In this reaction, the methyl group would be
weakly electron donating, and this effect would indicate the effect on cyclisation and
rearrangement with respect to the parent precursor 278a.
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Scheme 93 Radical reaction of tosyl derivative 278e
Entry
278e
Reaction
Conditions
Conversion
%
Mass
Balance %
Ratio
280e:336/ (278e)a
I Toluene, 50 ºC, 18h 46 64 0.4:1 (1:1)
II Toluene, 110 ºC, 24h 100 94 0.6:1 (0.3:1)
III DCM, 37 °C, 18h 85 65 1.2:1 (1.4:1)
IV THF, 50 °C, 18h 76 69 1:1 (2:1)
V H2O, 50 °C, 18h 24 74 1:1 (2:1)
a Ratios for cyclisation of parent 278a in parenthesis for comparison
Table 5 Effects of varying conditions on product distribution for 278e.
As with the substituted phenyl precursor 278a a selection of solvents were used to
determine the effects on product distribution and conversion. As before the reaction
in toluene and DCM were the cleanest with those in THF and H2O producing other
uncharacterised by-products. In addition, the reversal of selectivity moving from
toluene to DCM (Entry II and III, Table 5) reflects the same trend as for the parent
structure 278a (Entry IV and V, Table 3, page 100). The reason for the selectivity
would most likely be due to a competition between cyclisation and rearrangement
from the amidyl radical intermediate 335. In the case of a poor hydrogen donor, the
reaction is pushed towards cyclisation. However, in the case of polar solvents such as
DCM, the reaction is pushed towards rearrangement; this is because the amidyl
radical intermediate can be quenched more readily from a better hydrogen donor.
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5.0 N-Butyl-2, 4, 6-trimethyl-benzenesulfonamide 278f
Having established that reaction of both 278a and 278e led to both rearranged and
oxindole formation, the following experiment involved investigating the reaction of
the mesitylene sulfonamide 278f. The presence of the ortho methyl groups ensures
that no oxindole can be formed but theoretically allowing only the rearranged
compound to be produced 280f. However, the presence of the ortho methyl groups is
also likely to retard the rate of formation of the rearranged amide 280f due to
increased steric hinderence for the ipso attack at the aromatic sulfonamide carbon.
No reaction was obtained upon heating in toluene at 50 ºC for 18h (this should be
compared to 46% conversion of the tosyl analogue 278e under these conditions).
Interestingly it was possible to convert 278f to the desired 280f if the reaction was
run in the ionic liquid BMIM BF4 . Although the reaction indicated no starting
material, only a 25% isolated yield of 280f was obtained (Table 6). Poor yields were
attributed to difficulty in isolating the product from the ionic liquid.
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Scheme 94 Radical reaction of mesitylene sulphonamide 278f
Entry
279f
Reaction
Conditions
Conversion
%
Mass
balance
Ratio
280f
I Toluene, 50 ºC, 18h 0 100 0
II BMIM BF4, 50 ºC, 18h 100 25 1
Table 6 Effects of reaction conditions on product distribution for 278f
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The exact reason why the ionic liquid is successful in this reaction is not fully
understood, and further research will need to be undertaken. However, the use of the
same ionic liquid in conventional 1,5-exo ATRC reactions leads to significant rate
enhancement.223
6.0 N-Butyl-2-naphthylsulfonamide 278g
Previous work by Speckamp147 has shown that when the 2-naphthyl substrate 248
was treated with tributyltin hydride and AIBN, the cyclised product 249 was
obtained together with the reduced product 250. In light of these observations, an
investigation toward the reaction of the analogous sulfonamide 278g involved using
the sulfonamide 278g. NMR analysis (see Appendix 5) showed the rearranged
amide 280g was produced in 44% yield. The reaction was messy and several
unidentified products were produced as has been previously described with other
substates.
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Scheme 95 Speckamp’s naphthalene sulfonamide radical reaction
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Scheme 96 Radical reaction of naphthalene sulfonamide 278g
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7.0 N-Butyl-4-methoxy-benzenesulfonamide 278h
Having investigated the scope of the reaction with simple substrates, it was now
decided to determine the effects of various electron donating and withdrawing aryl
groups on the efficiency and selectivity of the mechanism. The first substrate to be
examined involved the electron donating para methoxy derivative 278h.
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Scheme 97 Radical reaction of 4-methoxy sulfonamide 278h
Reacting the bromo radical precursor 278h with copper bromide/TPA in
dichloromethane at 37 ºC for 18h [II] furnished 3 products in 73% overall yields.
Chromatography separated two cyclised regioisomeric products 352 and 353 from
the rearranged amide 280h obtained from individual column fractions. Upon 1H
NMR analysis of the cyclised products (Appendix 6), it was determined that the
major cyclised product had similar 1H NMR characteristics to the 6-substituted
oxindole 336. This would indicate that the major cyclised product was oxindole 352
(Figure 10) and might be produced via the same mechanistic pathway described in
Scheme 87 (via the amidyl radical intermediate 335).
N
O
O N
O
O
352 353
Figure 10 Structure of regioisomeric oxindoles 352 and 353
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The minor cyclised product was tentatively assigned as the 5-substituted oxindole
353224 that was analogous to the previously synthesised oxindole 333. This could
occur via the extrusion of sulfur dioxide mechanism as shown in Scheme 87. A
minor compound tentatively assigned as the reduced product 323h was also isolated
(Figure 11).
O S N
O
H
O
O
323h .
Figure 11 Structure of possible reduced product 323h
Analysis of mass spectrometry using LSIMS-FAB showed an M+ (100%) at 248,
which was consistent with the M+ of the oxindole 352. An analogous compound to
353 was synthesised by Hartwig.224 (Figure 12) Spectroscopic data was similar to
the minor oxindole 353225
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Figure 12 Hartwig’s N-Me oxindole 354
An important observation was that the reaction appeared to be faster than for the
tosyl derivative 278e (85% conversion under the same conditions). This trend was
explored more thoroughly (Table 7). Initial studies using dichloromethane at 37 ºC
for 3h [I] showed complete conversion to products. The reaction was repeated using
toluene at 50ºC [III] and 80ºC [IV] for 18h. Again, there was complete conversion to
products (as a comparison 278e proceeded to 56% conversion under identical
conditions to entry III). The ratio of products 280h to 352 from these reactions was
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1:1. This agrees with the observed trend for the other substrates where DCM gives a
better selectivity in favour of the rearranged products 280. As before an investigation
of different solvents to determine the effect on product distribution was carried out.
When the reaction was conducted in methanol at 50 ºC for 18h [entry V] only a slight
increase in selectivity towards the rearranged amide 280h was observed (1.2:1)
compared to toluene. However, when THF [entry VI] 280h was used at same
temperature and time, complete selectivity for the rearranged amide was observed.
The reason for this solvent effect is unclear but it was not observed when the phenyl
(278a, Table 4) or tosyl (278e, Table 5) precursors were employed.
S N
O Br
N
O
O
HN
278h 352
O
O
OMe
MeO
CuBr/TPA 279 O
280h
Scheme 98 Radical reaction of 4-methoxy sulphonamide 278h
Entry
278h
Reaction
Conditions
Conversion
%
Mass
balance
Ratio
280h:352
I DCM, 37 ºC, 3h 100 10 5:1
II DCM, 37 ºC, 18h 100 73 4:1
III Toluene, 50 ºC, 18h 100 45 1:1
IV Toluene, 80 ºC, 18h 100 45 1:1
V THF, 50 ºC, 18h 100 78 1:0
VI MeOH, 50 ºC, 18h 100 73 1.2:1
Table 7: The effects of reaction conditions on product distribution for the
methoxy substrate 278h.
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8.0 Effects of different halogens in the para position.
Speckamp226 has investigated the effect of halogen substitution in the para position
on the related rearrangement of 235. Scheme 99. It was found that the ratio of
products 236 and 237 was similar for the bromine and chlorine derivatives (1:1.2)
whereas the fluoro derivative was similar to the parent (235, X = Y = H) (1:0.6). A
comparison of the fluoro derivative 278h was made with the parent compound 278a
and a comparison of the results for bromo 278c and iodo 278d derivatives (the chloro
derivative was unavailable for this study).
N
I
S
Y Y
X
AIBN, Bu3SnH, PhH
Reflux
NH
YY
X
N
S
X
NS
Y Y
X
235 236 237 238
O
O
O
O
O
O
Key: (a) X = F, Y = H; (b) X = Br, Y = H; (c) X = Cl, Y = H
Scheme 99 General reaction for Speckamp radical reaction
8.1 The fluoro radical precursor 278b
F
S
O N
O O
Br N
OFF
O
HNCuBr/TPA
278b 280b 355
Scheme 100 Radical reaction of 4-fluoro sulphonamide 278b
Heating the fluoro substrate in refluxing toluene for 18h [II] Table 8 showed after
column chromatography two products, which upon NMR analysis were shown to be
the cyclised product and the rearranged amide 280b. The NMR for the cyclised
product showed only one product tentatively assigned as 355. Mass spectrometry
showed an M+ at 235 (85%) indicative of an oxindole instead of the M+ = 299 for the
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cyclic sulfonamide and elemental analysis of sulfur indicated 0.35% sulfur, where
10.7% was required for the cyclic sulfonamide 356 (Figure 13).
F
S
O N
O O
Br N
OFF
O
HNCuBr/TPA
278b 280b 355
Scheme 101 Radical reaction of 4-fluoro sulfonamide 278b
Entry Solvent/Temp./Conversion Ratio 280b:355
I 280aa DCM, 37 ºC, 100% 1.4:1
II 280b DCM, 37 ºC, 100% 1.4:1
III 280a PhMe, 110 ºC, 100% 0.3:1
IV 280b PhMe, 110 ºC, 100% 0.5:1
Key: a = The phenyl substrate.
Table 8: The effects of solvent on product distribution of the phenyl substrate
278a and fluoro substrate 278b.
N
S
O
O O
F
356
Figure 13 Structure of proposed fluoro compound 356
Due to the complex 1H NMR spectra (Appendix 7), it was not possible to determine
which regioisomers of the oxindole was the major material, and it was not possible to
purify them further. A possible method would be to synthesis the two regioisomers
as outlined in Schemes 89/90, page 112-114. It was observed that the ratio of
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products for the fluoro substrate 278b and the phenyl derivative 278a were similar in
refluxing toluene and dichloromethane (Entry I-IV).
8.2 The bromo and iodo radical precursors 278c-d
Heating the bromo substrate 278c, X = Br in dichloromethane at 37 ºC for 7h
furnished two products which were identified from NMR analysis as the rearranged
amide 280c and a cyclised product 357 (Table 9). Careful chromatography separated
the rearranged amide from the cyclised product; however, isolation of pure cyclised
product was not achievable. The 1H NMR spectra of the cyclised product indicated
one cyclised product only, which was similar to the NMR of the 6-substituted
oxindole227 336.
X
S
O
O
N
O
Br
CuBr/TPA 279 N
OX
278c-d 280c-d 357 or 359
X
O
HN
Scheme 102 Radical reaction for 4-bromo and 4-iodo sulfonamides
Entry
Reaction
Conditions
Conversion
%
Mass
balance
Ratio
280:357/359
I 278c, DCM, 37 °C, 7h 100 66 2.4:1
II 278c, THF, 50 °C, 12h 100 74 13:1
III 278d, DCM, 37 °C, 8h 100 80 2.7:1
Key: 278c X = Br; 278d X = I, 357 = X = Br, 359 = X = I
Table 9: Effects of solvents/time on product distribution for the halogen
substrates 278c-d.
An analogous compound to 357, namely 358 has been synthesised by Atwal et al.227
as shown in Figure 14.
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NBr
O
358
Figure 14 Atwal’s structure of oxindole 358
Heating the iodo substrate 278d in dichloromethane at 37 ºC for 7h facilitated a
similar outcome (although the reaction was messier with a range of by-products
being formed) (Table 9). Once again, isolation of pure cyclised oxindole 359 was
unachievable thus, it was not possible to ascertain with certainty which cyclised
regioisomer product was present. However, the ratio of rearranged amide
280/cyclised 359 was similar to that obtained for the analogous bromo derivative
(see Table 9). Following the interesting observation that heating the methoxy
derivative 278h in THF led to the rearranged product selectively, this was repeated
for one of the halogen derivatives 278c, Entry II. Although not completely selective
this time when run in THF a larger selectivity for the rearranged product (2.4/1 to
13/1) was obtained. This may suggest that THF is a far better H-donar towards
amidyl radicals than DCM or toluene. In fact as amidyl radicals are thought to be
electrophilic radicals the polarity of abstraction (C, NCH, H-atom) from the α-
position of THF is electronically matched.
The rates of reaction between the parent sulfonamide 278a and the halogens 278b-d
in DCM under copper(I)bromide/TPA conditions showed that the halogens reacted
faster than the parent compound 278a.
9.0 Effects of para and meta electron-withdrawing groups
Having investigated the effects of electron donating groups and halogens, the next
step was to investigate the electron withdrawing groups to determine (a) whether
there was a similar trend in selectivity towards the rearranged amide 280 and
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cyclised 360-363 products compared to the electron donating groups, and (b) and the
effects of solvents on product distribution. Consequently, the following step was to
investigate the electron withdrawing groups: the cyano compound 278i and nitro
compound as 278j were the chosen substrates, both containing strong electron-
withdrawing groups.
9.1 The cyano and nitro radical precursor 278i-j
S N
O Br
N
O
OHN
278i-j 360 and 361280i-j
O
O
R R
CuBr/TPA [282] N
O
362 and 363
R
R
Key: 279i = CN; 279j = NO2; R = CN = 360 and 362, R = NO2 = 361 and 363
Scheme 103 Radical reactions of 4-cyano and 4-nitro sulfonamides
Heating the bromide 279i (R = CN) in dichloromethane at 37 ºC for 4 hours led to
complete conversion to products. This was a significantly more rapid reaction than
either the parent (R = H) or p-methoxy (R = OMe) substrate. The crude 1H NMR
showed two products the rearranged amide 280i and the cyclised product.
Chromatography separated the rearranged amide from the cyclised product 364 with
the rearranged amide 280i being obtained pure in good yield (60%) (see Appendix
8). Only one cyclised product was present, and no minor cyclised product was
observed as in the previous reactions. However, it was not possible to obtain the pure
cyclised product due to co-elution with other minor by-products. In order to improve
conditions, the bromide 278i was heated in refluxing toluene for 18 hours this time.
The crude NMR showed three products identified as the rearranged amide 280i and
the cyclised products 360 and 362 see Appendix 9). Chromatography separated the
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rearranged product 280i from the two inseparable cyclised products 360 and 362
(0.2/1). Mass spectrometry showed an M+ at 242, which had the same mass as the
oxindole 360/362 (Table 10). To be certain, a sulfur analysis was obtained. Sulfur
analysis showed 0.35% sulfur instead of the theoretical 10.47% for the cyclic
sulfonamide 364 (Figure 15).
N
O
364
S
O O
NC
Figure 15 Proposed minor cyclised sulfonamide 364
The CHN gave C, 74.3; H, 7.8; N, 11. 6, and the calculated oxindole was C, 74.1; H,
7.8; N, 11.0. It was most likely that the cyclised products were the regioisomers of
the oxindoles 360 and 362.
An analogous compound by Hartwig224 whereby a methyl group was used in place of
the butyl group had similar NMR assignment and coupling constants, which showed
that Hartwig’s oxindole 365 (Figure 16) was similar to the minor oxindole 360. The
major cyclised product was tentatively assigned as the meta oxindole 362.
N
O
NC
365
Figure 16 Hartwig’s structure 365
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362
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Scheme 104 Radical reaction of 4-cyano sulfonamide 278e
Entry
278i-j
Reaction
Conditions
Conversion
%
Mass
Balance
Ratio
280 :360:362
I 278i, DCM, 37 °C, 4h 100 53 4:0:1
II 278i, PhMe, 110 ºC, 18h 100 66 1.3:0.2:1
Table 10: Table for the cyano substrate 278i under various conditions using
toluene and DCM.
Heating the nitro derivative 278j in dichloromethane at 37 ºC for 2.5h led to
complete conversion to products (see Table 11). This reaction was even faster than
for the p-CN derivative 278i The crude NMR showed two products identified as the
rearranged amide 280j and a cyclised product 366. The rearranged amide was
obtained pure in fair yield (43%). The cyclised product was obtained as only one
regioisomer but it was impossible to obtain pure. The reaction was repeated under
identical condition but for 4h. This time the cyclised product 366 was isolated pure
as one product, though in only trace amounts. In order to improve the cyclisation, the
reaction was repeated for 24h; however now the crude NMR showed several
products, which after chromatography led to two inseparable cyclised products (see
Appendix 10) in a ratio of (0.5/1) and the rearranged amide 280j.
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Scheme 105 Radical reaction of 4-nitro sulfonamide 278j
Entry
278i-j
Reaction
Conditions
Conversion
%
Mass
Balance
Ratio
280 :361:363
I 162 j, DCM, 37 °C, 2.5h 100 69 6.5:1:0
II 162j DCM, 37 ºC, 4h 100 74 4:1:0
III 162j, PhMe, 110 °C, 24h 100 54 1.3:0.5:1
Table 11 The effects of solvent, time and temperature on product distribution
for nitro substrate 278j
Mass spectrometry using LSIMS-FAB showed an M+ at 262 (100%) for 361/363
which the mass of the oxindoles 361/363. To be certain, a sulfur analysis was
obtained. Sulfur analysis showed 6.13% compared to theoretical sulfur 9.81% for the
cyclic sulfonamide. CHN analysis was also obtained to determine whether this
mixture contained the cyclic sulfonamide 366 (Figure 17). The theoretical content
for the cyclic sulfonamide was C, 51.5; H, 5.5; N, 8.6., compared to the isolated
product, which was found to be C, 55.7; H, 7.7; N, 6.6. It is unclear at present, if
these inseparable mixtures of two cyclised compounds can be unambiguously
assigned as the sulfonamide 366 and one corresponding oxindole. It is most likely
that the high sulfur content could be attributed to the cyclic sulfonamide, since there
is no evidence for any other known sulfur compound. The minor product would be
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attributed to one of the oxindoles, but it is not possible to determine which oxindole
as this would be from the crude NMR.
N
S
OO2N
O O
366
Figure 17 Proposed cyclic sulfonamide 366
The observation of a sulfur-containing compound was unexpected, since all
compounds have shown minimum sulfur. The reason for this case is unclear and
further study would be required. It is interesting to note that the reaction was rapid
compared to the other compounds studied (2.5h). As in previous reactions, the
cyclised compound predominated when refluxing toluene was used.
9.2 The trifluoromethyl and meta-3,5-trifluoromethyl radical precursors
278k-l
The previous compounds 278i-j predominately led to the rearranged amides 280i-j in
dichloromethane at 37 ºC. Although only seen as a minor by-product, a significant
amount of the hydrolysed sulfonamide 283i-j (see page 86), was also isolated from
these reactions. This maybe due to the electron withdrawing aryl group that would
make hydrolysis of the sulfonamide more facile. Consequently, the next step was to
study other compounds containing electron-withdrawing groups namely 278k-l
(Scheme 106).
F3C
S
O N
O O
Br
F3C
O
HNCuBr/TPA
278k 280k
F3C
ON
367/368
Scheme 106 Radical reaction of 4-trifluoromethylbenzenesulfonamide 278k
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Heating the bromide 278k in dichloromethane at 37 ºC for 4.5h led to complete
disappearance of the starting material. Again the reaction was more rapid than the
parent (R = H) and p-methoxy (R = OMe) with a similar rate to R = CN. The crude
1H NMR showed two compounds which were identified as the hydrolysed
sulfonamide 283k (Figure 18) and the rearranged amide 280j (see Appendix 11). As
before the electron-withdrawing nature of the sulfonamide led to significant
decomposition. It was not possible to isolate a pure sample of the rearranged amide
280k as it co-ran with the hydrolysed sulfonamide 283k.
F3C
S
O
O
H
N
283k
Figure 18 Structure of trifluoromethylbenzenesulfonamide
The reaction was repeated under identical condition using THF instead of
dichloromethane, since previous studies have shown that THF can enhance
selectivity towards the rearranged amide 280. The crude NMR showed that the
reaction had only gone to 50% conversion. Only the rearranged amide 280k was
present, but isolation of pure 280k was now unsuccessful as it was impossible to
separate from unreacted starting material 278k. The next step was to investigate the
3,5-meta substrate 278l to determine the effect on product distribution. The bromide
278l was heated in dichloromethane at 37 ºC for 1.5h. Although recovered in only
67% after chromatography, there was only one product. This was identified
spectroscopically as the rearranged amide 280l. No oxindole 367/368 were isolated
(Table 12).
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Scheme 107 Radical reaction of 3,5-trifluoromethylbenzenesulfonamide 278l
Entry
278k-l
Reaction
Conditions
Conversion
%
Mass
balance
Ratio
280:367/368:283
I 278k, DCM, 37 °C, 4h 100 72 1:0/0:3
II 278k, THF, 50 °C, 4h 50 97 1:0/0:0
III 278l, DCM, 37 °C, 1.5h 67 67 1:0/0:0
IV 278l, PhMe, 110 ºC, 24h 100 22 1:1:0
Table 12:
The effects of solvents, time and temperature on product distribution for the
substrates 278k-l.
The use of the electron withdrawing substituents 278l has led predominately to the
rearranged amide 280l (see Appendix 12) when carried out in dichloromethane at
37 ºC. This also fits the trend found with the electron donating substituents 278a-h.
However, in general, changing the solvent to toluene (in all the previous examples
studied) leads to a reversal in selectivity. When 278l was heated in refluxing toluene,
this switch of selectivity away from the rearranged products, was also observed,
(although now in equal ratios). Most intriguingly is the formation of one cyclised
product 367/368. The use of strongly activated substrates such as the para
trifluromethyl substrate 278k, p-cyano 278i and p-nitro 278j produced unexpected
results as the formation of the large amount of hydrolysed sulfonamide 283i-k was
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detected. This may arise due to the increased ease of hydrolysis of amides and
sulfonamides with strongly electron withdrawing groups
10.0 Conclusion for chapter two
As can be seen the rate and ratio of products (rearranged amides and oxindoles) is
dependent upon the electronic nature of the aryl substituent. The main product arises
from rearrangement via 1,5-ipso cyclisation in all cases with the relative amount
increasing for the strongly electron withdrawing and donating substituents (e.g. ratio
H, F< 4-Br, 4-I, 2-naphthyl < 4-NO2, 4-CN < 4-OMe, 3, 5-CF3). The rates of reaction
also seem to be influenced by the substituent with the rate following (2-naphthyl <
H, 4-CH3 < 4-I, F, 4-Br, < 4-CN, CF3 < 4-OMe < 4-NO2, <3,5-CF3). The
intermediate cyclohexadienyl radical 355 will be stabilised by both electron
withdrawing and donating substitutents which should favour cyclisation and is
reflected in this order. Furthermore, in these studies the effect of temperature and
solvent on the reaction (278a for example), showed that at high temperature
(toluene/110 °C), the cyclised oxindole products 293 predominated (e.g. ratio
rearranged/oxindole = 0.3/1.0), whilst at lower temperature and in better H-donor
solvents (dichloromethane 37 °C) the rearranged product 293 predominated (e.g.
ratio rearranged/oxindole = 1.4:1.0). For all substrates 278 when ran in DCM or
THF, there is a greater selectivity towards the rearranged amide over the cyclised
oxindoles (compared to toluene). Reduction of the intermediate amidyl radical
intermediate 355 possibly occurs via hydrogen abstraction from the solvent and is
likely to be faster than DCM/THF than from toluene. This is reflected in the
increased ratio of rearranged products to cyclised products in these reactions.
Identification of the cyclised products as oxindoles was achieved by preparing them
authentically via alternative routes and by comparing their spectroscopic details to
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those previously published. The major cyclised oxindole product appears to arise
from the cyclisation of the intermediate amidyl radical and not SO2 extrusion from a
cyclic sulfonamide intermediate.
Further work
Further work could investigate the effect of the catalyst, concentration, on the
reaction and try to develop conditions to optimise the oxindole products by retarding
the rate of H-abstraction from the solvent by the amidyl radical intermediate.
An array of amine ligands should be tested. This would involve all amines used by
the Clark group, in particular, the use of TMEDA proved successful for Wongtap’s
work156 (see Chapter three). Fullaway has had success with the pentyl-pyridin-2-
ylmethyleneamine ligand.
A series of experiments on ligand concentration should be investigated. In the case of
the nitro derivative, using excess ligand may have generated the cyclic sulfonamide
based on the high sulfur content from the S analysis.
In order to push the reaction towards cyclisation. A series of poor hydrogen donor
solvents should be used. In theory, this should give exclusively cyclised products.
Each substrate must be treated differently, and several methods might be required to
optimise the radical conditions.
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CHAPTER THREE
RADICAL REACTIONS OF N-
ALKYL/(ARYL)-4-METHYL-
BENZENESULFONAMIDES
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1.0 Aims and Objectives
Having investigated the effect of the aryl group on the reaction outcome, a range of
nitrogen substituents (R1) 369 ranging from 1º substituents of increasing length
(C2H5, C3H7, C4H9, C5H11, C6H13, C12H25) to branched alkyl groups (e.g. i-Bu, (±)-s-
Bu, t-Bu) to chiral groups (R)-1-cyclohexyl, to extremely hindered (1-adamantyl)
were chosen for investigation. In order to ascertain the effects of these substituents,
the aryl group (tosyl) and initiation group (CMe2Br) were kept constant.
S
N O
Br
N
O
O
NH
369 371370
CuBr, TPA 279
R1 R
1
R1
O
O
N
O
372
R1
Scheme 108 General reaction scheme for N-alkyl substrates 369 with
CuBr/TPA
1.1 Synthesis of radical precursors
The initial approach to furnish these compounds was identical to that described in
Chapter 2. Thus, p-tosyl chloride 281e (1.0 eq.) was treated with the amine of
choice 373a-k, (1.0 eq.) and triethylamine (1.0 eq.) in dichloromethane Method A
or with just 3 equivalents of amine 373a-k in diethyl ether Method B yields the N-
alkyl-4-methylbenzenesulfonamides 374a-k in moderate to excellent yields (41-
97%).
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Method A
Method B
281e
373a-k 374a-k
R-NH2
Scheme 109 Synthesis of N-alkyl-methylbenzenesulfonamides 374a-k
Entry R-NH2 Method Entry Yield %
373a Ethyl B 374a 84 228
373b Propyl B 374b 81 229
281e n-Butyla B 283e 89 230
373c Pentyl B 374c 92 231
373d Hexyl A 374d 62 232
373e Docecyl B 374e 92 233
373f Isopropyl B 374f 65 234
373g iso-Butyla B 374g 85 235
373h (±)-sec-Butyla B 374h 41236
373i tert-Butyl B 374i 76 237
373j (R)-(-)-1-Cyclohexylethyl A 374j 97 238
373k Adamantan-1-yl A 374k 76 239
Key: a = Synthesised by D. Fullaway165 283e = 88%, 374g = 95%, 374h = 85%
Table 13 N-alkyl-4-methylbenzenesulfonamide
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1.2 Current synthesis of radical precursors
With a range of sulfonamides 374a-k in hand, the next goal was to react these with
2-methyl-2-isobutyryl bromide 284, to prepare the range of substrates 369a-k
suitable for investigation (Table 14). Initially triethylamine (1.0 eq.) was used
followed by addition of the acid bromide 284, (see Method C). For the majority of
reactions this method worked 369a-e,g-h, albeit with low yields for hindered and
longer chain amines. However, for the hindered amines 369f,i-k only starting
material 374 was recovered. By changing the conditions to use equimolar amounts of
n-BuLi (1.6M) Method D, it was hoped to be able to force the formation of the
hindered substrates 369f ,i-k. However, even under these conditions no products were
detected. Therefore this synthesis was abandoned, and the rest of the work
concentrated on the substrates 369a-e, g-h. For sulfonamides 278e, 374c-d, g-h
traces of an olefinic product (tentatively assigned as 375 (Figure 19) based upon 1H
NMR and previous precedent), was also isolated (See Chapter Two).
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Scheme 110 Synthesis of the radical precursors 369
Entry Substrate Method Yield
369a Ethyl C 58
369b Propyl C 52
278e n-Butyl C 70a
369c Pentyl C 43
369d Hexyl C 22
369e Dodecyl C 22
369f iso-Propyl C 0
369g iso-Butyl C 48a
369h (±) sec-Butyl C 56a
369i tert-Butyl C 0
369j ( R )-(-)-Cyclohexylethyl C/D 0
369k Adamantyl C/D 0
Key: a = previously synthesised by D. Fullaway163. Yield: 278e = 79%, 379g = 62%, 369h = 50%
Table 14 Synthesis of radical precursors 278e, 369a-k
S
O N
O
R
O
375
Figure 19 The structure of the acrylamide 375
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2.0 Reaction of N-alkyl-4-methylbenzenesulfonamide with copper (I)
bromide and TPA
As previously mentioned in Chapter 2, the reaction of substituted aryl sulfonamides
when heated in refluxing toluene in the presence of copper (I) bromide and TPA 279
led predominately to the cyclised oxindole products. On the other hand changing the
solvent to either DCM or (in some cases) THF led predominately to the rearranged
amide. In light of these results an investigation was conducted on the effects of the
alkyl N-substituent on the outcome of the reaction in DCM.. Previous work by
Fullaway163 had shown that for the iso-butyl sulfonamide 369g, using a slight excess
of the copper (I) bromide/TPA complex in dichloromethane furnished the rearranged
amide 370g in 26% yield and the cyclised product 371g/372g in 20%. On repeating
the reaction for the N-iso-butyl substrate 369g under similar conditions, there was
greater selectivity towards the rearranged amide 370g in 76% yield and the cyclised
product 371g/372g in 24% yield. The drawback with Fullaway’s method, was that
the conditions used in these experiments were not recorded, so it is uncertain as to
what temperature was used and the length of time taken for complete conversion to
products. Further work by Fullaway was done using the N-sec-butyl sulfonamide
369h, using a slight excess of the copper (I) bromide/TPA complex in
dichloromethane. Again, there was greater selectivity over the rearranged amide
versus the cyclised product 2:1 ratio. There was no indication concerning neither the
temperature used nor the length of time taken for complete conversion to products.
2.1 Current work
Consequently, this work involved a re-investigation of these reactions. Heating the
bromides 369a-h in dichloromethane at 37 ºC for 18 hours furnished the expected
products arising from rearrangement 370a-h and the two cyclised oxindoles
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regioisomers 371a-h and 372a-h, as illustrated in Table 15. Entry I, Table 15 is for
the parent compound aromatic = phenyl obtained in Chapter 2 and is listed as a
comparison.
S
N O
Br
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NH
369a-h 371a-h370a-h
CuBr, TPA 279
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1
R1
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372a-h
R1
Scheme 111 General scheme for N-alkyl substrates 369 with CuBr/TPA
Entry 369 Reaction
Conditions
Conversion
%
Mass
balance
Ratio
370:371/372
I (278a) DCM, 37 ºC, 18h 100 78 1.4:1
II (369a) DCM, 37 ºC, 18h 96 67 10:1
III (278e) DCM, 37 ºC, 18h 85 65 1.3:1a
IV (369c) DCM, 37 ºC, 18h 100 81 2.5:1
V (369d) DCM, 37 ºC, 18h 100 75 3.3:1
VI (369e) DCM, 37 ºC, 18h 100 74 1:0
VII (369g) DCM, 37 ºC, 18h 100 73 1.4:1a
VIII (369h) DCM, 37 ºC, 18h 100 72 1.4:1a
Key: 369a = ethyl, 278e = n-butyl, 369c = pentyl, 369d = hexyl, 369e = dodecyl, 369g = iso-butyl,
369h = sec-butyl. a = previously synthesised by Fullaway.163
Table 15 The effects of dichloromethane on product distribution
The table for the C4 series 278a (parent, Ar = Ph, N-n-Bu), 278e (N-n-Bu), 369g (N-
i-Bu), 369h (N-s-Bu) shows the ratio of rearranged 370 to cyclised products 371:372
remains fairly constant (1.4:1 to 1.3:1). However when the chain length was
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increased from C4, C5, C6, C12 (i.e. 369c-e) the reaction becomes more selective for
the rearranged product 370 (1.4:1, 2.5:1, 3.3:1 to 1:0). Full characterisation of the N-
pentyl cyclised 371d/372d products was not possible due to the small amounts of
isolated product (see Appendix 13). No cyclised material was isolated with the
longest dodecyl substituted precursor 369e.
On the other hand, the smaller N-Et substitutent 369a did not fit this trend as the
reaction was also selective for the rearranged product 370a. An authentic sample of
370a was prepared from the acid chloride 351, (see Chapter 2, Scheme 92) in order
to unambiguously assign the structure of this compound.
The reasons for the trends are not clear. Presumably, the product distribution is
determined from the relative rates of cyclisation versus reduction of the intermediate
amidyl radical 335, (see Chapter 2, Scheme 87). The factors, which govern these
rates, must be relatively complicated as in n-Bu, i-Bu, s-Bu series where there are
slowly increasing steric hinderance at the nitrogen atom (but keeping the number of
carbons constant) the ratios are very similar. Hence, steric effects alone cannot
explain the trends. Reduction of the intermediate amidyl radicals can theoretically
occur via two pathways; a) reduction by abstraction of an H-atom from the solvent,
or b) reduction by intramolecular H-translocation followed by solvent (see 376 → 
377) as depicted in Scheme 112.
N
O
376
N
H
O
hydrogen abstraction
377
H
H
H H
H solvent
Scheme 112 Proposed mechanism for radical hydrogen translocation
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There are two characteristic experiments, which might determine whether this
intramolecular approach to reducing the amidyl radical intermediate is taking place.
The first method would involve using a series of poor hydrogen donor solvents
(t-BuOH, etc), and determining their effect on product outcome. The poor hydrogen
donor solvents should retard the rate of intermolecular reduction but not that of
intramolecular reduction and larger ratios of cyclisation should occur, since there
would be poorly abstractable hydrogen atoms on the solvent. Another approach
would be to use alternative groups at the C-5 position, to ensure that 1,5-H
abstraction could not take place. As a suggestion, the following compound 378
(Figure 20) could be used. In this case, the C-F bond is much stronger than the C-H
and thus would be more difficult to break. The result being that a 1,5-abstraction
could not take place.
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Figure 20 Structure of compound to block 1-5-H abstraction 378
Alternatively, the nature of the R group might affect the relative rates of oxindole
formation. Presumably, with the small N-ethyl group, reduction via pathway (a) is
relatively fast and/or cyclisation must be slow. Reduction via intramolecular 1,3-H
abstraction is unlikely to occur. The smallest N-alkyl group capable of a 1,5-H
translocation is the N-Bu precursor 278e. As the N-alkyl group increases in size
potentially more H-translocation pathways may be possible (1.6, -1.7 etc). This may
explain why more selectivity towards reduction of the intermediate amidyl radical
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(leading to rearrangement) is observed; alternatively the larger chain alkyl groups
may retard the cyclisations.
2.2 Reactions in other solvents
In Chapter 2 it was shown that changing the solvent for the reaction from DCM to
toluene led to a reversal of selectivity (i.e., in DCM the rearranged products normally
predominated, but in toluene the cyclised compounds predominated). This was
explained as DCM being a better H-donor towards the amidyl radicals An
investigation of the reaction of three precursors 369a, 278e and 369g in toluene and
in the ionic liquid BMIM BF4, were conducted and compared with the results from
DCM. A brief investigation of the effect of temperature on product outcome was
also conducted (Table 16).
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Scheme 113 General reaction scheme for N-alkyl substrates 369 with CuBr/TPA
Entry Solvent Temp. Conv. Ratio 370:371/372
I 369a Toluene 50 47 0.8:1
II 369a Toluene 110 100 0.7:1
III 369a IL 50 91 1:1
IV 278e Toluene 50 46 0.4:1
V 278e Toluene 110 94 0.6:1
VI 278e IL 50 91 0.2:1
VII 369g Toluene 50 14 0:1
VIII 369g Toluene 110 73 0.6:1
IX 369g IL 50 94 0.5:1
Key: 369a = Ethyl, 278e = n-butyl, 369g = iso-butyl
Table 16 The effects of toluene and ionic liquid BMIM BF4 on product
distribution.
As can be seen from Table 16 the expected reversal of selectivity is observed upon
switching from DCM to toluene (e.g. 369a DCM 10:1 to toluene 0.8:1, 278e DCM
1.3:1 to toluene 0.4:1, 369g DCM 1.4:1 to toluene 0:1). The conversion however is
less in toluene when compared to DCM presumably due to the relatively insoluble
nature of the CuBr/TPA in toluene compared to DCM.
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Comparing the reactions in toluene at 50 ºC and 110 °C the N-Et 369a undergoes the
fastest reaction, followed by N-n-Bu 278e and N-i-Bu 369g. This would be expected
on steric grounds. The low conversion of N-i-Bu (369g Entry VII) made
determining the product ratio difficult from the crude NMR and so the result of this
experiment should be treated with caution.
In toluene at 110 ºC the ratio for all three reactions II, IV and VI remain similar
(0.7:1 to 0.6:1).This maybe due to the fact that the CuBr/TPA complex is more
soluble than in toluene but that the H-abstraction properties of both solvents might be
similar.
This would indicate that the ionic liquid whilst only attaining similar selectivities for
the rearranged amide/cyclised products shows that the ionic liquid has a higher rate
of conversion. Further work would be required to determine with certainty this rate
difference. Presumably, the ionic liquid can coordinate with the ligand complex and
structure more favourably than that for toluene at the same temperature.
2.3 Other reactions
The following investigation concerning the reaction of the N-Et 369a, N-Pr
derivative 369b and N-nBu 281e in the ionic liquid BMIM BF4 at 50 ºC for 18hs as
depicted in Table 17.
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Scheme 114 General reaction scheme for N-alkyl substrates 369 with CuBr/TPA
Entry Ratio 370:371/372
N-Et (369a) 1:1
N-Pr (369b) 0.5:1
N-nBu (281e) 0.2:1
Table 17 The effects of the ionic liquid BMIM BF4 on product distribution.
In this case as the chain length increases the relative amounts of cyclised materials
increases (in the case of the N-propyl, the cyclised products were isolated although
full characterisation was not possible due to other by-products-see Appendix 14).
This is opposite to the trend observed in DCM with increasing chain length. In order
to investigate this further, similar experiments using C5, C6 and C12 alkyl groups
should be conducted and compared to toluene at both 50 ºC and 110 ºC. However,
due to time constraints this was not achieved.
2.4 Effects of dichloromethane at room temperature on product distribution
Having previously investigated the effects on substrates 369 (Table 15) in
dichloromethane at 37 ºC, an investigation of the following substrates N-ethyl 369a,
N-hexyl 369d, N-dodecyl 369e, N-i-butyl 369g, N-s-butyl 369h at room temperature
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(3 days) was conducted (Table 18). These results show that there is excellent
selectivity towards the rearranged amide 370 compared to the cyclised regioisomeric
oxindoles 371/372. It is uncertain as to whether this increased selectivity is due to the
lower temperature used (room temperature) or the longer reaction time (3 days), or a
combination of both. Results from Table 15 (DCM 37 oC, 18hrs) are represented
here as a comparison.
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Key: 369a = ethyl, 369c = hexyl, 369d = dodecyl, 369g = iso-butyl, 369h = sec-butyl.
Scheme 115 General reaction scheme for N-alkyl substrates 369 with CuBr/TPA
Entry Reaction
Conditions
Conversion
%
Mass
Balance
Ratio
370:371/372/a
I (369a) DCM, rt, 72h 100 33 25:1 (10:1)
II (369d) DCM, rt, 72h 93 53 10:1 (3.3:1)
III (369e) DCM, rt, 72h 75 22 1:0 (1:0)
IV (369g) DCM, rt, 72h 87 56 7.7:1 (1.4:1)
V (369h) DCM, rt, 72h 58 68 6.2:1 (1.4:1)
a The ratios from Table 12 (DCM 37 ºC 18h) in parenthesis.
Table 18 The effects of dichloromethane at room temperature on product
distribution.
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3.0 Synthesis of N-(hetero)aromatic radical precursors 380a-i
Having investigated the effects of simple alkyl chains attached to the nitrogen atom
and their effects on product outcome, a further study was initiated whereby replacing
the alkyl groups with benzyl derivatives such as (4-methyl benzyl, 4-methoxy benzyl
and 2-trifluoromethyl benzyl) as well as aryl groups (phenyl, pyridylmethyl,
quinuclidine, furan and thiophene) was investigated. In order to ascertain the effects
of these substituents, the aryl acceptor group (tosyl) and initiation group (CMe2Br)
were kept constant.
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Figure 21 General structure for the (hetero)aryl derivatives 381
The approach to furnish these compounds was identical to that described in Section
3.1. Thus, p-tosyl chloride (1.0 eq.) 281e was treated with the amine of choice (1.0
eq.) 379a-i and triethylamine (1.0 eq.) in dichloromethane (Method A), as depicted
in Table 19 to furnished the N-(hetero)aryl-(4-methyl)-benzenesulfonamides 380a-i
(Scheme 116).
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Scheme 116 Synthesis of N-hetero(aromatic) substrates 380a-i
Entry R-NH2 Method Entry Yield %
379a N-p-Methylbenzyl A 380a 22 240
379b N-p-Methoxybenzyl A 380b 33 241
379c N-o-Trifluoromethylbenzyl A 380c 83 242
379d N-Pyridin-2-ylmethyl A 380d 32 243
379e N-Furfuryl A 380e 75 244
379f N-Thiophenemethyl A 380f 75
379g N-Phenyl A 380g 0
379h N-Pyrid-2-yl A 380h 0
379i N-Quinucldinyl A 380i 1
Table 19: Synthesis of N-(hetero)aromatic-4-methylbenzenesulfonamides
The N-benzyl derivatives, (with the exception of the trifluoromethyl group 380c)
gave poor yields (< 33%). Better yields were obtained for the heterocyclic substrates
(furfuryl 380e in 75% yield and 2-thiophenemethyl 380f in 75% yield). No product
could be isolated from the phenyl 380g, pyrid-2-yl 380h and quinuclidine 380i
substrates. Consequently, this work focussed only on the substrates 380a-f .
Chapter Three
: 143
3.1 Synthesis of radical precursors
With the sulfonamides 380a-f in hand, the next goal was to react these with 2-
methyl-2-isobutyryl bromide 284, to prepare the range of substrates 381a-f suitable
for investigation (Scheme 117). This method involved triethylamine (1.0 eq.)
followed by addition of the acid bromide 284 (Method B) as depicted in Table 20.
For the majority of reactions this method worked 381a-e. However, for the
thiophene derivative 381f only starting material 380f was re-isolated. Unlike the
previous substrates, there was no presence of any elimination product in the crude
NMR.
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Scheme 117 Synthesis of N-(hetero)aromatic sulfonamide radical precursors
Entry Substrate Method Yield
381a 4-Methylbenzyl B 72
381b 4-Methoxybenzyl B 91
381c 2-Trifluoromethyl-benzyl B 79
381d 2-Pyridylmethyl B 100
381e 2-Furfuryl B 100
381f 2- Thiophenemethyl- B 0
Table 20: Synthesis of N-(hetero)aromatic sulfonamide radical precursors.
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3.2 Attempted radical reactions of (hetero)aromatic sulfonamides 381
Motherwell151 has shown that benzylic sulfonamides can selectively furnish cyclic
sulfonamides as depicted in Scheme 118. In all these reactions, a 1-7 addition onto
the sulfonamide aromatic ring furnished the cyclic sulfonamides. In the following
example, the pyridyl sulfonamide 257 furnished the desired cyclic product 258
(55%) and the dihydropyridine 382. Switching to sulfur heterocyclics, the thiophene
sulfonamide 259 led to the desired cyclised product 383 and two
dihydroheteroaromatics 260 and 384 and 23% and 8% yield respectively. When the
reaction was repeated for the quinoline sulfonamide 261 only the cyclised product
262 in 9% yield was furnished.
I
N S
O
O
257
Bu3SnH AIBN
N N S O
O
N
N
S O
O
NH
258 382
I
N S
O
O
259
Bu3SnH AIBN
S N S O
O
S
N
S O
O
S
N
S O
O
S
H
H H
H
384260 383
I
N S
O
O
N N
S O
O
N
261 262
Bu3SnH AIBN
Scheme 118 Motherwell radical cyclisation onto heteroaromatics
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Based on these observations, it may be possible for the radical 385 produced from N-
4-methoxybenzyl substrate 381b (Scheme 119), to undergo two competitive
cyclisation pathways. (A) Radical cyclisation onto the benzylic group via a 1,6-
addition to furnish analogous cyclic sulfonamide 386 as above. (B) Addition into the
ipso position of the sulfonamide via a 1,5- addition (as observed in our previous
studies) to lead to the rearranged amide 387. It should be noted that a previous
reaction by Wongtap156 using the substrate 381a furnished the rearranged amide
analogous to 387.
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Scheme 119 Proposed radical mechanism for the substrate 387
The first experiment involved treating the benzyl bromide 381b with CuBr/TPA in
tetrahydrofuran at 50 ºC for 24h. Unfortunately, the crude NMR showed several
products. None of these products could be unambiguously identified and no evidence
of either cyclised products 386 or rearranged amide 387 could be detected. In light of
this result, and due to time constraints additional investigations for the benzylic
precursors 381a,c were cancelled, and instead analysis of the heterocyclic aromatic
derivatives, (e.g. the N-furan derivative 381e) was performed.
Zard245 has recently shown that a suitably substituted furan xanthate 388 can undergo
ipso-type radical cyclisation to furnish spirocyclised products (e.g. 392). (Scheme
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120). The xanthate 388 was treated with DLP (dilauroyl peroxide) to give the acyl
radical intermediate 389, which underwent an ipso-type cyclisation leading to the
spirocyclised radical intermediate 390 followed by oxidation to the cation 391 which
is quenched by the solvent to give the spirocyclised product 392.
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Scheme 120 Zard’s synthetic approach to spirocyclised products using furan
xanthates
It may be possible for the present substrate 381e to undergo a similar type of
cyclisation to furnish spirocyclised products as well as the radical rearrangement 395
and oxindole formation that have been observed in related studies to this work,
alternatively, the substrate may undergo other cyclisations as shown in Scheme 121.
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Scheme 121 Proposed radical mechanisms for the substrate 381e
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However, on heating the bromide 381e in tetrahydrofuran at 50 ºC for 24 hours the
crude NMR and the TLC indicated several products as before with 381b. None of
these could be properly isolated and purified and therefore they were not
exhaustively analysed. Consequently, due to both 381b and 381e that gave
complicated mixtures, this resulted in cessation of further investigations into this
class of substrates.
4.0 Conclusion for Chapter Three
The starting sulfonamides were treated with 2-bromo-2-isobutyl bromide and
triethylamine to yield the radical precursors. The N-butyl group gave the best yield
(70%). The yields decreased from N-butyl to N-docecyl. With more hindered
substrates the reaction failed presumably due to steric hinderance. The iso-butyl and
sec-butyl substrates gave average yields of 48% and 56% respectively. Again, steric
hindrance was responsible for the lower yield.
As with Chapter 2, in the copper mediated radical reactions there was a similar trend
in selectivity towards the rearranged amide 370 (in dichloromethane), and
regioisomeric oxindoles 371:372 (in toluene or ionic liquid BMIM BF4). The initial
study on a range of substrates 369 in dichloromethane at 37 °C, showed marked
selectivity towards the rearranged amide 370 (compared to the parent compound
278a). It was shown that as the N-alkyl chain increases, the selectivity towards the
rearranged amide increases also, with the exception of 369a which showed high
selectivity. The reasons for this trend are reduction of the amidyl radical which leads
to amide 370 whereas cyclisation leads to 371/372. The reduction of the amidyl
radical could arise from two possible pathways, (a) hydrogen abstraction of the H-
atom from the solvent or (b) from an intramolecular H-translocation. The efficiency
of the latter would be expected to increase with increasing chain length (as
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observed). The selectivity observed with the N-Et group would indicate that there is a
rapid reduction of the amidyl radical from the solvent (DCM), relative to cyclisation.
Dichloromethane at room temperature has a greater selectivity towards the
rearranged amide 370, (but keeping the trend the same) compared to
dichloromethane at 37°C. The nature of the N-alkyl group has two possible rules. It
is known that it can affect rates of cyclisations of both carbon and nitrogen based
radicals and also provides pathways for intramolecular reduction. In 5-exo
cyclisation of α-amide radicals, small nitrogen substituents cause a relatively slow
rate of cyclisation due to unfavorable rotamer ratios. However, in this case (amidyl
radicals) cyclisation has been shown to be retarded by bulky substituents.158 Thus it
is unclear why the relative rate of cyclisation for the N-ethyl substituent is slow. This
suggests that it is the rate of reduction which is fast (presumably intermolecular
reduction).
In a another set of reactions, (this time using toluene at both 50 ºC and refluxing
temperature (110 ºC) and ionic liquid at 50 ºC) of three substrates, N-Et 369a, N-n-
Bu 369d and N-i-Bu 369i the expected reversal of selectivity leading to the cyclised
products 371:372 was observed. As in Chapter Two, the selectivity towards the
cyclised products was evident. The explanation for this is that toluene is a poor
hydrogen donor compared to DCM, and that the major path must be through addition
onto the aromatic ring via the amidyl radical intermediate 335. Interesting, when the
ionic liquid-BMIM BF4 was compared to toluene at 50 ºC, there was a greater rate of
conversion presumably due to increased solubility of CuBr/TPA, but a similar ratio
of products were observed due to similar H-donor ability to toluene. With the ionic
liquid reactions, there was a reversal of selectivity toward cyclisation (C2-C5). The
reason for this remains unclear. Further investigation by replacing the alkyl group
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with an aryl or heteroaromatic group was conducted. It was not possible to obtain
any meaningful data however.
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REACTIONS OF N-ETHYL-N-
TRICHLOROACETYL-4-
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1.0 Introduction
Having investigated the effects of N-butyl-(substituted)-benzenesulfonamides 278, N-
alkyl-4-methylbenzenesulfonamides 369 and N-aryl-4-methylbenzenesulfonamides
381 upon product outcome, a series of radical initiators were investigated as depicted
in Figure 22.
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Figure 22 Structure of arylsulfonamide using various radical initiators
All previous investigations have been conducted using unactivated radical initiators,
as described in both Chapter 2 and 3. Due to time constraints, a thorough
investigation of all initiators was not possible. Therefore, substrates were used based
on the previous work by the Clark group154 as described in Chaper 1 section 3.5 page
81. In this case, the radical precursor 275 when treated with copper (I) chloride and
TPA complex lead to the rearranged amide 277 as depicted in Scheme 122. Although,
this was only determined through the crude proton NMR, as it was not possible to
obtain the pure product.
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Scheme 122 Clark’s rearrangement reaction using arylsulfonamide 275
1.1 Investigation of the trichloroacetamide substrate 396
A brief investigation of the effects of varying the initiator portion of the molecule on
one of the previously investigated derivative 369a was undertaken as depicted in
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Figure 22. In this case, the unactivated bromide initiator (CMe2Br) was substituted
for an activated (CCl3) initiator 396.
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Figure 23 The structures of the radical precursors 369a and 396
The precursor 396 was prepared from commercially pure 369a (1.0 eq.) with
trichloroacetyl chloride 397 (1.0 eq.) and n-butyllithium (1.0 eq.) in excellent yields in
84% yield as depicted in Scheme 123.
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Scheme 123 Synthesis of trichloroacetamide 396
It should be possible to observe a similar reaction with the substrate 396 to furnish the
rearranged amide 398 as outlined below.
S
O
O
N
O
Cl Cl
Cl
396
NHO
Cl
Cl
398
CuCl/TPA
Scheme 124 General reaction scheme for substrate 396 with CuBr/TPA
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1.2 Radical reaction of the trichloroacetamide 396
The next step was to react this under identical conditions to that in Chapter Three-
Table 15. The trichloroacetamide 396 was heated in dichloromethane at 37 °C for 18
hours. The reaction was carefully monitored by TLC, which showed several products
which included unreacted starting material 396. In addition it was possible to identify
the expected rearranged amide 398, and the cyclised product 399 (see Scheme 125) in
a ratio of [1.0:1.6] 398:399 (based upon crude NMR spectra). Based on the analogous
reaction with the bromide 369a it was observed that the use of the trichloroacetamide
396 as a substrate was less efficient in mediating the rearranged amide (compared to
the bromide where there was excellent selectivity for 370a, e.g. 10:1 versus 1.6:1).
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Figure 24 Structures of the N-ethyl cyclised and rearranged products
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Scheme 125 Radical reaction of trichloroacetamide with CuBr/TPA
An analogous reaction by Wongtap156 with N-butyl trichloroacetamide furnished the
rearranged amide in excellent yield (100%), but surprisingly as shown in Chapter
One-Section 3.5, the N-allyl derivatives 275 furnished only a low yield (10%),
although only tentatively assigned by NMR.
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2.0 Synthesis of oxindoles from halo-amides
Oxindoles have been prepared via radical cyclisation onto aromatic rings. An example
is Nishio’s radical cyclisation178 (Scheme 126) whereby the bromide 400 when treated
with tributyltin hydride and AIBN underwent radical cyclisation into the aromatic ring
to give the radical intermediate 401, followed by re-aromatisation to furnish the
oxindole 402. Another related reaction is Storey’s59 (Scheme 127) tributyltin hydride
radical cyclisation of ortho halo anilides derivatives (not shown) to furnish oxindoles
(eg. 405). In this case 1,5-H translocation of the aryl radical 403 to 404 followed by
addition into the aromatic and oxidation furnishes the observed product.
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Scheme 126 Nishio’s radical approach to oxindoles
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Scheme 127 Storey’s radical approach to oxindoles
The following investigation to determine if similar cyclisations of haloacetamides (eg.
278e, 406-409) could be mediated by copper-TPA complex was undertaken. Thus it
was postulated that generating the radical from the precursors 406-408 using either
CuBr or CuCl and TPA would lead to a radical cyclisation into the aromatic ring
followed by oxidation via the copper (II) halide complex to give the cyclised oxindole
products 409-411 (Scheme 128).
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278e: X = Br, R1, R2 = Me
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Scheme 128 Proposed mechanism for oxindole synthesis using CuBr/TPA
Cyclisation precursors were prepared whereby the initiating radical would be
produced from functionality which contained the tertiary bromide 341, a
dichloroacetamide 406, a trichloroacetamide 407 and a primary bromide 408 (Figure
24).
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Figure 25 The functionized initiators 341 and 406-408
2.1 Synthesis of precursors 278e, 406-408
The dichloroacetamide 406 was prepared by reacting the amine (1.0 eq.) 340 with
dichloroacetyl chloride (1.0 eq.) 412 with butyllithium (1.0 eq.) as a base. NMR
spectroscopic analysis showed the desired precursor 406 was produced (in 46% yield)
but also the de-alkylated amide 413 was obtained and this was inseparable by
chromatography from 406 (Scheme 129).
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Scheme 129 Synthetic approach to dichloro precursor 406
The trichloroacetamide (1.0 eq.) 407 was prepared successfully by simply reacting the
amine (1.0 eq.) 340 with trichloroacetyl chloride (1.0 eq.) 397 and butyllithium (1.0
eq.) in excellent yield (82%). The primary bromide 408 was prepared by reacting the
amine 340 with acetyl bromide and triethylamine (1.0 eq).
2.2 Reactions of radical precursors 281e, 409-411
The precursor 281e was heated in refluxing toluene with one equivalent of CuBr and
TPA for 24 hours. The crude NMR showed one compound, which was identified as
the oxindole 333 upon purification (98%) as depicted in Scheme 130. Oxindole 333
may be formed via the desired radical cyclisation mechanism outlined earlier (see
Scheme 87, page 110) or it could be produced by a similar mechanism to the Friedel-
Crafts alkylation (with the CuBr acting as a Lewis acid mediator). The radical process
would likely be catalytic as the copper (II) bromide formed in the initiation event
would oxidise the intermediate cyclohexadienyl radical 414 to the aromatic oxindole
and regenerate the copper (I) bromide. On the other hand, Friedel-Crafts alkylation
reactions are not generally catalytic and stoichiometric amounts of lewis acid reagent
are required.
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Scheme 130 Copper-mediated radical cyclisation of precursor 341
It was impossible to distinguish between these mechanisms because one equivalent of
CuBr/TPA was used. In light of this result, and in order to determine whether a
stoichiometric amount of copper bromide was required, the reaction was repeated
using 30% CuBr/TPA under otherwise identical conditions as before. Although NMR
analysis of the crude reaction confirmed that the oxindole 333 was present, there were
a number of other by-products formed. The oxindole 333 was formed in only 16%
isolated yield. In this case, because of the low yield, it was still unclear whether a
catalytic radical process was involved, or a stoichiometric Friedel-Craft cyclisation-
although it may suggest the latter.
2.3 Additional reactions
The next step was to investigate the reaction of the trichloroacetamide 407 to
determine if this too would undergo a similar reaction. Thus 407 was heated in
refluxing toluene for 24 hours with CuCl and TPA and the reaction was monitored by
TLC. The crude NMR showed unreacted starting material and oxindole 415 (Scheme
131) (tentatively assigned from the NCH2 group and by comparison of spectroscopic
details of the related oxindole 333. As with the sulfonamide analogue 396 there were
a number of by-products.
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Scheme 131 Copper-mediated radical cyclisation of trichloroacetamide 396
Finally, an investigation of the primary bromide precursor 408 was performed to
determine if cyclisation could occur. The primary halide is likely to be much more
difficult to cleave homolytically due to a stronger C-Br bond than the tertiary bromide
341. In fact, previous work in the group had shown that generating radicals from
primary bromides often did not succeeed. The halide was heated in refluxing toluene
for 48 hours with a stoichiometric amount of CuBr and TPA. This time, the crude
NMR showed unreacted starting material.
3.0 Conclusion for Chapter Four
Firstly changing the initiating group from tertiary bromide 284 to trichloroacetyl 397
in the CuCl/TPA mediated rearrangement reactions was found to be detrimental to the
rate, yield and substituents of the process. This highlights the limitation of the
rearrangement reactions described.
Secondly it has been shown that it is possible to prepare oxindoles directly from
dimethylbromoacetylamides by heating with CuBr/TPA. Mechanistically this reaction
might proceed by a Friedel-Crafts alkylation mediated by the copper lewis acid or a
radical addition/oxidation process. The low yield produced with sub-stoichiometric
amounts of reagent tentatively indicated the former process. As with the
rearrangement reactions of sulfonamides, changing the group from tertiary bromide
284 to trichloroacetyl 397 was detrimental to the overall yield of the process.
Attempted cyclisation of the bromoacetamide 408 failed, either because the C-Br
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bond could not be broken (either homolytically or heterolytically) or due to relatively
slow cyclisation of primary bromides relative to tertiary bromides 284 (due to absence
of the gem methyl effect).
4.0 Future work
The following recommendation may help improve the oxindole forming reaction and
thus improve yields..
 The use of a series of different ligands should be tested. In these studies only
the copper (I) bromide (chloride) and TPA were used. Varying the ligand may
effect solubility, reactivity and mechanistic properties.
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1.0 General
1H NMR spectra were recorded at 300, 400 and 500MHz on the Bruker DPX300,
DPX400 and DPX500 spectrometer respectively, and are in CDCl3 unless otherwise
stated. All chemical shifts (δ) are quoted in parts per million (ppm) with deuterated
chloroform (CDCl3,δH = 7.26 ppm) in tetramethylsilane (Si(CH3)4, (TMS),δH = 0.00) as
internal reference unless otherwise stated. Coupling constants (J) were measured in Hz.
13C NMR (DEPT) were recorded at 75.5, 100.6 and 125.8MHz on the Bruker DPX300,
DPX400, and DPX500 spectrometer respectively, with CDCl3 in TMS as internal
reference unless otherwise stated. Infrared spectra were recorded on a Perkin-Elmer
1720X fourier-transform infrared spectrometer (Golden-Gate method). Mass Spectra
were recorded using a Micromass Autospec. Mass Spectra were recorded using EI
(Electron Impact), CI (Chemical Ionisation), or LSIMS (Liquid Secondary Ion Mass
Spectrometry)-FAB (Fast Atom Bombardment) at both low and high resolution. LSIMS
were carried out in a PEG300 in 3-NBA matrix. Melting points were recorded on a
Gallenkamp melting point apparatus and are uncorrected. Analytical TLC were
performed using Merck aluminium sheet silica gel 60 F254. Column chromatography was
performed with Fluorochem® silica gel 40-63 60Å. Visualizations were performed using
ultraviolet radiation at 254nm, acidic polymolybdonate or basic potassium
permanganate, unless otherwise stated. All chemicals were commercially available from
Aldrich and used without further purification. All solvents were used without further
purification. All organic reactions were performed under nitrogen atmosphere unless
otherwise stated. All organic products were dried over either anhydrous magnesium
sulfate or anhydrous sodium sulfate. Nomenclature for the compounds was obtained
from Beilstein Autonom software programmes. All elemental analysis was obtained
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from Warwick Analytical Service or Medac Elemental Analysis. The following
compounds 283b-j, 374b-j,l and 379a-b,d-f are commercially available in milligram
quantanties only.
Abbreviations:
s = singlet, bs = broad singlet, bd = broad doublet, d = doublet, t = triplet, q = quartet,
quin. = quintet, sxt. = sextet, spt. = septet, oct. = octet d.t = doublet of triplets, t.t =
triplet of triplets, d.d = doublet of doublets, s = quarternary carbon (C), d methide
carbon (CH), t = methylene carbon (CH2), q = methyl carbon CH3, app. = apparent, m.
= multiplet, WAS = Warwick Analytical Service.
1.1 General synthesis of N-butyl-(substituted)-arylsulfonamides
S
N
H
R
O O
1.1.1 Method A
To a stirred solution of the arylsulfonyl chloride 281 (1.2 eq.) in dichloromethane
(DCM) (50 mL) was added n-butylamine 282 (1.0 eq.) and triethylamine (TEA) (1.36
eq.). The solution was stirred at 0 °C (ice bath) for four hours unless otherwise stated.
The reaction was quenched with distilled water (50 mL) and the product extracted with
DCM or ether (3 x 50 mL). The combined organic extracts were dried over anhydrous
magnesium sulfate and the solvent removed in vacuo to yield the crude arylsulfonamide
283. Purification was by recrystallization (diethyl ether/hexane) or flash chromatography
(petroleum ether/ethyl acetate).
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1.1.2 Method B
As above but arylsulfonyl chloride (1.0 eq.) 281 and amine (3.0 eq.) 282 were reacted in
diethyl ether. No purification was required with this method.
N-Butyl-benzenesulfonamide 283a 168
S
H
NO
O
Commercially available from Aldridge [3622-84-2]. Method B: Furnished N-butyl-
benzenesulfonamide 283a as a clear oil (27.60g, 99%). IR (neat) νmax: 3274, 2958, 2869,
1316, 1155, 795, 687 cm-1. 1H NMR (400MHz, CDCl3, δ): 7.92-7.89 (d, J = 7.0, 2H,
ArCH), 7.58-7.48 (m, 3H, ArCH), 5.41 (bs, 1H, NH), 2.92 (t, J = 7.0, 2H, CH2), 1.46-
1.39 (quin., J = 7.0, 2H, CH2), 1.33-1.23 (sxt., J = 7.0, 2H, CH2), 0.80 (t, J = 7.0, 3H,
CH3). 13C NMR (100.5MHz, CDCl3, δ): 139.9 (s, C-SO2-), 132.5 (d, ArCH), 129.1 (2 x
d, ArCH), 127.0 (2 x d, ArCH), 42.9 (t, CH2), 31.4 (t, CH2), 20.0 (t, CH2), 13.5 (q,
CH3). LRMS (LSIMS-FAB+) m/z: 214 (MH+ = 100%), 154 (57), 136 (40). HRMS
(LSIMS-FAB+) m/z: calcd for C10H15NO2S, 214.0902; found, 214.0895.
N-Butyl-4-fluoro-benzenesulfonamide 283b 169
S
F
H
NO
O
Commercially available from ZereneX Molecular Limited [312-67-4]. Method B:
Furnished N-butyl-4-fluoro-benzenesulfonamide 283b as a yellow crystalline solid
(5.78g, 90%). Hydroscopic, mp 44-45 °C (lit.169 (EtOH) 37 ºC). IR (neat) νmax: 3280,
2958, 2929, 2868, 1325, 1155, 788 cm-1. 1H NMR (300MHz, CDCl3,δ): 7.92-7.86 (m,
2H, ArCH), 7.22-7.14 (app. t, J = 9, 2H, ArCH), 4.94 (bs, 1H NH), 2.92 (t, J = 7.0, 2H,
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CH2), 1.48-1.38 (quin. J = 7.0, 2H, CH2), 1.34-1.21 (sxt. J = 7.0, 2H, CH2), 0.85 (t, J =
7.0, 3H, CH3). 13C NMR (75.5MHz, CDCl3, δ): 165.0 (s, J = 254.5, C-F), 136.4 (s, C-
SO2-), 130.1 (2 x d, ArCH), 116.6 (2 x d, ArCH), 43.3 (t, CH2), 31.9 (t, CH2), 20.0 (t,
CH2), 13.9 (q, CH3). LRMS (EI+) m/z: 232 (100% M+), 188 (95), 176 (15), 159 (65).
HRMS (CI) m/z: calcd for C10H14FNO2S, 231.0729; found, 231.0729.
4-Bromo-N-butyl-benzenesulfonamide 283c 170
S
Br
H
NO
O
Commercially available from Aurora Fine Chemicals [1984-28-7]. Method B: Furnished
4-bromo-N-butyl-benzenesulfonamide 283c as a pale yellow crystalline solid (3.34g,
42%). mp (neat) 59.8 °C. IR (neat) νmax: 3262, 2955, 2867, 1321, 1153, 1088, 736 cm-1.
1H NMR (300MHz, CDCl3, δ): 7.74-7.71 (d.t, J = 9.0 and 2.0, 2H, ArCH), 7.61-7.59
(d.t, J = 9.0 and 2.0, 2H, ArCH), 4.90 (bs, 1H, NH), 2.93, (t, J = 7.0, 2H, CH2), 1.47-
1.39 (quin., J = 7.0, 2H, CH2), 1.31-1.22 (sxt., J = 7.0, 2H, CH2), 0.83 (t, J = 7.0, 3H,
CH3). 13C NMR (75.5MHz, CDCl3,δ): 139.1 (s, C-SO2-), 132.4 (2 x d, ArCH), 128.6 (2
x d, ArCH), 127.5 (s, C-Br), 42.9 (t, CH2), 31.5 (t, CH2), 19.7 (t, CH2), 13.9 (q, CH3).
LRMS (EI+) m/z: 294 (81Br MH+ 2%), 293 (81Br M+ 7), 292 (79Br MH+ 6), 291 (79Br M+
10), 250 (81Br 98), 248 (79Br 96), 156 (81Br 75), 154 (79Br 76). HRMS (CI) m/z: calcd for
C10H14BrNO2S, 290.9929 (M+); found, 290.9915. Elemental Analysis (WAS): Calcd for
C10H14BrNO2S: C, 41.1; H, 4.8; N, 4.7. Found: C, 41.4, H, 5.0, N, 4.8%.
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N-Butyl-4-iodo-benzenesulfonamide 283d 171
S
H
N
I
O
O
Commercially available from Aurora Screening Library [600638-58-2]. Method A:
Recrystallisation furnished N-butyl-4-iodo-benzenesulfonamide 283d as a crystalline
solid (5.04g, 89%). IR (neat) νmax: 3282, 2958, 2932, 2870, 1570, 1325, 1160, 818 cm-1.
1H NMR (400MHz, CDCl3, δ): 7.91-7.86 (d.t, J = 9.0 and 2.0, 2H, ArCH), 7.62-7.58
(d.t, J = 9.0 and 2.0, 2H, ArCH), 4.91 (bs, 1H, NH), 2.94 (q, J = 7.0, 2H, CH2), 1.50-
1.42 (quin., J = 7.0, 2H, CH2), 1.35-1.26 (sxt., J = 7.0, 2H, CH2), 0.87 (t, J = 7.0, 3H,
CH3). 13C NMR (100MHz, CDCl3,δ): 139.7 (s, C-SO2), 138.3 (2 x d, ArCH), 128.5 (2 x
d, ArCH), 99.8 (s, C-I), 43.0 (t, CH2), 31.5 (t, CH2), 19.8 (t, CH2), 14.0 (q, CH3).
LRMS (LSIMS-FAB+) m/z: 340 (M+ = 73%). HRMS (LSIMS-FAB+) m/z: (MH+) calcd
for C10H15INO2S, 339.9868; found, 339.9879.
N-Butyl-4-methyl-benzenesulfonamide283e 172
S
O O
N
H
Commercially available from ABCR GmbH KG [1907-65-9]. Previously synthesised by
Fullaway.163 Method B: Recrystallisation furnished N-butyl-4-methyl-benzene-
sulfonamide 283e, as a yellow crystalline solid (6.39g, 89%). mp 40-41 ºC. IR (neat)
υmax: 3244, 2937, 2868, 1427, 1316, 1155, 668 cm-1. 1H NMR (400MHz, CDCl3,δ): 7.68
(d, J = 8.0, 2H, ArCH), 7.19 (d, J = 8.0, 2H, ArCH), 5.26 (app.t, J = 6.0, 1H, NH), 2.80
(q, J = 7.0, 2H, CH2), 2.31 (s, 3H, ArCH3), 1.37-1.29 (app. quin. J = 7.0, 2H, CH2),
1.22-1.13 (app. sxt. J = 7.0, 2H, CH2), 0.72 (t, J = 7.0, 3H, CH3). 13C NMR (100.5MHz,
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CDCl3, δ): 143.2 (s, C-Me), 137.0 (s, C-SO2-), 129.7 (2 x d, ArCH), 127.1 (2 x d,
ArCH), 42.9 (t, CH2), 31.5 (t, CH2), 21.5 (q, ArCH3), 20.0 (t, CH2), 14.9 (q, CH3).
LRMS (EI+) m/z: 227 (M+ = 10), 184 (72), 154 (100). HRMS (LSIMS-FAB+) m/z: calcd
for C11H17NO2S, 227.0980; found, 227.0974. Elemental Analysis (WAS): Calcd for
C11H17NO2S: C. 58.1; H. 7.5; N. 6.2. Found: C. 58.1; H. 7.4; N. 6.2%.
Naphthalene-2-sulfonic acid-butyramide 283g 173
S
H
N
O
O
Commercially available from Aurora Fine Chemicals [40207-14-5]. Method A: Purified
by flash chromatography (petrol ether/ethyl acetate 6:1), to furnish naphthalene-2-
sulfonic acid-butyramide 283g as beigh translucent crystalline solid (4.54g, 26%). mp
56 ºC (lit. 248 54-55 °C). 1H NMR (300MHz, CDCl3, δ): 8.50 (s, 1H, ArCH), 7.92-7.85
(m, 4H, ArCH), 7.63-7.52 (m, 2H, ArCH), 5.57 (app t, J = 6.0, 1H, NH), 2.96 (q, J =
7.0, 2H, CH2), 1.49-1.39 (quin., J = 7.0, 2H, CH2), 1.31-1.19 (sxt., J = 7.0, 2H, CH2),
0.77 (t, J = 7.0, 3H, CH3). 13C NMR (100.5MHz, CDCl3, δ): 136.8 (s, C), 134.8 (s, C),
132.2 (s, C), 129.5 (d, ArCH), 129.2 (d, ArCH), 128.7 (d, ArCH), 128.4 (d, ArCH),
127.9 (d, ArCH), 127.5 (d, ArCH), 122.4 (d, ArCH), 43.0 (t, CH2), 31.6 (t, CH2), 20.1
(t, CH2), 14.6 (q, CH3). LRMS (LRMS-FAB+) m/z: 264 (MH+ = 100), 220 (10), 191
(52), 154 (40), 137 (27), 127 (46), 115 (16). HRMS (LSIMS-FAB+) m/z: calcd for
C14H17NO2S, 263.0980; found 263.0978. Elemental Analysis (WAS): Calcd for
C14H17NO2S: C, 63.8; H, 6.5; N, 5.3. Found: C, 63.5; H, 6.5; N, 5.2 %.
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N-Butyl-4-methoxy-benzenesulfonamide 283h 174
S
MeO
H
NO
O
Commercially available from Ambinter [35088-85-8]. Method A: Recrystallization
yielded N-butyl-4-methoxy-benzenesulfonamide 283h as a golden yellow solid, (5.71g,
94%). mp 39-40 °C. IR (neat) νmax: 3272, 2957, 2868, 1596, 1301, 1148, 1023, 803 cm-1.
1H NMR (300MHz, CDCl3, δ): 7.80 (app. d, J = 9.0, 2H, ArCH), 6.97 (app. d, J = 9.0,
2H, ArCH), 4.43 (t, J = 6.0, 1H, NH), 3.87 (s, 3H, OCH3), 2.93 (q, J = 7.0, 2H, CH2),
1.49-1.39 (quin., J = 7.0, 2H, CH2), 1.35-1.23 (sxt., J = 7.0, 2H, CH2), 0.85 (t, J = 7.0,
3H, CH3): 13C NMR (75.5MHz, CDCl3,δ): 161.7 (s, C-OMe), 130.5 (s, C-SO2-), 128.2
(2 x d, ArCH), 113.2 (2 x d, ArCH), 54.6 (q, OCH3), 41.9 (t, CH2), 30.5 (t, CH2), 18.7
(t, CH2), 12.5 (q, CH3). LRMS (LSIMS-FAB+) m/z: 243 (M+ = 40), 200 (54), 171 (100),
155 (15). HRMS (LSIMS-FAB+) m/z: calcd for C11H17NO3S, 243.0929; found,
243.0924. Elemental Analysis (WAS): Calcd for C11H17NO3S: C, 54.3; H, 7.0; N, 5.8.
Found: C, 54.1; H, 7.0; N, 5.7%.
N-Butyl-4-cyano-benzenesulfonamide 283i 176
S
H
N
NC
O
O
Commercially available from Ambinter [858497-76-4]. Method A: Recrystallisation
furnished N-butyl-4-cyano-benzenesulfonamide 283i as a pale yellow crystalline solid
(4.79g, 85%). mp 104.5-105.5 °C (lit. 176 99 ºC). IR (neat) νmax: 3282, 2959, 2931, 2870,
2237, 1329, 1158, 735cm-1. 1H NMR (300MHz, CDCl3, δ): 7.98 (app. d, J = 8.0, 2H,
ArCH), 7.83 (app. d, J = 8.0, 2H, ArCH), 4.5 (bs, 1H, NH), 3.0 (q, J = 7.0, 2H, CH2),
Experimental
168
1.52-1.42 (quin., J = 7.0, 2H, CH2), 1.36-1.24 (sxt., J = 7.0, 2H, CH2), 0.87 (t, J = 7.0,
3H, CH3). 13C NMR (75.5MHz, CDCl3, δ): 144.8 (s, C-SO2-), 133.4 (2 x d, ArCH),
128.1 (2 x d, ArCH), 117.8 (s, C-C≡N), 116.6 (s, C-C≡N), 43.4 (t, CH2), 31.9 (t, CH2),
20.0 (t, CH2), 13.9 (q, CH3). LRMS (LSIMS-FAB+) m/z: 239 (MH+ = 28%), 154 (100),
137 (70). HRMS (LSIMS-FAB+) m/z: calcd for C11H14N2O2S, 239.0854; found,
239.0857.
N-Butyl-4-nitro-benzenesulfonamide 283j 176
S
O2N
H
NO
O
Commercially available from Aurora Fine Chemicals [66473-14-1]. Method B:
Furnished N-butyl-4-nitro-benzenesulfonamide 283j as a pale yellow crystalline solid
(20.19g, 86%). mp 80-81 °C. (Lit. mp.176 84 ºC). IR (neat) νmax: 3294, 2939, 2860, 1522,
1345, 1305, 1151, 852 cm-1. 1H NMR (300MHz, CDCl3, δ): 8.37 (d.t, J = 9.0 and 2.0,
2H, ArCH), 8.06 (d.t, J = 9.0 and 2.0, 2H, ArCH), 4.57 (bs, 1H, NH), 3.02 (q, J = 7.0,
2H, CH2), 1.52-1.43 (quin., J = 7.0, 2H, CH2), 1.37-1.25 (sxt., J = 7.0, 2H, CH2), 0.83
(t, J = 7.0, 3H, CH3). 13C NMR (75.5MHz, CDCl3, δ): 150.4 (s, C-NO2), 146.4 (s, C-
SO2-), 128.7 (2 x d, ArCH), 124.8 (2 x d, ArCH), 43.5 (t, CH2), 32.0 (t, CH2), 20.0 (t,
CH2), 13.9 (q, CH3). LRMS (EI+) m/z: 259 (M+ = 10), 216 (12), 210 (100), 185 (65),
122 (29); HRMS (LSIMS-FAB+) m/z: (MH+) calcd for C10H15N2O4S, 258.0674; found
258.0670.
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N-Butyl-4-trifluoromethyl-benzenesulfonamide 283k
S
F3C
H
NO
O
Method A: Recrystallization yielded N-butyl-4-trifluoromethyl-benzenesulfonamide
283k as a beige reflective crystalline solid (3.61g, 94%). mp 76-77 °C. IR (neat) νmax:
3263, 2960, 2931, 2867, 1322, 1162, 713 cm-1. 1H NMR (300MHz, CDCl3,δ): 8.01 (d, J
= 8.5, 2H, ArCH), 7.79 (d, J = 8.5, 2H, ArCH), 4.68 (bs, 1H, NH), 2.97 (t, J = 7.0, 2H,
CH2), 1.51-1.42 (m, 2H, CH2), 1.36-1.24 (sxt., J = 7.0, 2H, CH2), 0.87 (t, 7.0, 3H, CH3).
13C NMR (100.5MHz, CDCl3,δ): 144.0 (s, C-SO2-), 134.5 (s, J = 286.6, C-CF3), 127.6
(2 x d, ArCH), 126.4 (2 x d, ArCH), 124.5 (s, J = 34, ArC-CF3), 43.0 (t, CH2), 31.5 (t,
CH2), 19.9 (t, CH2), 13.6 (q, CH3). LRMS (LSIMS-FAB+) m/z: 282 (M+ = 100%), 280
(15), 226 (26), 209 (17), 154 (43). HRMS (LSIMS-FAB+) m/z: (MH+) calcd for
C11H15F3NO2S, 282.0776; found, 282.0772.
N-Butyl-(bis-3, 5-trifluoromethylbenzene)-sulfonamide 283l
S
H
N
CF3
F3C
O
O
Method A: Purified using column chromatography (diethyl ether/hexane; 3:1) to furnish
N-butyl-(bis-3,5-trifluoromethylbenzene)-sulfonamide 283l as an off-white (beige)
crystalline solid (2.86, 76%). mp 83.8-84.8 °C. IR (neat) νmax: 3287, 2967, 2934, 2872,
1340, 1136, 904, 689 cm-1. 1H NMR (300MHz, CDCl3,δ): 8.31 (s, 2H, ArCH), 8.07 (s,
1H, ArCH), 4.67 (t, J = 6.0, 1H, NH), 3.04 (q, J = 7.0, 2H, CH2), 1.54-1.44 (quin., J =
7.0, 2H, CH2), 1.37-1.25 (sxt., J = 7.0, 2H, CH2), 0.87 (t, J = 7.0, 3H, CH3). 13C NMR
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(75.5MHz, CDCl3,δ): 142.1 (s, ArC-SO-), 132.1 (2 x s, J = 273.4, C-CF3), 126.29 (2 x
d, ArCH), 125.1 (d, ArCH), 121.0 (2 x s, J = 34.4, ArC-CF3), 42.1 (t, CH2), 30.56 (t,
CH2), 18.6 (t, CH2), 12.3 (q, CH3). LRMS (EI+) m/z: 350 (MH+ = 83), 213 (100), 195
(28), 145 (21) and 121 (50). HRMS (CI): calcd for C12H13F6NO2S, 349.0571; found,
349.0571; Elemental Analysis (WAS): Calcd for C12H13F6NO2S: C, 41.3; H, 4.0; N, 3.8.
Found: C, 41.5; H, 3.8; N, 4.0%.
2.0 General synthesis of N-alkyl-4-methyl-benzenesulfonamides
S NH
R
O
O
2.1 Method A
To a stirred solution of 4-methyl-benzenesulfonyl chloride 281 (1.2 eq.) in
dichloromethane (DCM) (50 mL) was added the alkylamine 373 (1.0 eq.) and
triethylamine (TEA) (1.36 eq.). The solution was stirred at 0 °C (ice bath) for four hours
unless otherwise stated. The reaction was quenched with distilled water (50 mL) and the
product extracted with DCM or ether (3 x 50 mL). The combined organic extracts were
dried over anhydrous magnesium sulfate and the solvent removed in vacuo to yield the
crude arylsulfonamide 374. Purification was by recrystallization (diethyl ether/hexane)
or flash chromatography (petroleum ether/ethyl acetate).
2.2 Method B
As above but 4-methylbenzenesulfonyl chloride 281 and alkylamine 373 (3.0 eq.) were
reacted in diethylether. No purification was required with this method.
Experimental
171
N-Ethyl-4-methyl-benzenesulfonamide374a228
HN
S O
O
Commercially available from Aldrich [80-39-7]. Method B: Furnished N-ethyl-4-methyl-
benzenesulfonamide 374a as an hydroscopic white crystallized solid (4.78g, 84%). mp
67.9-68.9 ºC. IR (neat) νmax: 3268, 2978, 2876, 2361, 1322, 1157, 814 cm-1. 1H NMR
(300MHz, CDCl3, δ): 7.79 (d, J = 8.0, 2H, ArCH), 7.32 (d, J = 8.0, 2H, ArCH), 5.11
(app. t, J = 5.0, 1H, NH), 2.97 (quin., J = 7.0, 2H, CH2), 2.42 (s, 3H, ArCH3), 1.08 (t, J
= 7.0, 3H, CH3). 13C NMR (75.5MHz, CDCl3, δ): 143.1 (s, C-Me), 136.7 (s, C-SO2-),
129.4 (2 x d, ArCH), 126.9 (2 x d, ArCH), 37.3 (t, CH2), 21.3 (q, ArCH3), 14.7 (q,
CH3). LRMS (EI+) m/z: 199 (M+ = 20%), 184 (90), 155 (100). HRMS (LSIMS-FAB+)
m/z: calcd for C9H14NO2S (MH+), 200.0745; found, 200.0742. Elemental Analysis
(WAS): Calcd. for C9H13NO2S: C, 54.2; H, 6.6; N, 7.0. Found: C, 54.3; H, 6.5; N, 7.0%.
N-Propyl-4-methyl-benzenesulfonamide 374b 229
S
O
O
H
N
Commercially available from Interchim [1133-12-6]. Method B; Furnished N-propyl-4-
methyl-benzenesulfonamide 374b as a yellow viscous solid (5.43g, 81%). mp 27-28 ºC.
IR (neat) νmax: 3275, 2968, 2875, 1315, 1156 and 814 cm-1. 1H NMR (300MHz, CDCl3,
δ): 7.66 (d, J = 8.0, 2H, ArCH), 7.17 (d, J = 8.0, 2H, ArCH), 5.52 (app.t, J = 5.0, 1H,
NH), 2.75 (t, J = 7.0, 2H, CH2), 2.28 (s, 3H, ArCH), 1.40-1.31 (sxt., J = 7.0, 2H, CH2),
0.72 (t, J = 7.0, 3H, CH3). 13C NMR (100MHz, CDCl3,δ): 143.0 (s, C-Me), 136.8 (s, C-
SO2-), 129.4 (2 x d, ArCH), 126.9 (2 x d, ArCH), 44.7 (t, CH2), 22.6 (t, CH2), 21.1 (q,
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ArCH3), 10.9 (q, CH3). LRMS (CI) m/z: 214 MH+ = 22%), 196 (35), 184 (67), 155 (90),
139 (15). HRMS (CI) calcd for C10H15NO2S; 213.0823, found 213.0817. Elemental
Analysis (WAS): Calcd. for C10H15NO2S; C, 56.1; H, 7.1; N, 6.6. Found: C, 55.9; H,
7.1; N, 6.4%.
4-Methyl-N-pentyl-benzenesulfonamide 374d
HN
S O
O
Commercially available from Aurora Fine Chemicals [106011-68-1]. Method B:
Furnished 4-methyl-N-pentyl-benzenesulfonamide 374d as a colourless oil (5.80g, 92%).
IR (neat) νmax: 3276, 2929, 1322, 1155, 813, 659 cm-1. 1H NMR (300MHz, CDCl3, δ):
7.74 (d.t, J = 8.0 and 2.0, 2H, ArCH), 7.30 (d, J = 8.0, 2H, ArCH), 4.35 (t, J = 6.0, 1H,
NH), 2.92 (q, J = 7.0, 2H, CH2), 2.43 (s, 3H, ArCH3), 1.49-1.41 (app. quin., J = 7.0, 2H,
CH2), 1.27-1.21 (m, 4H, CH2), 0.84 (t, J = 7.0, 3H, CH3). 13C NMR (100MHz, CDCl3,
δ): 143.3 (s, C-Me), 137.0 (s, C-SO2-), 129.7 (2 x d, ArCH), 127.1 (2 x d, ArCH), 43.2
(t, CH2), 29.2 (t, CH2), 28.7 (t, CH2), 22.1 (t, CH2), 21.5 (q, ArCH3), 14.3 (q, CH3).
LRMS (LSIMS-FAB+) m/z: 242 (MH+ 100%), 154 (22%), 137 (16%). HRMS (LSIMS-
FAB+) m/z: (MH+) calcd for C12H20NO2S, 242.1215; found, 242.1210. Elemental
Analysis (WAS): Calcd for C12H19NO2S: C, 59.7; H, 7.9; N, 5.8. Found: C, 59.5; H, 7.8;
N, 5.7%.
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N-Hexyl-4-methyl-benzenesulfonamide 374e 231
HN
S O
O
Commercially available from Interchim [1143-01-7]. Method A: Recrystallisation
furnished N-hexyl-4-methylbenzenesulfonamide 374e as a white crystallised solid (4.34g,
62%). mp 83.0-84.0 ºC (lit. 231 DCM/Pentane 59.5 °C). IR (neat) νmax: 3280, 2922, 2854,
1319, 1153, 664 cm-1. 1H NMR (300MHz, CDCl3, δ): 7.74 (d.t, J = 8.0 + 2.0, 2H,
ArCH), 7.29 (d, J = 8.0, 2H, ArCH), 4.39 (app. t, J = 6.0, 1H, NH), 2.89 (t, J = 7.0, 2H,
CH2), 2.42 (s, 3H, ArCH3), 1.48-1.36 (sxt., J = 7.0, 2H, CH2), 1.29-1.13 (m, 6H, 3 x
CH2), 0.83 (t, J = 7.0, 3H, CH3). 13C NMR (100MHz, CDCl3,δ): 143.2 (s, C-Me), 137.0
(s, C-SO2-), 129.6 (2 x d, ArCH), 127.1 (2 x d, ArCH), 43.2 (t, CH2), 31.2 (t, CH2),
29.5 (t, CH2), 26.2 (t, CH2), 22.4 (t, CH2), 21.5 (q, ArCH3), 15.0 (q, CH3). LRMS (CI)
m/z: 256 (MH+ 23%), 184 (80), 155 (100), 100 (28), 91 (80). HRMS (EI+) calcd for
C13H21NO2S, 255.1293; found, 255.1293. Elemental Analysis (WAS): Calcd for
C13H21NO2S: C, 61.1; H, 8.3; N, 5.5. Found: C, 61.0; H, 8.1; N, 5.5%.
N-Docecyl-4-methyl-benzenesulfonamide 374f 232
HN
S O
O
Commercially available from Aurora Fine Chemicals [1635-09-2]. Method B: Furnished
N-dodecyl-4-methylbenzenesulfonamide 374f as a white crystallised solid (4.19g, 45%).
mp 86.0-87.0 ºC. IR (neat) νmax: 3284, 2914, 2845, 1324, 1157, 814, 670 cm-1. 1H NMR
(300MHz, CDCl3,δ): 7.74 (d.t, J = 8.0 + 2.0, 2H, ArCH), 7.30 (d, J = 8.0, 2H, ArCH),
5.0 (bs, 1H, NH), 2.90 (t, J = 7.0, 2H, CH2), 2.42 (s, 3H, ArCH3), 1.19-1.46 (m, 20H
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CH2), 0.87 (t, J = 7.0, 3H, CH3). 13C NMR (75.5MHz, CDCl3, δ): 143.6 (s, C-Me),
137.4 (s, C-SO2-), 130.0 (2 x d, ArCH), 127.5 (2 x d, ArCH), 43.6 (t, CH2), 32.3 (t,
CH), 30.0 (t, CH2), 29.9 (t, CH2), 29.9 (t, CH2), 29.8 (t, CH2), 29.8 (t, CH2), 29.7 (t,
CH2), 29.5 (t, CH2), 26.9 (t, CH2), 23.1 (t, CH2), 21.9 (q, ArCH3), 14.5 (q, CH3).
LRMS (EI+) m/z: 340 (MH+ 35%), 184 (100), 172 (40), 155 (98), 91 (85%). HRMS
(EI+) m/z: calcd for C19H33NO2S, 339.2232; found, 339.2246. Elemental Analysis
(WAS): Calcd for C19H33NO2S: C, 67.2; H, 9.8; N, 4.1. Found: C, 66.8; H, 9.6; N, 3.8%.
N-Isopropyl-4-methyl-benzenesulfonamide 374g234
HN
S O
O
Commercially available from Aurora Fine Chemicals [21230-07-9]. Method B:
Furnished N-isopropyl-4-methylbenzenesulfonamide 374g, as a pale yellow crystalline
solid (3.66g, 65%). mp 55.2-56.2 ºC. IR (neat) υmax: 3275, 2974, 1320, 1141, 1092, 729.
1H NMR (400MHz, CDCl3,δ): 7.76 (d.t, J = 8.0 and 2.0, 2H, ArCH), 7.29 (d, J = 8.0,
2H, ArCH), 4.26 (d, J = 7.0, 1H, NH), 3.45 (oct. J = 7.0, 1H, CH), 2.43 (s, 3H, ArCH3),
1.07 (d, J = 7.0, 6H, 2 x CH3). 13C NMR (100MHz, CDCl3, δ): 143.6 (s, C-Me), 138.5
(s, C-SO2-), 130.5 (2 x d, ArCH), 127.4 (2 x d, ArCH), 46.4 (d, CH), 24.1 (2 x q, CH3),
21.9 (q, ArCH3). LRMS (LSIMS-FAB+) m/z: 214 (MH+ 100%), 172 (30), 155 (15), 137
(13). HRMS (LSIMS-FAB+) m/z: calcd for C10H16NO2S, 214.0902; found, 214.0912;
Elemental Analysis (WAS): Calcd for C10H15NO2S: C, 56.3; H, 7.1; N, 6.5. Found: C,
56.1; H, 7.1; N, 6.4%.
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N-Isobutyl-4-methyl-benzenesulfonamide 374h 235
S
O
O HN
Commercially available from Ambinter [23705-38-6]. Previously synthesised by
Fullaway.164 Method B: Furnished N-isobutyl-4-methylbenzenesulfonamide 374h as a
pale yellow crystallised solid (5.14g, 85%). mp (neat) 80.0-81.0 ºC (lit. 77-78 °C). IR
(neat) νmax: 3273, 2960, 2872, 1320, 1155, 729 cm-1. 1H NMR (300MHz, CDCl3, δ):
7.74 (d, J = 8.0, 2H, ArCH), 7.30 (d, J = 8.0, 2H, ArCH), 4.55 (bs, 1H, NH), 2.74 (t, J =
7.0, 2H, CH2), 2.43 (s, 3H, ArCH3), 1.71 (spt., J = 7.0, 1H, CH), 0.86 (d, J = 7.0, 6H, 2
x CH3). 13C NMR (75.5MHz, CDCl3, δ): 143.1 (s, C-Me), 136.8 (s, C-SO2-), 129.5 (2 x
d, ArCH), 126.8 (2 x d, ArCH), 50.3 (t, CH2), 28.2 (d, CH2), 21.9 (q, ArCH3), 19.7 (2 x
q, CH3). LRMS (LSIMS-FAB+) m/z: 228 (MH+ 100%), 154 (100), 137 (70). HRMS
(LSIMS-FAB+) m/z: (MH+) calcd. 228.1058 for C11H18NO2S; found, 228.1065.
Elemental Analysis (WAS): Calcd for C11H17NO2S: C, 58.1; H, 7.5; N, 6.1. Found: C,
57.8; H, 7.4; N, 6.1%.
N-sec-Butyl-4-methyl-benzenesulfonamide 374i 235
H
N
S
O
O
Commercially available from Interchim [23705-40-0]. Previously synthesised by
Fullaway.164 Method A: Recrystallisation furnished N-sec-butyl-4-methyl-
benzenesulfonamide 374i as a yellow crystalline solid (2.89g, 41%). mp (neat) 61.5-62.5
ºC (lit. 56-57 °C). IR νmax (neat) 3274, 2969, 2875, 1313, 1157, 814, 661 cm-1. 1H NMR
(300MHz, CDCl3, δ): 7.79 (d.t, J = 8.0 + 2.0, 2H ArCH), 7.29 (d, J = 8.0, 2H, ArCH),
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4.99 (bs, 1H, NH), 3.28-3.17 (app. sxt., J = 7.0, 1H, CH), 2.42 (s, 3H, ArCH3), 1.45-
1.35 (app. quin., J = 7.0, 2H, CH2), 1.00 (d, J = 7.0, 3H, CH3), 0.79 (t, J = 7.0 , 3H,
CH3). 13C NMR (75.5 (MHz, CDCl3,δ) 142.8 (s, C-Me), 138.1 (s, C-SO2), 129.4 (2 x d,
ArCH), 126.8 (2 x d, ArCH), 51.1 (d, CH), 30.0 (t, CH2), 21.6 (q, ArCH3), 21.1 (q,
CH3), 9.7 (q, CH3). LRMS (LSIMS-FAB+) m/z: 228 (MH+ 100%), 226 (15), 198 (25),
172 (67), 155 (45), 139 (26), 136 (24). HRMS (LSIMS-FAB+) m/z: (MH+) calcd. for
C11H18NO2S, 228.1058; found, 228.1051. Elemental Analysis (WAS): Calcd for
C11H17NO2S: C, 58.1; H, 7.5; N, 6.1. Found: C, 58.0; H, 7.4; N, 6.1%.
N-tert-Butyl-4-methyl-benzenesulfonamide 374j 236
HN
S O
O
Commercially available from Maybridge [2849-81-2]. Method B: Furnished N-tert-
butyl-4-methylbenzenesulfonamide 374j as a lemon-yellow crystallised solid (4.37g,
72%). mp 121.5-122.5 ºC. IR νmax (neat): 3262, 2921, 2852, 1300, 1134, 656 cm-1. 1H
NMR (400MHz, CDCl3,δ): 7.78 (d, J = 8.0, 2H, ArCH), 7.27 (d, J = 8.0, 2H, ArCH),
4.88 (bs, 1H, NH), 2.42 (s, 3H, ArCH3), 1.21 (s, 9H, 3 x CH3). 13C NMR (75.5MHz,
CDCl3, δ): 142.5 (s, C-Me), 140.3 (s, C-SO2-), 129.2 (2 x d, ArCH), 126.7 (2 x d,
ArCH), 54.3 (s, C-(CH3)3), 29.9 (3 x q, CH3), 21.26 (q, ArCH3). LRMS (LSIMS-FAB+)
m/z: 228 (MH+ 100), 212 (35), 172 (100), 137 (58). HRMS (LSIMS-FAB+) m/z: calcd.
for C11H18NO2S, 228.1058; found, 228.1051. Elemental Analysis (WAS): Calcd for
C11H17NO2S: C, 58.4; H, 7.6; N, 6.0. Found: C, 58.1; H, 7.5; N, 6.1%.
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N-(R)-(-)-(1-Cyclohexylethyl)-4-methylbenzenesulfonamide 374k 237
S
O
O
H
N
Method A: Recrystallisation furnished N-(R)-(-)-(1-cyclohexyl-ethyl)-4-methylbenzene
sulfonamide 374k as a white powdery crystalline solid (7.18g, 97%). mp 131.5-132.5 ºC.
IR (neat) νmax: 3288, 2916, 2860, 1321, 1159 and 671 cm-1. 1H NMR (300MHz; CDCl3,
δ): 7.77-7.74 (d.t, J = 8.0 and 2.0, 2H, ArCH), 7.29 (d, J = 8.0, 2H, ArCH), 4.30 (bd, J =
8.0, 1H, NH), 3.19-3.10 (m, 1H, NH), 2.42 (s, 3H, ArCH3), 1.72-1.52 (m, 6H, CH2),
1.29-0.76 (m, 8H, CH2 + CH3 overlap). 13C NMR (100MHz, CDCl3, δ): 143.1 (s, C-
Me), 138.4 (s, C-SO2-), 129.6 (2 x d, ArCH), 127.1 (2 x d, ArCH), 54.4 (d, CH), 43.5
(d, CH), 28.5 (2 x t, CH2), 26.1 (3 x t, CH2), 21.5 (q, ArCH3), 19.5 (q, CH3). LRMS
(LSIMS-FAB+) m/z: 282 (MH+ = 70%), 198 (30), 172 (24), 154 (100), 136 (95), 120
(20). HRMS (LSIMS-FAB+) m/z: (MH+) calcd for C15H24NO2S, 282.1528; found,
282.1541.
N-Adamantan-1-yl-4-methylbenzenesulfonamide 374l 238
HN
S
O
O
Commercially available from Ambinter [56432-99-6]. Method A: Recrystallisation
furnished N-adamantan-1-yl-4-methylbenzene sulfonamide 374l as a white floury solid
(6.10g, 76%); IR (neat) νmax: 3228, 2971, 2844, 1328, 1114 `and 665 cm-1; 1H NMR
(400MHz, CDCl3,δ) 7.77 (d.t, J = 8.0 and 2.0, 2H, ArCH), 7.27 (d, J = 8.0, 2H, ArCH),
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4.45 (s, 1H, NH), 2.42 (s, 3H, ArCH3), 2.00 (bs, 3H, CH), 1.78 (app. s, 6H, CH2), 1.57
(m, 6H, CH2). 13C NMR (100MHz, CDCl3,δ) 142.7 (s, C-Me), 141.1 (s, C-SO2-), 129.4
(2 x d, ArCH), 126.9 (2 x d, ArCH), 55.1 (s, C-NH-), 43.1 (3 x t, CH2), 35.9 (3 x t,
CH2), 29.5 (3 x d, CH), 21.5 (q, ArCH). LRMS (LSIMS-FAB+) m/z: 306 (MH+ = 46%),
154 (32), 135 (100). HRMS (LSIMS-FAB+) m/z: calcd for C17H23NO2S; 304.1371,
found 304.1370. Elemental Analysis (WAS): Calcd for C, 66.8, H, 7.6, N, 4.6;
C17H23NO2S, Found: C, 66.7, H, 7.5, N, 4.6%.
3.0 General synthesis of N-alkyl-(4-methyl)-benzenesulfonamides
S NH
Ar
O
O
3.1 Method A
To a stirred solution of 4-methylbenzenesulfonyl chloride 281e (1.2 eq.) in
dichloromethane (DCM) (50 mL) was added the amine 379 (1.0 eq.) and triethylamine
(TEA) (1.36 eq.). The solution was stirred at 0 °C (ice bath) for four hours unless
otherwise stated. The reaction was quenched with distilled water (50 mL) and the
product extracted with DCM or ether (3 x 50 mL). The combined organic extracts were
dried over anhydrous magnesium sulfate and the solvent removed in vacuo to yield the
crude arylsulfonamide 380. Purification was by recrystallization (diethyl ether/hexane)
or flash chromatography (petroleum ether/ethyl acetate).
5.3.2 Method B
As above but 4-methyl-benzenesulfonyl chloride (1.0 eq.) 281e and arylamine (3.0 eq.)
379 were reacted in diethylether. No purification was required with this method.
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4-Methyl-N-(4-methylbenzyl)-benzenesulfonamide 380a 239
S
O
O HN
Commercially available from Ambinter [10504-92-4]. Method A: Recrystallization
furnished 4-methyl-N-(4-methylbenzyl)-benzenesulfonamide 380a as a yellow
crystallised solid (1.59g, 22%). mp 80.5-81.5 °C. IR (neat) νmax: 3270, 2916, 1324, 1152,
843, 798, 741, 657 cm-1. 1H NMR (400MHz; CDCl3, δ): 7.76 (d. J = 8.0, 2H, ArCH),
7.27 (d. J = 8.0, 2H, ArCH), 7.10 (d, J = 8.0, 2H, ArCH), 7.08 (m, 2H, ArCH), 5.50 (t, J
= 6.0, 1H, NH), 4.06 (d, J = 6.0, 2H, CH2), 2.43 (s, 3H, ArCH3), 2.31 (s, 3H, CH3). 13C
NMR (100MHz, CDCl3, δ): 143.3 (s, C-Me), 137.3 (s, C-CH2-), 137.0 (s, C-SO2-),
133.6 (s, C-Me), 129.7 (2 x d, ArCH), 129.3 (2 x d, ArCH), 127.9 (2 x d, ArCH), 127.2
(2 x d, ArCH), 46.9 (t, CH2), 21.5 (q, ArCH2), 21.0 (q, ArCH3). LRMS (LSIMS-FAB+)
m/z: 276 (MH+ = 68%), 184 (26), 154 (100), 137 (70). HRMS (LSIMS-FAB+) m/z: calcd
for C15H17NO2S, 276.1058; found, 276.1050.
N-(4-Methoxybenzyl)-4-methylbenzenesulfonamide 380b
S
O
O HN
OCH3
Commercially available from Ambinter [54979-64-0]. Method A: Recrystallisation
furnished N-(4-methoxybenzyl)-4-methylbenzene sulfonamide 380b as hydroscopic
lemon-yellow (2.56g, 33%). mp 127.5-128.5 ºC. IR (neat) νmax: 3245, 2974, 2837, 1251,
1319, 1154 and 815 cm-1. 1H NMR (400MHz; CDCl3, δ): 7.75 (app. d., J = 8.0, 2H,
ArCH), 7.31 (d, J = 8.0, 2H, ArCH), 7.10 (d.t., J = 8.0 and 3.0, 2H, ArCH), 6.79 (d.t, J
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= 8.0 and 3.0, 2H, ArCH), 4.55 (app. t., J = 5.0, 1H, NH), 4.05 (d, J = 6.0, 2H, CH2),
3.77 (s, 3H, OCH3), 2.44 (s, 3H, ArCH3). 13C NMR (100MHz, CDCl3,δ): 159.4 (s, C-
OMe), 143.5 (s, C-Me), 136.9 (s, C-SO2-), 129.7 (2 x d, ArCH), 129.1 (2 x d, ArCH),
128.3 (s, C-CH2-), 127.2 (2 x d, ArCH), 114.1 (2 x d, ArCH), 55.3 (q, OCH3), 46.8 (t,
CH2), 21.5 (q, ArCH3). LRMS (LSIMS) m/z: 291 (M+ = 100%), 219 (20), 154 (100),
136 (100), 121 (65). HRMS (LSIMS-FAB+) m/z: (MH+) calcd for C15H18NO3S,
292.1007; found, 292.1015.
4-Methyl-N-(2-trifluoromethylbenzyl)-benzenesulfonamide 380c 240
S
O
O
NH
F3C
Method A: Recrystallisation furnished 4-methyl-N-(2-trifluoromethylbenzyl)-benzene-
sulfonamide 380c as a very pale yellow crystallised solid (7.13g, 83%). IR (neat) υmax:
3236, 2361, 1308, 1152, 714. mp. 98.5-99.5 °C. 1H NMR (400MHz, CDCl3,δ): 7.74 (d,
J = 8.0, 2H, ArCH), 7.59 (t, J = 8.0, 2H, ArCH), 7.49 (t, J = 8.0, 1H, ArCH), 7.37 (t, J =
8.0, 1H, ArCH), 7.30 (d, J = 8.0, 2H, ArCH), 4.85 (app. t, J = 7.0, 1H, NH), 4.29 (d, J =
7.0, 2H, CH2), 2.43 (s, 3H, ArCH3). 13C NMR (100MHz, CDCl3, δ): 143.7 (s, C-Me),
136.8 (s, C-CH2-), 134.9 (s, C-SO2-), 132.3 (d, ArCH), 130.8 (d, ArCH), 129.8 (2 x d,
ArCH), 128.0 (2 x d, ArCH), 127.1 (2 x d, CH), 125.5-123.5 (s, J = 200.0, C-C-F), not
observed (CF3), 43.7 (t, CH2), 21.5 (q, ArCH3). (LSIMS-FAB+) m/z: 330 (MH+ =
100%), 159 (23), 137 (12). HRMS (LSIMS-FAB+) m/z: (MH+) calcd. for
C15H15F3NO2S; 330.0775, found 330.0778. Elemental Analysis (WAS): Calcd for
C15H14F3NO2S: C, 54.6; H, 4.2; N, 4.1. Found: C, 54.7; H, 4.2; N, 4.2.
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4-Methyl-N-pyridin-2-ylmethylbenzenesulfonamide 380d 241
S
O
O
H
N
N
Commercially available from Ambinter [75391-97-8]. Method A: recrystallisation
furnished 4-methyl-N-pyridin-2-yl-methylbenzensulfonamide 380d as hydroscopic
lemon-yellow crystallised solid (2.21g, 32%). IR (neat) νmax: 3059, 2920, 2852, 1326,
1155 and 811 cm-1. 1H NMR (300MHz; CDCl3,δ): 8.5 (app. s, 1H, ArCH ), 7.75 (d.t, J
= 8.0 and 2.0, 2H, ArCH), 7.64 (app. d.t, J = 8.0 and 2.0, 1H, ArCH), 7.26-7.18 (m, 4H,
ArCH), 5.98 (app. t, J = 5.0, 1H, NH), 4.25 (d, J = 5.0, 2H, CH2), 2.39 (s, 3H, ArCH3).
13C NMR (100MHz, CDCl3, δ): 155.2 (s, C-pyridine), 148.9 (d, ArCH), 143.8 (2 x s,
C), 137.7 (d, ArCH), 130.0 (2 x d, ArCH), 127.6 (2 x d, ArCH), 123.2 (d, ArCH),
122.6 (d, ArCH), 47.6 (t, CH2), 21.9 (q, ArCH3). LRMS (LSIMS-FAB+) m/z: 263 (MH+
= 35%), 154 (100), 137 (67), 136 (60). HRMS (LSIMS-FAB+) m/z: (MH+) calcd for
C13H14N2O2S, 263.0854; found, 263.0858.
N-Furan-2-ylmethyl-4-methylbenzenesulfonamide 380e 242
S
O
O HN
O
Commercially available from Ambinter [121564-33-8]. Method A: Recrystallisation
furnished N-furan-2-ylmethylbenzenesulfonamide 380e as an hydroscopic golden yellow
crystallised solid (4.95g, 75%). IR (neat) νmax: 3275, 2918, 2839, 1321, 1185, 686 cm-1.
1H NMR (400MHz; CDCl3,δ): 7.72 (d.t, J = 8.0 and 2.0, 2H, ArCH), 7.27 (d, J = 8.0,
2H, ArCH), 7.24 (app. d, J = 2.0, 1H, ArCH), 6.21 (app. q., J = 2.0, 1H, ArCH), 6.09
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(app. d, J = 3.0, 1H, ArCH), 4.78 (app. t, J = 6.0, 1H, NH), 4.16 (d, J = 6.0, 2H, CH2),
2.42 (s, 3H, ArCH3). 13C NMR (100MHz, CDCl3, δ): 149.9 (s, C-furan), 143.9 (s, C-
Me), 142.9 (d, CH), 137.21 (s, C-SO2-), 130.6 (2 x d, ArCH), 127.5 (2 x d, ArCH),
110.8 (d, CH), 108.6 (d, CH), 40.5 (t, CH2), 21.9 (q, ArCH3). LRMS (LSIMS-FAB+)
m/z: 252 (MH+ = 20%), 250 (33), 184 (64), 154 (100), 136 (96), 133 (54), 128 (25), 120
(15). HRMS (LSIMS-FAB+) m/z: (MH+) calcd for C12H14NO3S, 252.0694; found,
252.0696. Elemental Analysis (WAS): Calcd. for C12H13NO3S: C, 57.3; H, 5.2; N, 5.6.
Found: C, 57.1; H, 5.2; N, 5.5%.
4-Methyl-N-(2-thienylmethyl)-benzenesulfonamide 380f
S
O
O
H
N
S
Commercially available from Ambinter [545358-50-7]. Method A: Recrystallisation
furnished 4-Methyl-N-(2-thienylmethyl)-benzenesulfonamide 380f as golden yellow
crystallised solid (4.95g, 75%). IR (neat) νmax: 3286, 2977, 2862, 1320, 1117, 613 cm-1.
1H NMR (400MHz; CDCl3, δ): 7.73 (d, J = 8.0, 2H, ArCH), 7.28 (d, J = 8.0, 2H,
ArCH), 7.16 (app. d., J = 1.0, 1H, ArCH), 6.85 (app. quin., J = 3.0, 2H, ArCH), 5.00
(bs, 1H, NH), 4.31 (s, 2H, CH2), 2.42 (s, 3H, ArCH3). 13C NMR (100MHz, CDCl3, δ):
143.6 (s, C-Me), 139.0 (s, C-thiophene), 136.8 (s, C-SO2-), 129.8 (2 x d, ArCH), 127.8
(d, CH), 126.9 (d, CH), 126.5 (d, CH), 125.8 (2 x d, ArCH), 42.1 (t, CH2), 21.6 (q,
ArCH3). LRMS (LSIMS-FAB+) m/z: 268 (MH+ = 28%), 219 (20), 184 (40), 154 (100),
136 (70). Elemental analysis (WAS): Calcd for C12H13NO2S2: C, 53.9; H, 4.9; N, 5.2.
Found: C, 53.7; H, 4.8; N, 5.1%.
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4.0 General procedure for radical precursors 278a-l
S
N O
Br
R1
O
O
4.1 N-BUTYLLITHIUM METHOD:
To a stirred solution of N-butyl-4-(substituted)-benzenesulfonamide 283 (1.0 eq.) in
anhydrous tetrahydrofuran was added n-butyllithium (1.6 M in hexanes) (1.0 eq.) and 2-
bromo-isobutyryl bromide 284 (1.0 eq.) at -78°C (dry ice/acetone) overnight. The
reaction was quenched with saturated ammonium chloride (10 mL), and the product
extracted with dichloromethane (200 mL), followed by saturated sodium bicarbonate
(200 mL). The aqueous phase was washed with dichloromethane (2 x 200 mL) and the
combined organic fractions were washed with saturated sodium chloride. The organic
phase was dried with magnesium sulfate, and the solvent evaporated in-vacuo to yield a
crude product. Purification of the crude product (petrol ether: ethyl acetate) furnished the
radical precursor 278.
4.2 TRIETHYLAMINE METHOD
To a stirred solution of N-butyl-(substituted) benzenelsulfonamide 283 (1.0 eq.) in dry
dichloromethane was added triethylamine (1.0 eq.) and 2-bromo-isobutyryl bromide 284
(1.0 eq.), under nitrogen at room temperature overnight. The reaction was quenched with
distilled water (50 mL), and the product extracted with diethyl ether (3 x 50 mL). The
combined organic extracts were dried over magnesium sulfate and the solvent
evaporated in vacuo to furnish the crude product. Purification with petrol ether: ethyl
acetate, yield the radical precursor 278.
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4.3 HÜNIG’S BASE METHOD
To a solution of N-butyl-(substituted)-benzenesulfonamide (1.0 eq.) 283 in
dichloromethane, was added N-ethyldiisopropylamine (Hünig’s base, 1.3 eq.) and 2-
bromo-isobutyryl bromide (1.1 eq.) 284 at room temperature overnight. The reaction
was quenched with distilled water (50 mL), and the product was extracted with
dichloromethane (3 x 50 mL). The combined organic extracts were dried with
magnesium sulfate and the solvent evaporated in-vacuo to yield the crude product.
Purification with petrol ether: ethyl acetate furnished the radical precursor 278.
4.4 IMPROVED METHOD
When the radical precursor 283 (1.0 eq.), triethylamine (1.0 eq.) and the acid bromide
284 (3.0 eq.) are used, no eliminated product 286 is observed. Work up is same as for
method 2.
N- (2-Bromo-2-methyl-propionyl)-N-butyl-benzenesulfonamide 278a
S N
O
Br
O
O
Flash chromatography (petrol ether/ethyl acetate, 6:1) furnished N-(2-bromo-2-methyl-
propionyl)-N-butyl-benzenesulfonamide 278a as a light yellow viscous solid (13.17g,
31%). IR (neat) υmax: 2955, 1675, 1346, 1166, 1069, 723 cm-1. 1H NMR
(400MHz/CDCl3,δ): 7.99-7.96 (app. d.t, J = 8.0 and 2.0, 2H, ArCH), 7.61-7.59 (m, 1H,
ArCH), 7.54-7.50 (m, 2H, ArCH) 4.19 (app. t, J = 8.0, 2H, CH2), 1.96-1.88 (m, 8H,
CH2 and C (CH3)2) 1.46-1.37 (app. sxt., J = 7.0, 2H, CH2), 0.99 (t, J = 7.0, 3H, CH3).
13C NMR (75.5MHz, CDCl3,δ): 170.8 (s, C═O), 139.7 (s, C-SO2-), 133.9 (d, ArCH),
Experimental
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133.0 (d, ArCH), 128.8-128.1 (3 x d, ArCH), 57.0 (s, C-(CH3)2), 48.8 (t, CH2), 33.3 (2
x q, C(CH3)2), 31.7 (t, CH2), 19.9 (t, CH2), 13.7 (q, CH3). LRMS (EI+) m/z: 364 (81Br
MH+ = 54%), 362 (79Br MH+ = 56), 284 (81Br = 15), 282 (79Br = 98), 206 (81Br = 65),
204 (79Br = 66), 170 (55), 141 (100). HRMS (EI+) m/z: (MH+) calcd for C14H21BrNO3S,
362.0425; found, 362.0425.
N-(2-Bromo-2-methyl-propionyl)-N-butyl-4-fluoro-benzenesulfonamide 278b
F S
O
O
N
O Br
Flash chromatography (petrol ether/ethyl acetate, 6:1) furnished N-(2-bromo-2-methyl-
propionyl)-N-butyl-4-fluoro-benzenesulfonamide 278b as a yellow viscous solid (2.52g,
52%). IR (neat) υmax: 2955, 1669, 1350, 1156, 1068, 838 and 696 cm-1. 1H NMR
(400MHz, CDCl3,δ): 8.03-7.99 (m, 2H, ArCH), 7.18 (app. t, J = 8.0, 2H, ArCH), 4.19
(app. t, J = 8.0, 2H, CH2), 1.93-1.85 (m, 8H, CH2 and C(CH3)2), 1.46-1.36 (sxt., J = 7.0,
2H, CH2), 0.99 (t, J = 7.0, 3H, CH3). 13C NMR (100MHz, CDCl3, δ): 170.5 (s, C═O),
165.0 (s, J = 256, C-F), 136.0 (s, C-SO2-), 131.6 (2 x d, JCF = 9.6, CH), 115.9 (2 x d, JCF
= 22.8, CH), 56.5 (s, C-(CH3)2), 48.9 (t, CH3), 32.9 (t, CH2), 31.8 (2 x q, C(CH3)2) 20.0
(t, CH2) 14.0 (q, CH3). LRMS (EI/CI) m/z: 382 (81Br-M+ = 100), 380 (79Br-M+ = 100),
159 (20), 135 (81Br 68), 133 (79Br 70). HRMS (EI+) m/z: (MH+) calcd for
C14H20BrFNO3S, 380.0331; found, 380.0314; Elemental Analysis (WAS): Calcd. for
C14H19BrFNO3S: C, 44.2; H, 5.0; N, 3.7. Found: C, 44.4; H, 5.0; N, 3.6.
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4-bromo-N-(2-Bromo-2-methyl-propionyl)-N-butyl-benzenesulfonamide 278c
S
N
Br
O
Br
O
O
Flash chromatography (petrol ether/ethyl acetate, 8:1) afforded 4-bromo-N-(2-bromo-2-
methyl-propionyl)-N-butyl-benzenesulfonamide 278c as a yellow viscous solid. (1.43 g,
70%). IR (neat) νmax: 2960, 2933, 2361, 1681, 1355, 1170 1068, 739 cm-1. 1H NMR
(300MHz, CDCl3,δ): 7.85-7.81 (d.t, J = 8.0 and 2.0, 2H, ArCH), 7.66-7.61 (d.t, J = 8.0
and 2.0, 2H, ArCH), 4.17 (app. t, J = 7.0, 2H, CH2), 1.94-1.85 (m, 8H, (CH3)2 + CH2),
1.39 (sxt., J = 7.0, 2H, CH2), 1.00 (t, J = 7.0, 3H, CH3). 13C NMR (100MHz, CDCl3,δ):
170.0 (s, C═O), 137.7 (s, C-SO2-), 131.3 (2 x d, ArCH), 129.5 (2 x d, ArCH), 128.1 (s,
C-Br), 56.0 (s, C(CH3)2), 48.3 (t, CH2), 32.3 (t, CH2), 31.1 (2 x q, C(CH3)2), 20.0 (t,
CH2), 14.5 (q, CH3). LRMS (EI+) m/z 443 (81Br M+ = 10%), 441 (79Br M+ = 20), 361
(81Br = 25), 359 (79Br = 24), 249 (81Br = 31), 247 (79Br = 30), 219 (81Br = 99), 217 (79Br
= 98), 204 (81Br = 100), 202 (79Br = 99), 157 (81Br = 82), 155 (79Br = 81), 123 (81Br =
88), 121 (79Br = 87). HRMS (LSIMS) calcd for C14H19Br2NO3S, 441.9510, found
441.9507.
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N-(2-Bromo-2-methyl-propionyl)-N-butyl-4-iodo-benzenesulfonamide 278d
S
N O
Br
I
O
O
Flash chromatography (petrol ether: ethyl acetate, 4.1) furnished N-(2-bromo-2-methyl-
propionyl)-N-butyl-4-iodo-benzenesulfonamide 278d as a greyish-white viscous solid
(1.82g, 43%). IR (neat) υmax: 2961, 2361, 1681, 1354, 1170, 1073, 738 cm-1. 1H NMR
(300MHz, CDCl3,δ): 7.89-7.85 (d.t, J = 9.0 and 2.0, 2H, ArCH), 7.68-7.66 (d.t, J = 9.0
and 2.0, 2H, ArCH), 4.18-4.14 (app.t, J = 8.0, 2H, CH2), 1.95-1.88 (m, 8H, CH2 and C
(CH3)2), 1.37-1.47 (sxt., J = 7.0, 2H, CH2), 0.98 (t, J = 7.0, 3H, CH3). 13C NMR
(100MHz, CDCl3,δ) 170.2 (s, C═O), 139.0 (s, C-SO2-), 137.7 (2 x d, ArCH), 129.7 (2
x d, ArCH), 101.3 (s, C-I), 56.2 (s, C-(CH3)2), 48.7 (t, CH2), 32.0 (t, CH2), 31.3 (2 x q,
C(CH3)2), 19.5 (t, CH3), 13.4 (q, CH3). LRMS (EI+) m/z 489 (81Br M+ = 12%), 487
(79Br M+ = 12), 343 (25), 296 (49), 267 (100), 206 (81Br 81), 204 (79Br 100). HRMS (CI)
m/z: (MH+) calcd for C14H2079BrINO3S 487.9392, found: 487.9390.
N-(2-Bromo-2-methyl-propionyl)-N-butyl-4-methyl-benzenesulfonamide 278e
S
O
O
N
O
Br
Previously synthesised by Fullaway.165 Flash chromatography (petrol ether/ethyl acetate,
6:1) furnished N-(2-bromo-2-methyl-propionyl)-N-butyl-4-methyl-benzenesulfonamide
278e as a viscous yellow crystallised solid (2.20g, 25%). IR (neat) νmax: 2979, 2361,
1710, 1173, 1071 cm-1. 1H NMR (400MHz, CDCl3, δ): 7.85 (d, J = 8.0, 2H, ArCH),
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7.30 (d, J = 8.0, 2H, ArCH), 4.16 (bt, J = 7.0, 1H, NH), 2.43 (s, 3H, ArCH3), 1.96-1.87
(m, 8H, CH2 + (CH3)2), 1.45-1.36 (sxt, J = 7.0, 2H, CH2), 0.98 (t, J = 7.0, 3H, CH3). 13C
NMR (100MHz, CDCl3,δ) 165.7 (s, C═O), 144.4 (s, C-Me), 136.41 (s, C-SO2-), 129.3
(2 x d, ArCH), 128.6 (2 x d, ArCH), 56.7 (s, C-(CH3)2), 48.8 (t, CH2), 32.9 (t, CH2),
32.9 (2 x q, C(CH3)2), 21.6 (q, ArCH3), 20.0 (t, CH2), 14.5 (q, CH3). LRMS (EI+) m/z:
378 (81Br MH+ = 20%), 377 (81Br M+ = 98), 375 (79Br MH+ = 100), 296 (42), 234 (32),
206 (81Br 62), 204 (79Br 60), 155 (46). HRMS (EI+) m/z: (MH+) calcd for
C15H22BrNO3S, 376.0582; found, 376.0568.
N-(2-Bromo-2-methyl-propionyl)-N-butyl-2,4,6-trimethyl-benzenesulfonamide 278f
S
O
O
N
O
Br
Previously synthesised by Fullaway.165 Flash chromatography furnished (petrol
ether/ethyl acetate, 6:1) N-(2-bromo-2-methyl-propionyl)-n-butyl-2,4,6trimethyl-
benzene-sulfonamide 278f as a yellow crystallised solid (2.74g, 34%). IR (Neat) υmax:
2972, 2361, 1709, 1345, 1164, 1066, 811 cm-1. 1H NMR (400MHz, CDCl3, δ) 6.95
(app.s 2H, ArCH), 4.20 (app. t. J = 8.0, 2H, CH2), 2.65 (s, 3H, ArCH3), 2.28 (s, 3H,
ArCH3), 2.08-1,93 (m, 8H, CH2 and C(CH3)2), 1.87 (s, 3H, ArCH3), 1.49-1.37 (sxt. J =
7.0, 2H, CH2), 1.00 (t, J = 7.0, 3H, CH3). 13C NMR (100MHz, CDCl3, δ) 170.4 (s,
C═O), 143.0 (s, C-Me), 140.4 (s, C-SO2-), 138.0 (s, C-Me), 133.8 (s, C-Me), 132.3 (d,
ArCH), 131.9 (d, ArCH), 56.9 (s, C-(CH3)2), 47.8 (t, CH2), 33.0 (t, CH2), 31.6 (2 x q,
C(CH3)2) 22.4 (q, ArCH3), 21.0 (q, ArCH3), 20.0 (t, CH2), 18.00 (q, ArCH3), 13.5 (q,
CH3).
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2-Naphthalene-sulfonic-acid-(2-bromo-2-methyl-propionyl)-butylamide 278g
S
N
O
Br
O
O
Flash chromatography (petrol ether/ethyl acetate 4:1) furnished 2-naphthalene-sulfonic-
acid-(2-bromo-2-methyl-propionyl-butylamide 278g as a light yellow viscous solid
(0.90g, 20%). IR (neat) νmax: 2927, 1681, 1347, 1167, 1134, 1070, 750 cm-1. 1H NMR
(300MHz, CDCl3,δ): 8.58 (s, 1H, ArCH), 8.02-7.93 (m, 1H, ArCH), 7.93-7.88 (m, 3H,
ArCH), 7.69-7.59 (m, 2H, ArCH), 4.25 (app.t, J = 8.0, 2H, CH2), 2.02-1.92 (m, 2H,
CH2), 1.87 (s, 6H, 2 x CH3), 1.43 (sxt., J = 7.0, 2H, CH2), 1.01 ( t, J = 7.0, 3H, CH3).
13C NMR (100MHz, CDCl3, δ): 170.5 (s, C═O), 136.2 (s, C-SO2-), 135.2 (s, C-C),
131.8 (s, C-C), 130.7 (d, ArCH), 129.6 (d, ArCH), 129.2 (d, ArCH), 128.8 (d, ArCH),
127.9 (d, ArCH), 127.5 (d, ArCH), 122.9 (d, ArCH), 56.6 (s, C-(CH3)2), 49.0 (t, CH2),
33.0 (t, CH2), 31.8 (2 x q, C(CH3)2), 20.0 (t, CH2), 15.0 (q, CH3). LRMS (EI+) m/z: 414
(81Br MH+ = 90%), 412 (79Br MH+ 90), 334 (81Br 15), 332 (79Br 33), 270 (81Br 71), 268
(79Br 90), 206 (81Br 60), 204 (79Br 54), 144 (81Br 100). Elemental Analysis (WAS):
Calcd C18H22BrNO3S: C, 52.4; H, 5.3; N, 3.4. Found: C; 52.4; H, 5.4; N, 3.3.
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N-(2-Bromo-2-methyl-propionyl)-N-butyl-4-methoxy-benzenesulfonamide 278h
S
N
MeO
O
Br
O
O
Flash chromatography (petrol ether/ethyl acetate, 4:1) furnished N-(2-bromo-2-methyl
propionyl)-N-butyl-4-methoxy-benzenesulfonamide 278h as a white viscous solid (3.48g,
46%). IR (neat) υmax: 2956, 2927, 1711, 1664, 1351, 1156, 840 cm-1. 1H NMR
(400MHz, CDCl3, δ): 7.91 (d.t, J = 9.0 and 3.0, 2H, ArCH); 6.96 (d.t, J = 9.0 and 3.0,
2H, Ar-CH), 4.15 (app. t, J = 7.0, 2H, CH2), 3.85 (s, 3H, OCH3), 1.92-1.85 (m, 8H, CH2
and C (CH3)2), 1.44-1.35 (sxt., J = 7.0, 2H, CH2), 0.98 (t, J = 7.0, 3H, CH3). 13C NMR
(100MHz, CDCl3,δ): 170.4 (s, C═O), 163.5 (s, C-OMe), 131.0 (2 x d, ArCH), 130.5 (s,
C-SO2-), 113.7 (2 x d, ArCH), 56.7 (s, C-(CH3)2), 55.7 (q, OCH3), 48.7 (t, CH2), 32.9
(t, CH2), 31.8 (2 x q, C(CH3)2), 19.9 (t, CH2), 13.0 (q, CH3). LRMS (LSIMS) m/z: 394
(81Br-M+ = 99%) 392 (79Br-M+ = 100), 314 (81Br 30), 312 (79Br 10), 250 (81Br 100), 248
(79Br 55), 205 (81Br 59), 203 (79Br 62) 149 (81Br 91), 148 (79Br+ 30). HRMS (CI): calcd
for C15H22BrNO4S, 392.0531; found, 392.0523.
N-(2-Bromo-2-methyl-propionyl)-N-butyl-4-cyano-benzenesulfonamide 278i
S
N O
Br
NC
O
O
Flash chromatography (petrol ether/ethyl acetate, 4:1) furnished N-(2-bromo-2-methyl-
propionyl)-N-butyl-4-cyano-benzenesulfonamide 278i as transparent crystalline flakes,
(1.16g, 57%). IR (neat) νmax: 2961, 1681, 1463, 1356, 1168, 1072, 911 and 729 cm-1. 1H
Experimental
191
NMR (300MHz, CDCl3,δ): 8.11 (d.t, J = 8.5 and 2.0, 2H, ArCH), 7.84 (d.t, J = 8.5 and
2.0, 2H, ArCH), 4.22 (app. t, J = 7.0, 2H, CH2), 1.92 (m, 8H, CH2 and C (CH3)2), 1.49-
1.38 (app. quin., J = 7.0, 2H, CH2), 1.10-0.98 (m, 3H, CH3). 13C NMR (75.5MHz,
CDCl3, δ): 171.0 (s, C═O), 143.9 (s, C-SO2-), 132.9 (2 x d, ArCH), 129.4 (2 x d,
ArCH), 117.6 (s, C≡N), 117.4 (s, ArC-C≡N), 56.7 (s, C-(CH3)2), 49.4 (t, CH2), 32.7 (t,
CH2), 32.0 (2 x q, C(CH3)2), 20.5 (t, CH2), 14.0 (q, CH3). LRMS (LSIMS-FAB+) m/z:
389 (81Br M+ = 15%), 387 (79Br M+ = 15), 154 (100), 137 (76). HRMS (LSIMS-FAB+)
m/z: (M+) calcd for C15H19BrN2O3S, 387.0378; found, 387.0376.
N-(2-Bromo-2-methyl-propionyl)-N-butyl-4-nitro-benzenesulfonamide 278j
S
N
O2N
O
Br
O
O
Flash chromatography (petrol ether/ethyl acetate, 4:1), furnished N-(2-bromo-2-methyl-
propionyl)-N-butyl-4-nitro-benzenesulfonamide 278j as a light yellow viscous solid
(2.89g, 90%). IR (neat) υmax: 2936, 1671, 1350, 1170 and 742, cm-1. 1H NMR (400MHz,
CDCl3,δ): 8.65 (d, J = 7.0, 2H, ArCH), 8.16 (d.t, J = 7.0, 2H, ArCH), 4.22 (app. t, J =
8.0, 2H, CH2), 2.06-1.87 ( m, 8H, CH2 + C(CH3)2), 1.48-1.39 (sxt., J = 7.0, 2H, CH2),
1.00 (t, J = 7.0, 3H, CH3). 13C NMR (100MHz, CDCl3,δ): 171.0 (s, C═O), 150.4 (s, C-
NO2), 145.0 (s, C-SO2-), 129.8 (2 x d, ArCH), 123.9 (2 x d, ArCH), 56.2 (s, C-(CH3)2),
49.1 (t, CH2), 33.0 (t, CH2), 30.5 (2 x q, C(CH3)2), 19.9 (t, CH2), 14.0 (q, CH3). LRMS
(EI+) m/z: 409 (81Br-M, 8%), 407 (79Br-M, 8%), 327 (19), 206 (40), 186 (100), 165 (50),
122 (81Br, 72), 120 (79Br, 75). HRMS (EI+) m/z: (MH+), calcd for C14H20BrN2O5S,
407.0276; found: 407.0267.
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N-(2-Bromo-2-methyl-propionyl)-N-butyl-4-trifluoromethyl-benzenesulfonamide
278k
S
N O
Br
F
F
F
O
O
Flash chromatography (petrol ether/ethyl acetate, 4:1) furnished N-(2-bromo-2-methyl
propionyl)-N-Butyl-4-trifluoromethyl-benzenesulfonamide 278k as a pale yellow viscous
solid (1.12g, 2.62mmol, 36.9%). IR (neat) υmax: 2965, 1326, 1161, 1129, 839, cm-1. 1H
NMR (300MHz, CDCl3,δ): 8.03 (d, J = 8.0, 2H, ArCH), 7.70 (d, J = 8.0, 2H, ArCH),
4.15-4.05 (app. t, J = 8.0, 2H, CH2), 1.87-1.80 (m, 8H, CH2 and C (CH3)2), 1.38-1.27
(app. sxt. J =7.0, 2H, CH2), 0.91 (m, 3H, CH3). 13C NMR (75.5MHz, CDCl3, δ): 170.9
(s, C═O), 143.4 (s, C-SO2-), 135.0 (s, J = 33, C-CF3), 127.6 (2 x d, ArCH), 126.3 (2 x
d, ArCH), 121.7 (s, J = 273Hz, CF3), 55.3 (s, C-(CH3)2) 49.3 (t, CH3), 33.5 (t, CH2),
31.3 (2 x q, C(CH3)2), 21.2 (t, CH2), 12.1 (q, CH3). LRMS (LSIMS) m/z: 431 (81Br M+
= 45%), 429 (79Br M+ = 44), 349 (10), 153 (100), 137 (90); HRMS (LSIMS) m/z: calcd
for C15H19BrF3NO3S, 430.0299; found 430.0309.
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N-(2-Bromo-2-methyl-propionyl)-N-butyl-3,5-trifluoromethyl-benzenesulfonamide
278l
S
N
O
Br
FF
F
F
F
F O
O
Flash chromatography (petrol ether/ethyl acetate, 4:1) furnished N-(2-bromo-2-methyl-
propionyl)-N-butyl-3,5-trifluoromethyl-benzenesulfonamide 278l a yellow oil (2.70g,
97%). IR (neat) υmax: 2964, 1685, 1360, 1279, 1142, 839 cm-1. 1H NMR (300MHz,
CDCl3,δ): 8.40 (s, 2H, ArCH), 8.08 (s, 1H, ArCH), 4.20 (app.t, J = 8.0, 2H, CH2), 1.93-
1.84 (m, 8H, CH2 and C (CH3)2), 1.37 (sxt., J = 7.0, 2H, CH2), 0.92 (t, J = 7.0, 3H,
ArCH3). 13C NMR (75.5MHz, CDCl3, δ): 171.2 (s, C═O), 142.5 (s, C-SO2-), 133.0 (2 x
s, J = 34.6Hz, (C(CF3)2), 129.3 (d, CH), 128.2 (2 x d, CH), 121.0 (2 x q, J = 273.6,
(CF3)2), 56.5 (s, C-(CH3)2), 49.7 (t, CH2), 32.8 (t, CH2) 30.0 (2 x q, C(CH3)2), 20.8 (t,
CH2), 14.00 (q, CH3). LRMS (EI+) m/z: 500 (81Br MH+ = 30%,), 498 (79Br M+ = 78),
420 (81Br M+ = 22), 418 (79Br = 100), 277 (78), 213 (82), 206 (81Br 30), 204 (79Br 32).
HRMS (EI+) m/z: (MH+) calcd for C16H19BrF6NO3S, 498.0173; found 498.0169.
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5.0 General procedure for synthesis of radical procedures 369
S
O
O
N
R
O
Br
R = alkyl
5.1 N-BUTYLLITHIUM METHOD:
To a stirred solution of N-alkyl-4-methylbenzenesulfonamide 374 (1.0 eq.) in anhydrous
tetrahydrofuran was added n-butyllithium (1.6 M in hexanes) (1.0 eq.) and 2-bromo-
isobutyryl bromide 287 (1.0 eq.) at -78°C (dry ice/acetone) overnight. The reaction was
quenched with saturated ammonium chloride (10 mL), and the product extracted with
dichloromethane (200 mL), followed by saturated sodium bicarbonate (200 mL). The
aqueous phase was washed with dichloromethane (2 x 200 mL) and the combined
organic fractions were washed with saturated sodium chloride. The organic phase was
dried with magnesium sulfate, and the solvent evaporated in-vacuo to yield a crude
product. Purification of the crude product (petrol ether: ethyl acetate) furnished the
radical precursor 369.
5.2 TRIETHYLAMINE METHOD
To a stirred solution of N-alky-4-methylbenzenesulfonamide 374 (1.0 eq.) in dry
dichloromethane was added triethylamine (1 eq.) and 2-bromo-isobutyryl bromide 284
(1 eq.), under nitrogen at room temperature overnight. The reaction was quenched with
distilled water (50 mL), and the product extracted with diethyl ether (3 x 50 mL). The
combined organic extracts were dried over magnesium sulfate and the solvent
evaporated in vacuo to furnish the crude product. Purification with petrolether: ethyl
acetate, yield the radical precursor 369.
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N-(2-Bromo-2-methyl-propionyl)-N-ethyl-4-methyl-benzenesulfonamide 369a
S
O
O
N
O
Br
Flash chromatography (petrol ether/ethyl acetate, 6:1) furnished N-(2-bromo-2-methyl-
propionyl)-N-ethyl-4-methyl-benzenesulfonamide 369a as a light yellow crystallised
solid (4.48g, 25%). mp 98.5-98.6 °C. IR (neat) νmax: 2978, 1709, 1391, 1163, 811 cm-1.
1H NMR (400MHz, CDCl3, δ): 7.86 (d, J = 8.0, 2H, ArCH), 7.30 (d, J = 8.0, 2H,
ArCH), 4.33 (q, J = 7.0, 2H, CH2), 2.42 (s, 3H, ArCH3), 1.96 (s, 6H, C(CH3)2), 1.51 (t,
J = 7.0, 3H, CH3). 13C NMR (100MHz, CDCl3, δ): 171.5 (s, C═O), 144.5 (s, C-Me),
136.5 (s, C-SO2-), 129.3 (2 x d, ArCH), 128.6 (2 x d, ArCH), 56.6 (s, C-(CH3)2), 44.0
(t, CH2), 31.8 (2 x q, C(CH3)2), 21.7 (q, ArCH3), 17.0 (q, CH3). LRMS (LSIMS-FAB+)
m/z: 350 (81Br-MH+ = 12%), 348 (79Br-MH+ = 10), 154 (100), 137 (68). HRMS (LSIMS-
FAB+) calcd for C13H18BrNO3S, 348.0269; found, 348.0262.
N-(2-Bromo-2-methyl-propionyl)-N-propyl-4-methyl-benzenesulfonamide 369b
S
O
O
N
O
Br
Flash chromatography (6:1 petrol ether:ethyl acetate) furnished N-(2-bromo-2-methyl-
propionyl)-N-propyl-4-methyl-benzenesulfonamide 369b as a viscous lemon-yellow
crystallised solid (1.19g, 34%). IR (neat) νmax: 2968, 1710, 1349, 1161, 814 cm-1. 1H
NMR (400MHz, CDCl3,δ): 7.75 (d, J = 8.5, 2H, ArCH), 7.19 (d, J = 8.5, 2H, ArCH),
4.03 (app.t, J = 8.5, 2H, CH2), 2.31 (s, 3H, ArCH3), 1.88-1.82 (app. quin., J = 7.0, 2H,
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CH2), 1.78 (s, 6H, 2 x CH3), 0.88 (t, J = 7.0, 3H, CH3). 13C NMR (100MHz, CDCl3, δ)
169.2 (s, C═O), 143.5 (s, C-Me), 135.2 (s, C-SO2-), 128.2 (2 x d, ArCH), 127.5 (2 x d,
ArCH), 55.6 (s, C-(CH3)2), 49.2 (t, CH2), 30.7 (2 x q, C(CH3)2), 23.2 (t, CH2), 20.6 (q,
ArCH3), 15.0 (q, CH3). LRMS (LSIMS-FAB+) m/z: 364 (81Br MH+ = 30%), 362 (79Br
MH+ = 28), 155 (35), 154 (100), 137 (70), 136 (60). HRMS (LSIMS-FAB+) m/z: calcd
for C14H20BrNO3S, 362.0425; found, 362.0434.
N-(2-Bromo-2-methyl-propionyl)-N-pentyl-4-methyl-benzenesulfonamide 369d
Discernible data:
S
O
O
N
O Br
Flash chromatography (6:1 petrol ether:ethyl acetate) furnished N-(2-bromo-2-methyl-
propionyl)-N-pentyl-4-methyl-benzenesulfonamide 369d as a yellow oil (0.54g, 22%). IR
(neat) νmax: 2929, 1598, 1494, 1321, 1155, 1092, 1019, 813 cm-1. 1H NMR (400MHz,
CDCl3, δ): 7.85 (d, J = 8.0, 2H, ArCH), 7.30 (d, J = 8.0, 2H, ArCH), 4.16 (app. t. J =
8.0, 2H, CH2), 2.41 (s, 3H, ArCH3), 1.96-1.88 (m, 8H, CH2 + C(CH3)2), 1.44-1.30 (m,
4H, 2 x CH2), 0.92 (t, J = 7.0, 3H, CH3). LRMS (LSIMS-FAB+) m/z: 392 (81Br-MH+ =
100), 390 (79Br-MH = 98), 310 (43), 154 (32), 136 (32). HRMS (LSIMS-FAB+) calcd
for C16H24BrNO3S, 390.0738; found, 390.0735.
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N-(2-Bromo-2-methyl-propionyl)-N-hexyl-4-methyl-benzenesulfonamide 369e
S
O
O
N
O Br
Flash chromatography (4:1 petrol ether:ethyl acetate) furnished N-(2-bromo-2-methyl-
propionyl)-N-hexyl-4-methyl-benzenesulfonamide 369e as lemon-yellow crystallised
solid (2.92g, 91%). mp. 55.4-55.5 ºC. IR (neat) νmax: 2927, 1679, 1348, 1163, 1072, 811
cm-1. 1H NMR (400MHz, CDCl3,δ): 7.85 (d.t, J = 8.0 and 2.0, 2H, ArCH), 7.30 (d, J =
8.0, 2H, ArCH), 4.15 (app. t. J = 8.0, 2H, CH2), 2.43 (s, 3H, ArCH3), 1.93-1.89 (m, 8H,
CH2 + (CH3)2), 1.38-1.26 (m, 6H, 3 x CH2), 0.90 (t, J = 7.0, 3H, CH3). 13C NMR
(100MHz, CDCl3,δ): “not observed” (C═O), 145.0 (s, C-Me), 135.0 (s, C-SO2-), 129.0
(2 x d, ArCH), 128.3 (2 x d, ArCH), 56.4 (s, C(CH3)2), 48.8 (t, CH3), 31.6 (2 x q, CH3),
31.0 (t, CH2), 30.7 (t, CH2), 26.1 (t, CH2), 22.4 (t, CH2), 21.4 (q, ArCH3), 13.8 (q,
CH2). LRMS (LSIMS-FAB+) m/z: 406 (81Br MH+ = 60%), 404 (79Br MH+ 60), 324 (30),
256 (31), 170 (20), 154 (100), 137 (81). HRMS (LSIMS-FAB+) m/z: (MH+) calcd for
C17H2779BrNO3S, 404.0895; found, 404.0909.
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N-(2-Bromo-2-methyl-propionyl)-N-dodecyl-4-methyl-benzenesulfonamide 369f
S
O
O
N
O Br
Flash Chromatography (6:1 petrol ether:ethyl acetate) furnished N-(2-bromo-2-methyl-
propionyl)-N-dodecyl-4-methyl-benzenesulfonamide 369f as a white crystallised solid
(1.79g, 41%). IR (neat) νmax: 2915, 1679, 1345, 1159, 1066, 886 cm-1. 1H NMR
(400MHz, CDCl3,δ): 7.78 (d, J = 8.0, 2H, ArCH), 7.19 (d, J = 8.0, 2H, ArCH), 4.09 (t,
J = 8.0, 2H, CH2), 2.30 (s, 3H, ArCH3), 1.86-1.79 (m, 8H, CH2 + (CH3)2), 1.29-1.22 (m,
18H, 9 x CH2), 0.83 (t, J = 7.0, 3H, CH3). 13C NMR (100MHz, CDCl3, δ): 170.2 (s,
C═O), 144.2 (s, C-Me), 136.5 (s, C-SO2-), 129.1 (2 x d, ArCH), 128.6 (2 x d, ArCH),
56.7 (s, C-(CH3)2), 49.9 (t, CH2), 32.5 (t, CH2), 31.7 (t, CH2), 31.7 (2 x q, C(CH3)2),
29.3-29.1 (6 x t, CH2), 26.6 (t, CH2), 22.7 (t, CH2), 21.5 (q, ArCH3), 14.7 (q, CH3).
LRMS (LSIMS-FAB+) m/z: 490 (81Br MH+ = 95%), 489 (81Br M+ = 94), 408 (41), 340
(48), 155 (45), 154 (100), 138 (48), 137 (100). HRMS (LSIMS-FAB+) m/z: (MH+) calcd
for C23H3981BrNO3S, 488.1834; found 488.1814.
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N-(2-Bromo-2-methyl-propionyl)-N-iso-butyl-4-methyl-benzenesulfonamide
369h
S
O
O
N
O
Br
Previously synthesised by Fullaway.163 Flash Chromatography (6:1 petrol ether:ethyl
acetate) furnished N-(2-bromo-2-methyl-propionyl)-N-iso-butyl-4-methyl-benzene-
sulfonamide 369h as pale yellow crystallised solid (3.06g, 90%). mp 91.3-91.5 ºC. IR
(neat) νmax: 2964, 1813, 1323, 1159, 1040 and 812 cm-1. 1H NMR (400MHz, CDCl3, δ):
7.74 (d, J = 8.0, 2H, ArCH), 7.30 (d, J = 8.0, 2H, ArCH), 3.90 (d, J = 8.0, 2H CH2),
2.42 (s, 3H, ArCH3), 1.96 (s, 6H, (CH3)2), 1.74-1.68 (spt., J = 7.0, 1H, CH), 1.07 (d, J =
7.0, 6H, (CH3)2). 13C NMR (100MHz, CDCl3, δ): 176.00 (s, C═O), 165.76 (s, C-Me),
143.32 (s, C-SO2-), 129.70 (2 x d, ArCH), 127.07 (2 x d, ArCH), 55.01 (s, C-(CH3)2),
50.55 (t, CH2), 30.01 (2 x q, C(CH3)2), 19.88 (2 x q, C(CH3)2), 28.44 (d, CH) 20.25 (q,
ArCH3). LRMS (LSIMS) m/z: 378 (81Br M+ = 19%), 376 (79Br M+ = 20%), 296 (25),
228 (79Br 100), 154 (30), 137 (35).
N-(2-Bromo-2-methyl-propionyl)-N-sec-butyl-4-methyl-benzenesulfonamide 369i
S
O
O
N
O
Br
Previously synthesised by Fullaway.163 Flash chromatography (6:1 petrol ether:ethyl
acetate) furnished N-(2-bromo-2-methyl-propionyl)-N-sec-butyl-4-methyl-benzene-
sulfonamide [369i] as a pale yellow crystallised solid (2.88g, 85%). mp 105.4-105.5 ºC.
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IR (neat) νmax: 2971, 1712, 1297, 1157, 1090, 663 cm-1. 1H NMR (400MHz, CDCl3, δ):
7.86 (d.t, J = 8.0 and 2.0, 2H, ArCH), 7.29 (d, J = 8.0, 2H, ArCH), 4.61 (app. spt. J =
7.0, 1H, CH), 2.42 (s, 3H, ArCH3), 2.40-2.30 (m, 1H, CH), 2.13-2.03 (m, 1H, CH), 1.90
(s, 6H, (CH3)2), 1.69 (d, J = 7.0, CH3), 1.03 (t, J = 7.0Hz, CH3). 13C NMR (100MHz,
CDCl3,δ): 176.6 (s, C═O), 143.2 (s, C-Me), 138.2 (s, C-SO2-), 129.5 (2 x d, CH), 127.0
(2 x d, CH), 55.3 (s, C-(CH3)2), 51.4 (d, CH), 30.6 (2 x q, CH3)2), 30.2 (t, CH2) 21.6 (2
x q, CH3), 15.0 (q, CH3).
6.0 N-(Hetero)aryl-4-methylbenzene sulfonamides 381
S
O
O
N
Ar
O
Br
6.1 TRIETHYLAMINE METHOD
To a stirred solution of N-(hetero)aryl-4-methylbenzenesulfonamide 380 (1.0 eq.) in dry
dichloromethane was added triethylamine (1 eq.) and 2-bromo-isobutyryl bromide 284(1
eq.), under nitrogen at room temperature overnight. The reaction was quenched with
distilled water (50 mL), and the product extracted with diethyl ether (3 x 50 mL). The
combined organic extracts were dried over magnesium sulfate and the solvent
evaporated in vacuo to furnish the crude product. Purification with petrolether: ethyl
acetate, yield the radical precursor 381.
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N-(2-Bromo-2-methyl-propionyl)-4-methyl-N-(4-methyl-benzyl)benzene-
sulfonamide 381a
S
O
O
N
O
Br
N-(2-bromo-2-methyl-propionyl)-4-methyl-N-(4-methyl-benzyl)-benzenesulfonamide
381a obtained as a light brown crystallised solid (3.14g, 100%). IR (neat) νmax: 2919,
1690, 1320, 1165, 725 cm-1. 1H NMR (400MHz, CDCl3, δ): 7.64 (d.t, J = 7.0 and 2.0,
2H, ArCH), 7.18 (app. t. J = 8.0, 4H, ArCH), 7.12 (app. d., J = 8.0, 2H, ArCH), 5.51
(bs, 2H, CH2), 2.39 (s, 3H, ArCH3), 2.34 (s, 3H, ArCH3), 1.86 (s, 6H, CH3)2). 13C NMR
(100MHz, CDCl3,δ): 170.94 (s, C═O), 144.39 (s, C-Me), 137.38 (s, C-Me), 133.32 (s,
C-SO2-), 128.80 (d, ArCH), 128.78 (d, ArCH), 128.31 (d, ArCH), 128.21 (d, ArCH),
127.93 (d, ArCH), 127.66 (d, ArCH), 127.38 (d, ArCH), 126.99 (d, ArCH), 60.00 (s,
C-(CH3)2), 51.72 (t, CH3), 31.84 (2 x q, C(CH3)2), 21.47 (q, ArCH3), 21.34 (q, ArCH3).
LRMS (LSIMS-FAB+) m/z: 426 (MH+ = 100%), 154 (100), 137 (50).
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N-(2-Bromo-2-methyl-propionyl)-4-methyl-N-(4-methoxy-benzyl)-benzene-
sulfonamide 381b
S
O
O
N
O
Br
O
N-(2-bromo-2-methyl-propionyl)-4-methyl-N-(4-methoxy-benzyl)-benzene-sulfonamide
381b obtained pure as a light brown solid (2.72g, 91%). IR (neat) νmax: 2928, 1676,
1336, 1168, 1088 and 811 cm-1. 1H NMR (400MHz, CDCl3, δ): 7.61 (d., J = 8.0, 2H,
ArCH), 7.21 (app. t., J = 8.0, 4H, ArCH), 6.85 (d.t, J = 8.0 and 3.0, 2H, ArCH), 5.47 (s,
2H, CH2), 3.80 (s, 3H, OCH3), 2.40 (s, 3H, ArCH3), 2.95 (s, 6H, C(CH3)2). 13C NMR
(100MHz, CDCl3, δ): 171.34 (s, C═O), 159.11 (s, C-OMe), 144.59 (s, C-Me), 128.45
(s, C-SO2-), 129.04 (2 x d, ArCH), 129.01 (2 x d, ArCH), 128.45 (d, ArCH), 128.40 (d,
ArCH), 114.37 (d, ArCH), 114.04 (d, ArCH), 57.20 (s, C-(CH3)2), 55.38 (q, OCH3),
51.70 (t, CH2), 32.08 (2 x q, C(CH3)2), 21.70 (q, ArCH3). LRMS (LSIMS-FAB+) m/z:
442 (MH+ = 5%), 154 (100), 137 (65), 121 (38).
Experimental
203
N-(2-bromo-2-methyl-propionyl)-4-methyl-N-(2-trifluoromethyl-benzyl)-
benzene-sulfonamide 381c
Discernible data
S
O
O
N
O
Br
F F
F
N-(2-bromo-2-methyl-propionyl)-4-methyl-N-(2-trifluoromethyl-benzyl)-benzene-
sulfonamide 381c as a light brownish-yellow crystallised solid (2.31g, 79%). IR (neat)
νmax: 2361, 1681, 1311, 1165, 1036, 775 cm-1. 1H NMR (300MHz, CDCl3, δ): 7.87 (d.t,
J = 8.0 and 2.0, 2H, ArCH), 7.71 (d, J = 8.0, 1H, ArCH), 7.65 (d, J = 8.0, 1H, ArCH),
7.58 (t, J = 8.0, 1H, ArCH), 7.41 (t, J = 8.0, 1H, ArCH), 7.32 (d, J = 8.0, 2H, ArCH),
5.83 (s, 2H, CH2), 2.46 (s, 3H, ArCH3), 1.73 (s, 6H, 2 x CH3). LRMS (LSIMS-FAB+)
m/z: 480 (81Br MH+ = 20%), 477 (79Br MH+ = 18), 154 (100), 136 (74), 120 (12). HRMS
(LSIMS-FAB+) m/z: (MH+) calcd for C19H20BrF3NO3S, 478.0299; found, 478.0305.
N-(2-bromo-2-methyl-propionyl)-4-methyl-N-pyridin-2-yl-methyl-benzene-
sulfonamide 381d
S
O
O
N
O
N
Br
N-(2-bromo-2-methyl-propionyl)-4-methyl-N-pyridin-2-yl-methyl-benzenesulfonamide
381d as a light brown crystallised solid (3.14g, 100%). IR (neat) νmax: 2923, 1682, 1346,
1168, 1112, 1086 and 782 cm-1. 1H NMR (400MHz, CDCl3, δ): 8.59 (app. d. J = 5.0,
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1H, ArCH), 7.81-7.76 (app. d., J = 8.0, 3H, ArCH), 7.55 (d, J = 8.0, 1H, ArCH), 7.27
(app.d, J = 8.0, 3H, ArCH), 5.71 (s, 2H, CH2), 2.43 (s, 3H, ArCH), 1.97 (s, 6H, (CH3)2).
13C NMR (100MHz, CDCl3, δ): 170.29 (s, C═O), 156.13 (s, C-pyridine), 148.23 (d,
ArCH), 144.73 (s, C-Me), 137.77 (d, ArCH), 135.31 (s, C-SO2-), 129.10 (2 x d, ArCH),
128.75 (2 x d, ArCH), 122.60 (d, ArCH), 121.33 (d, ArCH), 56.73 (s, C-(CH3)2), 52.50
(t, CH2), 30.64 (2 x q, C(CH3)2), 21.50 (q, ArCH3). LRMS (LSIMS-FAB+) m/z: 412
(81Br M+ = 18%), 410 (79Br M+ = 18), 331 (16), 219 (20), 165 (20), 154 (100), 136 (36).
HRMS (LSIMS-FAB+) calcd for C17H19BrN2O3S, 411.0378; found, 411.0371.
N-(2-Bromo-2-methyl-propionyl)-N-(furan-2-ylmethyl)-4-methyl-benzene-
sulfonamide 381e
S
O
O
N
O
Br
O
N-(2-bromo-2-methyl-propionyl)-N-(furan-2-ylmethyl)-4-methyl-benzenesulfonamide
381e obtained pure as a golden crystallised solid (3.56g, 100%). IR (neat) νmax: 2977,
1709, 1348, 1161, 1087, 811 cm-1. 1H NMR (400MHz, CDCl3, δ): 7.58 (d, J = 8.0, 2H,
ArCH), 7.30 (app s., 1H, furan-H), 7.21 (d, J = 8.0, 2H, ArCH), 6.45 (app. d, J = 3.0,
1H, furan-H), 6.38 (app.q. J = 3.0, 1H, furan-H), 5.47 (s, 2H, CH2), 2.40 (s, 3H,
ArCH3), 1.95 (app d. J = 4.0, 6H, (CH3)2). 13C NMR (100MHz, CDCl3, δ): 176.8 (s,
C═O), 149.6 (s, C-furan), 144.5 (s, C-Me), 142.3 (2 x d, ArCH), 135.9 (s, C-SO2-),
129.1 (d, ArCH), 128.9 (d, ArCH), 110.7 (d, CH), 109.7 (d, CH) 57.4 (s, C-(CH3)2),
45.2 (t, CH2), 32.3 (2 x q, CH3), 30.5 (q, C(CH3)2), 21.7 (q, ArCH3). LRMS (LSIMS)
m/z: 402 (81Br-M+ = 13%), 400 (79Br-M+ = 15), 244 (20), 219 (15), 154 (100), 136 (76).
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7.0 Synthesis of cyclised and rearranged amides from radical precursors 278
N
O R
O
HN
N
S
O O
O
R R
7.1 General method for copper-mediated radical reactions
To a stirred solution of the radical precursor 278 (1.0 eq.) in dichloromethane (DCM)
was added of tris-[(2-pyridyl)methyl]-amine (1.1 eq.) 279 and copper bromide (1.1 eq.).
The reaction was stirred under nitrogen at 37°C, and monitored by TLC until the
disappearance of starting material. Filtering the crude product through a silica plug with
ethyl acetate quenched the reaction mixture. The solvent was evaporated in vacuo to
yield an emerald green crude product. Purification by flash chromatography led to an
isolation of both the cyclised and rearranged products. Reactions done in toluene were
performed under inert atmosphere at reflux temperature unless otherwise stated.
2-(Phenyl)-N-butyl-isobutyramide 280a
NHO
Purification by column (petrol ether/ethyl acetate 8:1), furnished 2-(phenyl)-n-butyl-
isobutyramide 280a as apple-white translucent spherical solid (0.13g, 40%). IR (CH2Cl2)
νmax: 3359, 2928, 1643, 1525, 1365, 1164, 762 cm-1. 1H NMR (300MHz, CDCl3,δ): 7.36
(s, 4H, ArCH), 7.29-7.24 (m, 1H, ArCH), 5.18 (s, 1H, NH), 3.15 (q, J = 7.0, 2H, CH2),
1.56 (s, 6H, C(CH3)2), 1.40-1.30 (quin., J = 7.0, 2H, CH2), 1.26-1.14 (sxt., J = 7.0, 2H,
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CH2), 0.84 (t, J = 7.0Hz, 3H, CH3). 13C NMR (100MHz, CDCl3, δ): 177.4 (s, C═O),
145.3 (s, C-SO2-), 128.6 (d, ArCH), 127.0 (2 x d, ArCH), 126.4 (2 x d, ArCH), 47.0 (s,
C(CH3)2), 39.4 (t, CH2 ), 31.5 (t, CH2), 29.7 (2 x q, C(CH3)2), 20.00 (t, CH2), 14.00 (q,
CH3). LRMS (EI+) m/z: 220 (100 = M+), 120 (100), 119 (90), 105 (95). HRMS (EI+)
m/z: (M+) calcd for C14H21NO, 219.1623; found, 219.1624.
N-Butyl-3,3-dimethyl-1,3-dihydro-indol-2-one 290 190
N
O
Previously synthesised. Purification by flash chromatography furnished 1-butyl-3,3-
dimethyl-1,3-dihydro-indol-2-one 290 as a transparent spherical film (0.14g, 59%). IR
(CH2Cl2) νmax: 2962, 2928, 2868, 1357, 1133, 749 cm-1. 1H NMR (400MHz, CDCl3, δ):
7.21 (app. q., J = 7.5, 2H, ArCH), 7.04 (m, 1H, ArCH), 6.87 (d, J = 7.0, 1H, ArCH),
3.71 (t, J = 7.0, 2H, CH2), 1.71-1.61 (app. quin., J = 7.0, 2H, CH2), 1.44-1.31 (m, 8H,
CH2 + (CH3)2), 0.95 (t, J = 7.0, 3H, CH3). 13C NMR (75.5MHz, CDCl3, δ) 181.3 (s,
C═O), 142.1 (s, C-N-), 136.0 (s, C-C(CH3)2), 127.6 (2 x d, ArCH), 122.2 (d, ArCH),
108.3 (d, ArCH), 44.1 (s, C-(CH3)2), 39.6 (t, CH2), 29.5 (t, CH2), 24.5 (2 x q, C(CH3)2),
20.1 (t, CH2), 14.1 (q, CH3). LRMS (EI+) m/z: 218 (M-SO2 = 13%) 217 (M –SO2 =
82%), 174 (82), 146 (100), 130 (23). HRMS (LSIMS-FAB+) m/z: (M+) calcd for
C14H19NO, 217.1467; found, 217.1459.
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Authentic synthesis of the rearranged amide
2-Methyl-2-p-tolyl-propionic acid ethyl ester 348 219
O
O
Synthesised according to Küntzel et al. procedure. To a solution of anhydrous
dimethylformamide (DMF) (25 mL), was added ethyl-p-tolylacetate (10g, 9.9 mL, 56
mmol) (Flask A). In a separate flask (B) was added sodium hydride in mineral oil (60%)
(7.85g, 196 mmol) which was thrice washed in pentane under a nitrogen atmosphere and
the mineral oil decanted. To flask B between 5-10 °C was added anhydrous
dimethylformamide (DMF) (300 mL), and methyl iodide (CAUTION: Carcinogenic)
(12.16g, 196 mmol) to give a dark grey turbid solution. Ethyl-p-tolylacetate (Flask A)
was added dropwise over one hour. The mixture was stirred under nitrogen at room
temperature for 46 hours. The mixture was quenched with ethanol (100mL) and
saturated ammonium chloride (100mL). Extraction with ether (5 x 100mL) and washing
the organic layer with water (5 x 100mL), to neutrality, and drying over anhydrous
magnesium sulfate. The solvent was removed in-vacuo to an light reddish-orange mobile
oil (6.78g). The desired product 2-methyl-2-p-tolyl-propionic acid ethyl ester 348 was
furnished as a light greenish-yellow oil (2.36, 20%) following flash chromatography
(petrol ether:diethyl ether 20:1).
1H NMR (300MHz, CDCl3,δ): 7.24-7.15 (app. d.t. J = 8.0 and 2.0, 2H, ArCH3), 7.09
(app. d, J = 8.0, 2H, ArCH2), 4.14-4.05 (app. q, J = 7.0, 2H, CH2), 2.15 (s, 3H, ArCH3),
1.54 (s, 6H, (C(CH3)2), 1.21-1.12 (t J = 7.0, 3H, CH3). 13C NMR (100MHz, CDCl3, δ):
176.9 (s, C═O), 141.2 (s, C-Me), 136.2 (s, C-C(CH3)2), 129.0 (2 x d, ArCH), 125.5 (2 x
d, ArCH), 60.7 (t, CH2), 29.7 (2 x q, C-(CH3)2), 20.9 (q, ArCH3), 15.0 (q, CH3).
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α,α, 4-Trimethylbenzeneacetic acid 350 222
O
OH
Commercially available from Interchim [20430-18-6]. Previously synthesised by Smith
III et. al.220 To a flask containing the gem ester (1.5g) with potassium hydroxide pellets
(0.61g) was added absolute ethanol (50 mL), and the solution was stirred at reflux for six
days. The solvent was removed in-vacuo to yield an orange-yellow solid (2.30g). The
crude solid was treated with diethyl ether (2 x 125 mL) and then acidified down to pH 2
with hydrochloric acid (2M HCl). The organic phase was dried over anhydrous
magnesium sulfate. The solvent was removed in-vacuo to furnish a yellow solid (1.20g)
as α,α, 4-trimethylbenzeneacetic acid 350. 1H NMR (400MHz, CDCl3, δ): 9.4 (bs, 1H,
COOH), 7.10 (d.t, J = 8.0 and 2.0, 2H, ArCH), 6.99 (t, J = 8.0, 2H, ArCH), 2.19 (s, 3H,
ArCH3), 1.44 (s, 6H, (CH3)2). 13C NMR (100MHz, CDCl3,δ): 177.0 (s, C═O), 141.9 (s,
C-Me), 137.0 (s, C-C(CH3)2), 129.2 (2 x d, ArCH), 125.7 (2 x d, ArCH), 46.2 (s, C-
(CH3)2), 26.6 (2 x q, C(CH3)2), 21.0 (q, ArCH3).
2-Methyl-2-p-tolyl-propionyl chloride 351 222
O
Cl
Previously synthesised by Buckle et. al.247 To a flask containing the gem acid (0.40g)
was added oxalyl chloride (0.88g, 0.60 mL) and the mixture refluxed vigourously for
24h. The excess oxalyl chloride was removed in-vacuo to furnish 2-methyl-2-p-tolyl-
propionyl chloride 351 as a yellow oil (0.14g) 1H NMR (300MHz, CDCl3, δ): 7.16-7.08
(m, 4H, ArCH), 2.32 (s, 3H, ArCH3), 1.58 (s, 6H, (C(CH3)2).
Experimental
209
Authentic Synthesis N-Butyl-2-p-tolyl-isobutyramide 280e 222
H
NO
To a stirred solution of 2-methyl-2-phenyl-propionyl chloride 351 (0.02g, 0.1mmol) in
diethyl ether (2 mL), was added n-butylamine (0.01 mL, 0.3 mmol) at room temperature
for 2 days. The reaction was quenched with water (5 mL) and the organic phase
extracted with diethyl ether (5 x 5 mL), and dried with anhydrous magnesium sulfate.
The solvent was removed in-vacuo to furnish N-butyl-2-p-tosyl-isobutyramide 280e a
yellow viscous solid (0.012g, 26%). 1H NMR (400MHz, CDCl3, δ): 7.18 (d.t, J = 8.0
and 2.0, 2H, ArCH), 7.08 (d, J = 8.0, 2H, ArCH), 5.05 (bs, 1H, NH), 3.07 (q, J = 7.0,
2H, CH2), 2.27 (s, 3H, ArCH3), 1.47 (s, 6H, 2 x CH3), 1.31-1.24 (quin. J = 7.0, 2H,
CH2), 1.19-1.09 (app. sxt., J = 7.0, 2H, CH2), 0.78 (t, J = 7.0, 3H, CH3). 13C NMR
(100MHz, CDCl3,δ): 177.6 (s, C═O), 142.3 (s, C-Me), 136.6 (s, C-C(CH3)2), 129.3 (2 x
d, ArCH), 126.4 (2 x d, ArCH), 46.7 (s, C-(CH3)2), 39.4 (t, CH2), 31.6 (t, CH2), 27.2 (2
x q, C(CH3)2), 20.9 (q, ArCH3), 20.0 (t, CH2), 14.8 (q, CH3). LRMS (LSIMS-FAB+)
m/z: 234 (MH+ = 100%), 154 (100), 137 (66), 133 (22), 120 (12). HRMS (LSIMS-FAB)
m/z: (MH+) calcd for C15H24NO, 234.1858; found, 234.1868.
Authentic Synthesis of 1-butyl-3,3,5-trimethyl-1,3-dihydroindol-2-one
N-n-Butyl-p-toluidine 340 209
H
N
Commercially available from Wako Pure Chemicals [10387-24-3]. A flask (A)
containing sodium hydride in 60% mineral oil was thrice washed with pentane, and the
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oil decanted. In a separate flask (B) was added p-toluidine 339 (10g) in
dimethylformamide (DMF) (50 mL) which was transferred via syringe to flask (A)
which formed a light grey turbid solution. The solution turned dark brown over one
hour. Addition of n-butyl iodide (CAUTION: CARCINOGENIC), to flask (A) gave a
brownish-yellow solution. The solution was stirred overnight at room temperature where
upon the solution had become olive green. The reaction mixture was quenched with 95%
ethanol and strong effervensing was observed. The solution had changed to dark brown.
With addition of saturated ammonium chloride a bright orange solution was obtained.
Work up consisted of ether (5 x 50 mL) followed by water (10 x 50 mL), drying the
organic phase over anhydrous magnesium sulfate and removal of the solvent in-vacuo to
give an orange oil. Purification via distillation (bp 143 °C/10Torr) gave dark brown oil
identified as N-n-butyl-p-toluidine 340. 1H NMR (400MHz, CDCl3,δ): 6.90 (d, J = 8.0,
2H, ArCH), 6.45 (d.t, J = 8.0 and 2.5, 2H, ArCH), 3.01 (t, J = 7.0, 2H, CH2), 2.16 (s,
3H, ArCH3), 1.55-1.48 (q, J = 7.0, 2H, CH2), 1.40-1.30 (sxt. J = 7.0, 2H, CH2), 0.88 (t, J
= 7.0, 3H, CH3). 13C NMR (100MHz, CDCl3,δ): 146.3 (s, C-N-), 129.7 (2 x d, ArCH),
126.3 (s, C-Me), 122.9 (2 x d, ArCH), 44.1 (t, CH2), 31.8 (t, CH2), 20.4 (t, CH2), 20.4
(q, ArCH3), 15.0 (q, CH3).
2-Bromo-N-butyl-2-methyl-N-p-tolyl-propionamide 341 210
N
O
Br
To a flask containing N-butyl-p-toluidine 340 in diethyl ether (50 mL) was added
triethylamine (1.41g) and 2-bromo-2-isobutyryl bromide (5.5 mL). The reaction mixture
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was stirred for 3 hours. The reaction mixture was quenched with ether (2 x 100 mL)
followed by water (100 mL) and dilute hydrochloric acid (1M, 100 mL). The organic
phase was washed with sodium bicarbonate and the organic phase dried over anhydrous
magnesium sulfate.The solvent was removed in-vacuo to give brown viscous oil (1.65g).
Flash chromatography (petrol ether:ethyl acetate 6:1) furnished 2-bromo-N-butyl-2-
methyl-N-p-tolyl-propionamide 341 as a yellow oil (0.39g, 31%). 1H NMR (300MHz,
CDCl3, δ): 7.29-7.12 (m, 4H, ArCH), 3.65 (t, J = 7.0, 2H, CH2), 2.39 (s, 3H, ArCH),
1.70 (s, 6H, (CH3)2), 1.57-1.51 (app. quin., J = 7.0, 2H, CH2), 1.37-1.25 (app. sxt., J =
7.0, 2H, CH2), 0.89 (t, J = 7.0, 3H, CH3). 13C NMR (100MHz, CDCl3, δ): 169.5 (s,
C═O), 139.9 (s, C-N-), 137.5 (s, C-Me), 129.4 (4 x d, ArCH), 59.0 (s, C-(CH3)2), 53.2
(t, CH2), 29.8 (2 x q, C(CH3)2), 28.9 (t, CH2), 20.9 (q, ArCH3), 19.8 (t, CH2), 13.7 (q,
CH3). LRMS (LSIMS-FAB+) m/z: 314 (81Br MH+ = 98%), 313 (81Br M+ = 60), 312
(79Br MH+ = 100), 311 (79Br M+ = 40), 232 (43), 154 (70), 138 (30), 136 (50). HRMS
(LSIMS-FAB+) m/z: calcd for C15H22BrNO, 311.0885; found, 311.0882.
1-Butyl-3,3,5-trimethyl-1,3-dihydroindol-2-one 333 210
N
O
Anhydrous aluminium chloride was kept under a stream of nitrogen and to a single
necked flask was added (0.54g) and the precursor 341 (0.50g). An air condenser was
attached and the mixture was heated to 50 °C for 10 min, then maintained at 160 °C for
1h. A black viscous solid was obtained upon cooling. The reaction mixture was washed
with water (5 x 50 mL) furnished a yellow solution, and the organic phase extracted with
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diethyl ether. The ethereal phase was dried with anhydrous magnesium sulfate, and the
solvent removed in-vacuo to furnish a yellow oil (0.41g). Purification from flash
chromatography (petrol ether:ethyl acetate 9:1) furnished 1-butyl-3,3,5-trimethyl-1,3-
dihydroindol-2-one 333 as a light yellow oil (0.17g, 46%). IR (CH2Cl2) νmax: 2927, 1641,
1510, 1108 and 822 cm-1. 1H NMR (400MHz, CDCl3, δ) 6.94 (d, J = 7.0, 2H, ArCH),
6.64 (app. d, J = 7.0, 1H, ArCH), 3.60 (t, J = 7.0, 2H, CH2), 2.24 (s, 3H, ArCH3), 1.59-
1.52 (quin., J = 7.0, 2H, CH2), 1.32-1.22 (m, 8H, CH2 + (CH3)2), 0.85 (t, J = 7.0, 3H,
CH3). 13C NMR (100MHz, CDCl3,δ) 180.1 (s, C═O), 138.6 (s, C-N-), 135.0 (s, C-Me),
130.6 (s, C-C(CH3)2) 126.7 (d, ArCH), 122.2 (d, ArCH), 107.0 (d, ArCH), 43.0 (s, C-
(CH3)2), 38.5 (t, CH2), 28.5 (t, CH2), 23.4 (2 x q, C(CH3)2), 20.0 (q, ArCH3), 19.7 (t,
CH2), 13.5 (q, CH3); m/z (LSIMS) 232 (MH+ = 32%), 207 (27), 165 (11), 154 (100),
136 (80), 120 (27).
1-Butyl-3,3,5-trimethyl-1,3-dihydroindol-2-one 333
Copper-mediated radical reaction
O
N
To a three necked RB flask was added 341 (0.58g, 1.0 eq.), tris-(2-pyridylmethyl)-amine
279 (0.67g, 1.1 eq) and copper bromide (0.39g, 1.1 eq.) in toluene (16 mL) and the
reaction mixture stirred under nitrogen at 120 °C for 24 h. The crude product was
filtered through a silica plug with ethyl acetate to yield a pale yellow oil (0.42g, 98%) as
1-butyl-3,3,5-trimethyl-1,3-dihydroindol-2-one 333. IR (CH2Cl2) νmax 2927, 1706, 1494,
1192, 803cm-1; 1H NMR (400MHz, CDCl3) 6.93 (d, J = 7.0, 2H, ArCH), 6.65 (d, J =
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7.0, 1H, ArCH), 3.59 (t, J = 7.0, 2H, CH3), 2.24 (s, 3H, ArCH3), 1.59-1.51 (quin. J =
7.0, 2H, CH2), 1.29-1.21 (m, 8H, CH2 + (CH3)2), 0.84 (t, J = 7.0, 3H, CH3). 13C NMR
(100MHz, CDCl3,δ) “not observed” (s, C═O), 139.90 (s, C-N-), 136.1 (s, C-Me), 131.7
(s, C-C(CH3)2), 127.7 (d, ArCH), 123.3 (d, ArCH), 108.0 (d, ArCH), 68.2 (s, C-
(CH3)2), 39.6 (t, CH2), 29.5 (t, CH2), 24.5 (2 x q, C(CH3)2), 22.5 (q, ArCH3), 20.09 (t,
CH2), 14.75 (q, CH3).
Discernible data for butyl-3,3,6-trimethyl-1,3-dihydroindol-2-one 336
Butyl-m-tolylamine 343 212
H
N
Procedure same as above for 340. Distilled at 114 ºC/10Torr to furnish green mobile oil
(3.0g, 20%). 1H NMR (300MHz, CDCl3,δ): 7.14-7.06 (m, 1H, ArCH), 6.55 (app. d. J =
7.0, 1H, ArCH), 6.46 (app. d. J = 7.0, 2H, ArCH), 3.56 (bs, 1H, NH), 3.14 (t, J = 7.0,
2H, CH2), 2.31 (s, 3H, ArCH3), 1.68-1.59 (m, 2H, CH3), 1.50-1.40 (m, 2H, CH2), 1.00
(app. t, J = 7.0, 3H, CH3).
2-Bromo-N-butyl-2-methyl-N-m-tolyl-propionamide 345 210
N
O
Br
Same procedure as for 341. Flash chromatography (petrol ether: ethyl acetate 6:1)
furnished 2-bromo-N-butyl-2-methyl-N-m-tolyl-propionamide 345 as yellow oil (1.65g).
1H NMR (300MHz, CDCl3, δ) 7.35-7.13 (m, 4H, ArCH), 3.67 (t, J = 7.5, 2H, CH3),
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2.35 (s, 3H, ArCH3), 2.00 (s, 6H, C(CH3)2), 1.61-1.50 (m, 2H, CH2), 1.38-1.32 (m, 2H,
CH2), 0.90 (t, J = 7.5, 3H, CH3).
Butyl-3,3,6-trimethyl-1,3-dihydroindol-2-one 336 210
AlCl3 anhydrous reaction
O
N
Same procedure as used for 333. Flash chromatography (petrol ether:ethyl acetate 9:1)
furnished butyl-3,3,5-trimethyl-1,3-dihydroindol-2-one 336 inseparable mixture as
colourless oil (0.02g). 1H NMR (400MHz, CDCl3, δ) 7.08 (d, J = 7.5, 1H, ArCH), 6.85
(d, J = 7.5, 1H, ArCH), 6.68 (s, 1H, ArCH), 3.69 (t, J = 7.5, 2H, CH3), 2.38 (s, 3H,
ArCH3), 1.69-1.60 (m, 2H, CH2), 1.40-1.30 (m, 8H, CH2 + (CH3)2), 0.94 (t, J = 7.5, 3H,
CH3).
Butyl-3,3,6-trimethyl-1,3-dihydroindol-2-one 336
Copper (I) bromide/TPA reaction
O
N
Same procedure as used for 333. Purification from flash chromatography (petrol ether:
ethyl acetate 1:6) furnished 336 as a clear liq (0.04g, 10%); IR (neat) νmax 2963, 1713,
1609, 1384, 1117 and 810 cm-1. 1H NMR (300MHz, CDCl3, δ) 7.08 (d, J = 7.5, 1H,
ArCH), 6.85 (d, J = 7.5, 1H, ArCH), 6.68 (s, 1H, ArCH), 3.69 (t, J = 7.5, 2H, CH2),
2.38 (s, 3H, ArCH3), 1.69-1.61 (m, 2H, CH2), 1.42-1.31 (m, 8H, CH2 + (CH3)2), 0.95 (t,
J = 7.5, 3H, CH3); 13C NMR (100MHz, CDCl3, δ) 182.5 (s, C═O), 142.1 (s, C-N-),
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137.6 (s, C-Me), 133.2 (s, C-C(CH3)2), 122.7 (d, ArCH), 122.1 (d, ArCH), 109.3 (d,
ArCH), 43.9 (s, C-(CH3)2), 39.5 (t, CH2), 31.8 (t, CH2), 29.6 (t, CH2), 21.8 (2 x q,
C(CH3)2), 20.0 (q, ArCH3), 14.9 (q, CH3).
N-Butyl-2,4,6-trimethyl-phenyl-isobutryramide 280f
O
NH
Purification by column chromatography (petrol ether: ethyl acetate 6:1) furnish N-butyl-
2,4,6-trimethyl-phenyl-isobutryramide 280f and trace of N-butyl-2,4,6-trimethyl-
benzenesulphonamide 278f (1.0:0.1) as a colourless oil (0.05g, 10%). IR (CH2Cl2) νmax :
3316, 2958, 1736, 1521, 1161, 850 cm-1. 1H NMR (400MHz; CDCl3, δ) 6.80 (s, 2H,
ArCH), 5.28 (s, 1H, NH), 3.18 (q, J = 7.0Hz, 2H, CH2), 2.35 (s, 6H, 2 x ArCH3), 2.23
(s, 3H, ArCH3), 1.62 (s, 6H, (CH3)2), 1.46-1.37 (quin., J = 7.0, 2H, CH2), 1.30-1.21 (sxt,
J = 7.0, 2H, CH2), 0.88 (t, J = 7.0, 3H, CH3). 13C NMR (100MHz, CDCl3, δ) 180.3 (s,
C═O), 138.2 (s, C-C(CH3)2), 137.8 (2 x s, C-Me), 135.8 (s, C-Me), 131.9 (d, ArCH),
131.9 (d, ArCH), 49.7 (s, C-(CH3)2), 39.8 (t, CH2), 31.4 (t, CH2), 30.9 (q, ArCH3), 28.7
(q, ArCH3), 23.4 (2 x q, C(CH3)2), 20.3 (q, ArCH3), 20.0 (t, CH2), 14.7 (q, CH3).
LRMS (LSIMS-FAB+) m/z: 262 (MH+ = 100%), 161 (33), 154 (51), 136 (43 ). HRMS
(LSIMS-FAB+) m/z: calcd for C17H28NO, 262.2171; found, 262.2170.
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N-Butyl-2-naphthalen-2-yl-isobutyramide 280g
O
HN
Purification by column (petrol ether/ethyl acetate 4:1) furnished N- butyl-2-naphthalen-
2-yl-isobutyramide 280g as a yellow oil (0.12g, 44%). IR (CH2Cl2) νmax: 3347; 2960.
2930, 1649, 1527, 748 cm-1. 1H NMR (300MHz, CDCl3,δ): 7.82 (m 3H, ArCH), 7.41-
7.51 (m, 4H, ArCH), 5.19 (bs, 1H, NH), 3.15 (q, J = 7.0, 2H, CH2), 1.64 (s, 6H,
C(CH3)2), 1.12-1.34 (m, 4H, CH2), 0.83 ( t, J = 7.0, 3H, CH3). 13C NMR (125.8MHz,
CDCl3, δ) 177.2 (s, C═O), 142.8 (s, C-C(CH3)2), 133.3 (s, C-C), 132.3 (s, C-C), 129.5
(d, ArCH), 128.5 (d, ArCH), 127.7 (d, ArCH), 126.4 (d, ArCH), 126.1 (d, ArCH),
125.5 (d, ArCH), 124.4 (d, ArCH), 47.2 (s, C-(CH3)2), 39.5 (t, CH2), 31.6 (t, CH2), 27.0
(2 x q, C(CH3)2), 19.9 (t, CH2), 13.6 (q, CH3). LRMS (LSIMS-FAB+) m/z: 270 (MH+ =
87%), 219 (65), 169 (73), 154 (93), 133 (100), 129 (52). HRMS (LSIMS-FAB+) m/z:
(MH+) calcd for C18H24NO, 270.1858; found, 270.1858.
N-Butyl-2- (4-methoxy-phenyl)-isobutyramide 280h
H
NO
MeO
Purification by column (petrol ether/ethyl acetate 4:1), furnished N-butyl-2-(4-methoxy-
phenyl)-isobutyramide 280h as a transparent crystalline solid (0.02g 9%); IR (CH2Cl2)
νmax: 3349, 2960, 1645, 1511, 1249, 1182, 1017, 839 cm-1. 1H NMR (300MHz, CDCl3,
δ): 7.27 (d.t, J = 9.0 and 3.0, 2H, ArCH), 6.88 (d.t, J = 9.0 and 3.0, 2H, ArCH) 5.13 (bs,
1H, NH), 3.82 (s, 3H, OCH3), 3.15 (q, J = 7.0, 2H, CH2), 1.54 (s, 6H, C(CH3)2), 1.40-
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1.30 (quin., J = 7.0, 2H, CH2), 1.27-1.15 (sxt, J = 7.0, 2H, CH2), 0.87 (t, J = 7.0, 3H,
CH3). 13C NMR (75.5MHz, CDCl3,δ) 177.5 (s, C═O), 158.2 (s, C-OMe), 137.1 (s, C-
Me), 127.4 (2 x d, ArCH), 113.7 (2 x d, ArCH), 55.1 (q, OCH3), 46.1 (s, C-(CH3)2),
39.2 (t, CH2), 31.3 (t, CH2), 27.0 (2 x q, C(CH3)2), 19.7 (t, CH2), 13.5 (q, CH3). LRMS
(LSIMS-FAB+) m/z 250 (MH+ = 100), 154 (22), 149 (42), 136 (15). HRMS (LRMS-
FAB+) m/z: (MH+) calcd for C15H24NO2, 250.1807; found, 250.1811.
Butyl-5-methoxy-3,3-dimethyl-1,3-dihydro-indol-2-one 352
N
O
O
Purification by flash chromatography furnished an inseparable mixture of 1-butyl-5-
methoxy-3,3-dimethyl-1,3-dihydro-indol-2-one 352 as the major product (0.006g, 0.7%);
IR (CH2Cl2) νmax: 2966, 2203, 1712, 1624, 1504, 1384, 750 cm-1. 1H NMR (400MHz,
CDCl3,δ): 7.00 (app. d., J = 8.0, 1H, ArCH), 6.55 (m, 1H, ArCH), 6.45 (app. d, J = 2.0,
1H, ArCH), 3.81 (s, 3H, OCH3), 3.68 (t, J = 7.0, 2H, CH2), 1.70-1.61 (quin., J = 7.0,
2H, CH2), 1.42-1.31 (m, 8H, CH2 + (CH3)2), 0.94 (t, J = 7.0, 3H, CH3). 13C NMR
(100MHz, CDCl3,δ): 182.1 (s, C═O), 159.8 (s, C-OCH3), 143.1 (s, C-N-), 128.2 (s, C-
C(CH3)2), 122.8 (d, ArCH), 105.8 (d, ArCH), 96.7 (d, ArCH), 55.5 (q, OCH3), 43.7 (s,
C(CH3)2), 39.6 (t, CH2), 30.8 (t, CH2), 24.4 (2 x q, C(CH3)2), 20.0 (t, CH2), 13.50 (q,
CH3). LSRM (LSIMS-FAB+) m/z: 248 (MH+ = 100%), 232 (25), 176 (25), 154 (78), 136
(67). HRMS (LSIMS-FAB+) m/z: calcd for C15H21NO2, 247.1572; found, 247.1577.
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N-Butyl-2-(4-fluorophenyl)-isobutyramide 280b
F
O
HN
Purification by flash chromatography (petrol ether/ethyl acetate 6:1) furnished N-butyl-
2-(4-fluorophenyl)-isobutyramide 280b as an apple white oil (0.12g, 41%). IR (CH2Cl2)
νmax: 3345, 2960, 1641, 1508, 1229, 1164, 833 cm-1. 1H NMR (400MHz, CDCl3, δ):
7.36-7.30 (m, 2H, ArCH), 7.06-7.00 (m, 2H, ArCH), 5.10 (s, 1H, NH), 3.16 (q, J = 7.0,
2H, CH2), 1.55 (s, 6H, C(CH3)2), 1.40-1.33 (quin., J = 7.0, 2H, CH2), 1.27-1.17 (sxt., J
= 7.0, 2H, CH2), 0.86 (t, J = 7.0, 3H, CH3). 13C NMR (100MHz, CDCl3, δ): 177.0 (s,
C═O), 162.8-160.0 (d, J = 281, C-F), 141.1 (s, C-C(CH3)2), 128.1 (2 x d, ArCH), 115.5
(2 x d, ArCH), 46.5 (s, C-(CH3)2), 39.5 (t, CH2), 31.5 (t, CH2), 27.2 (2 x q, C(CH3)2),
19.9 (t, CH2), 14.5 (q, CH3). LRMS (LSIMS-FAB+) m/z: 238 (MH+ = 100%), 154 (42),
137 (44). HRMS (LSIMS-FAB+) m/z: (MH+) calcd for C14H21FNO, 238.1607; found,
238.1598.
1-Butyl-(6)-fluoro-3,3-dimethyl-1,3-dihydroindol-2-one 355b
N
O
F
Purification by flash chromatography (petrol ether/ethyl acetate 10:1) furnished 1-butyl-
(6)-fluoro-3,3-dimethyl-1,3-dihydroindol-2-one 355b as a clear oil (0.16g, 53%). IR
(CH2Cl2) νmax: 3292, 2960, 1667, 1514, 1284, 1127, 812 cm-1. 1H NMR (400MHz,
CDCl3, δ): 7.03 (app q. J = 8.0, 1H, ArCH), 6.62 (app. d.t J = 8.0 and 2.0, 1H, ArCH),
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6.50 (app. d.d J = 9.0 and 2.0, 1H, ArCH), 3.60 (t, J = 7.0, 2H, CH2), 1.61-1.53 (quin. J
= 7.0, 2H, CH2), 1.34-1.24 (m, 8H, CH2 + (CH3)2), 0.87 (t, J = 7.0, 3H, CH3). 13C NMR
(100MHz, CDCl3, δ): 182.0 (s, C═O), 163.9-161.5 (d, J = 242, C-F), 145.0 (s, C-N-),
131.2 (s, C-C(CH3)2), 123.2 (d, ArCH), 108.1 (d, ArCH), 97.1 (d, ArCH), 43.7 (s, C-
(CH3)2), 39.7 (t, CH2), 29.4 (t, CH2), 24.5 (2 x q, C(CH3)2), 20.0 (t, CH2), 13.0 (q,
CH3). LRMS (EI+) m/z: 235 (M+ = 80%), 192 (55), 164 (100), 148 (20). HRMS (EI+)
m/z: calcd for C14H18FNO, 235.1372; found, 235.1370.
2-(4-bromo-phenyl)-N-butyl-isobutyramide 280c
H
NO
Br
Purification by column petrol ether/ethyl acetate (4:1) furnished 2-(4-bromo-phenyl)-n-
butyl-isobutyramide 280c (0.41g, 58%) as a clear oil. IR (CH2Cl2) νmax: 3357, 2933
1651, 1519, 1169, 853 cm-1. 1H NMR (400MHz, CDCl3, δ): 7.45 (app. d.t, J = 8.5 and
2.0, 2H, ArCH), 7.23 (app. d.t, J = 8.5 and 2.0, 2H, ArCH), 5.16 (bs, 1H, NH), 3.15 (t,
J = 7.0, 2H, CH2), 1.53 (s, 6H, C(CH3)2), 1.40-1.32 (quin., J = 7.0, 2H, CH2), 1.26-1.19
(app. sxt., J = 7.0, 2H, CH2), 0.86 (t, J = 7.0, 3H, CH3). 13C NMR (75.5MHz, CDCl3,δ):
175.7 (s, C═O), 151.1 (s, C-C(CH3)2), 132.3 (2 x d, ArCH), 127.1 (2 x d, ArCH), 110.5
(s, C-Br), 47.2 (s, C-(CH3)2), 39.5 (t, CH2), 31.4 (t, CH2), 26.8 (2 x q, C(CH3)2), 20.0 (t,
CH2), 13.5 (q, CH3). LRMS (EI+) m/z: 299 (81Br-M+ = 7%), 297 (79Br-M+ 8), 218 (69),
199 (81Br 98), 197 (79Br 97), 183 (20), 170 (24), 169 (25), 119 (72). HRMS (EI+) m/z:
calcd for C14H2081BrNO2, 299.0708; found, 299.0710.
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6-Bromo-1-butyl-3,3-dimethyl-dihydro-indol-2-one 357b
Discernible data for major oxindole:
N
O
Br
Purification by flash chromatography (petrol ether/ethyl acetate (6:1) furnished 6-
bromo-1-butyl-3,3-dimethyl-dihydro-indol-2-one 357b as an inseparable clear globular
oil (0.035g, 13%); IR (CH2Cl2) νmax: 2961, 1712, 1603, 1485, 1360, 1123 and 808 cm-1.
1H NMR (400MHz, CDCl3, δ): 7.19 (d, J = 8.0, 1H, ArCH), 7.07 (d, J = 8.0, 1H,
ArCH), 7.03 (s, 1H, ArCH), 3.70 (t, J = 7.0, 2H, CH2), 1.70-1.62 (app. quin., J = 7.0,
2H, CH2), 1.43-1.36 (m, 8H (CH3)2) + CH2), 0.98 (t, J = 7.0, 3H CH3).
N-Butyl-2- (4-iodo-phenyl)-isobutyramide 280d
H
NO
I
Purification by column (petrol ether/ethyl acetate 4:1), furnished 2-(4-iodo-phenyl)-n-
butyl-isobutyramide 280d as clear oil (0.16g, 28%). IR (CH2Cl2) νmax: 3332, 2932, 1718,
1276, 1130, 895 cm-1. 1H NMR (400MHz, CDCl3, δ): 7.67 (d.t, J = 9.0 and 3.0, 2H,
ArCH), 7.11 (d.t, J = 9.0 and 3.0, 2H, ArCH), 5.12 (bs, 1H, NH), 3.16 (q, J = 7.0, 2H,
CH2), 1.53 (s, 6H, C(CH3)2), 1.41-1.38 (quin., J = 7.0, 2H, CH2), 1.27-1.18 (sxt., J =
7.0, 2H, CH2), 0.87 (t, J = 7.0, 3H, CH3). 13C NMR (100MHz, CDCl3, δ): 175.7 (s,
C═O), 144.1 (s, C-C(CH3)2), 136.7 (2 x d, ArCH), 127.5 (2 x d, ArCH), 91.5 (s, C-I),
45.8 (s, C-(CH3)2), 38.6 (t, CH2), 30.5 (t, CH2), 25.9 (2 x q, C(CH3)2), 19.8 (t, CH2),
13.5 (q, CH3). LRMS (LSIMS-FAB+) m/z: 346 (MH+ = 100%), 244.96 (20), 136 (15),
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133 (10). HRMS (LSIMS-FAB+) m/z: (MH+) Calc for C14H21INO 346.0668, found
346.0738.
N-Butyl-2- (4-cyano-phenyl)-isobutyramide 280i
H
NO
NC
Purification by column (petrol ether/ethyl acetate 4:1) furnished 2-(4-cyano-phenyl)-n-
butyl-isobutyramide 280i as translucent spherical film (0.10g, 60%); IR (CH2Cl2) νmax:
2928, 2867, 1685, 1509, 1399, 1205, 804 cm-1. 1H NMR (400MHz, CDCl3,δ): 7.56 (d.t,
J = 8.5 and 2.0, 2H, ArCH); 7.41 (d.t, J = 8.5 and 2.0, 2H, ArCH), 5.28 (bs, 1H, NH),
3.11 (q, J = 7.0, 2H, CH2), 1.50 (s, 6H, C(CH3)2), 1.37-1.27 (app. quin., J = 7.0, 2H,
CH2), 1.20-1.11 (app. sxt, J = 7.0, 2H, CH2), 0.80 (t, J = 7.0, 3H, CH3). 13C NMR
(100MHz, CDCl3,δ): 176.6 (s, C═O), 144.5 (s, C-C(CH3)2), 131.7 (2 x d, ArCH), 128.2
(2 x d, ArCH), 120.9 (s, C-C≡N), 111.1 (s, C-C≡N) 46.7 (s, C(CH3)2), 39.7 (t, CH2),
31.5 (t, CH2), 27.0 (2 x q, C(CH3)2), 20.0 (t, CH2), 14.1 (q, CH3). LRMS (LSIMS-
FAB+) m/z: 245 (30), 154 (100), 136 (70). HRMS (LSIMS-FAB+) m/z: (MH+) calcd for
C15H21N2O, 245.1654; found 245.1647.
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1-Butyl-3,3-dimethyl-2-oxo-2,3-dihydro-1H-indol-6-carbonitrile 360 and 1-butyl-
3,3-dimethyl-2-oxo-2,3-dihydro-1H-indole-5-carbonitrile 362
NNC
O
N
O
NC
Purification by column (petrol ether/ethyl acetate 4:1), furnished 1-butyl-3,3-dimethyl-2-
oxo-2,3-dihydro-1H-indol-6-carbonitrile 360 and 1-butyl-3,3-dimethyl-2-oxo-2,3-
dihydro-1H-indole-5-carbonitrile 362 as a yellow translucent oil (0.05g, 30%).
Discernible data for 360: 1H NMR (400MHz, CDCl3, δ): 7.59 (app. d, J = 8.0, 1H,
ArCH), 7.45 (app. s, 1H, ArCH), 6.92 (d, J = 8.0, 1H, ArCH), 3.73 (t, J = 7.5, 2H,
CH2), 1.69-1.61 (app.quin., J = 7.5, 2H, CH2), 1.41-1.35 (m, 8H, CH2 and ((CH3)2),
0.96 (t, J = 7.5, 3H, CH3). 13C NMR (100MHz, CDCl3,δ): 180.9 (s, C═O), 142.9 (s, C-
N-), 133.1 (d, ArCH), 136.0 (s, C-C(CH3)2), 125.9 (d, ArCH), 119.5 (s, C≡N), 111.4 (s,
C-C≡N), 108.7 (d, ArCH), 44.0 (s, C(CH3)2), 39.8 (t, CH2), 29.4 (t, CH2), 24.2 (2 x q,
C(CH3)2), 20.0 (t, CH2), 14.7 (q, CH3).
Discernible data for 362: 1H NMR (400MHz, CDCl3, δ): 7.39 (app. d, J = 7.0, 1H,
ArCH), 7.29 (d, J = 7.0, 1H, ArCH), 7.08 (s, 1H, ArCH), 3.73 (t, J = 7.5, 2H, CH2),
1.69-1.61 (app.quin., J = 7.5, 2H, CH2), 1.41-1.35 (m, 8H, CH2 + ((CH3)2), 0.97 (t, J =
7.5, 3H, CH3). 13C NMR (100MHz, CDCl3, δ): 180.4 (s, C≡O), 141.2 (s, C-N-), 136.0
(s, C-C(CH3)2), 119.0 (s, C≡N), 111.4 (s, C-C≡N), 126. 9 (d, ArCH), 123.1 (d, ArCH),
110.8 (d, ArCH), 44.3 (s, C(CH3)2), 39.8 (t, CH2), 29.3 (t, CH2), 24.1 (2 x q, C(CH3)2),
20.0 (t, CH2), 14.7 (q, CH3). LRMS (EI+) 360 and 362 242 (M = 81%), 204 (27), 199
(71), 186 (34), 171 (100), 155 (26), 141 (96), 121 (18). HRMS (LSIMS-FAB+) 362
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calcd for C15H18N2O, 242.1419; found, 242.1423. Data for 360/362. Elemental Analysis
(WAS) Calcd for C15H18N2O: C, 74.3; H, 7.5; N, 11.5; S, 10.5. Found C, 74.1; H, 7.8; N,
11.0; S, 0.35%.
N-Butyl-2-(4-nitro-phenyl)-isobutyramide 280j
H
NO
O2N
Purification by column (petrol ether/ethyl acetate 4:1), furnished 2-(4-nitro-phenyl)-n-
butyl-isobutyramide 280j as a yellow oil (0.14g, 43%). IR (CH2Cl2) νmax: 3346, 2961,
1648, 1600, 1518, 1466, 1344, 1279, 855 cm-1. 1H NMR (300MHz, CDCl3,δ): 8.17 (d.t,
J = 7.0 and 2.0, 2H, ArCH), 7.54 (d.t, J = 7.0 and 2.0, 2H, ArCH), 5.40 (bs, 1H, NH),
3.20 (q, J = 7.0, 2H, CH2), 1.61 (s, 6H, C(CH3)2), 1.47-1.37 (quin., J = 7.0, 2H, CH2),
1.16-1.31 (sxt, J = 7.0, 2H, CH2), 0.88 (t, J = 7.0, 3H, CH3). 13C NMR (75.5MHz,
CDCl3, δ): 175.2 (s, C═O), 152.8 (s, C-NO2), 146.5 (s, C-C(CH3)2), 127.0 (2 x d,
ArCH), 123.5 (2 x d, ArCH), 47.1 (s, C(CH3)2), 39.4 (t, CH2), 31.3 (t, CH2), 26.7 (2 x
q, C(CH3)2), 19.7 (t, CH2), 13.5 (q, CH3). LRMS (EI+) m/z: 266 (MH2+ = 31%), 265
(MH+ = 37), 206 (31), 204 (36), 165 (100), 149 (52), 135 (36). HRMS (LSIMS-FAB+)
m/z: (MH+) calcd for C14H21N2O, 265.1552, found 265.1561.
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1-Butyl-3,3-dimethyl-6-nitro-1,3-dihydroindol-2-one 361, 2-butyl-4,4-dimethyl-6-
nitro-1,1-dioxo-1,4-dihydro-2H-1λ6-benzo[e][1,2]-thiazin-3-one 366
N
O
NO2
N
O
S
O
OO2N
Purification by flash chromatography (petrol ether/ethyl acetate 6:1) furnished as an
inseparable mixture tentatively assigned as for butyl-4,4-dimethyl-(6)-nitro-1,1-dioxo-
1,4-dihydro-2H-1λ6-benzo[e][1,2]-thiazin-3-one 366 and 1-butyl-3,3-dimethyl-6-nitro-
1,3-dihydroindol-2-one 361 as a golden yellow viscous oil (0.31g, 26%). Found by
elemental analysis to be C14H18N2O5S and C14H19N2O3 [3:1].
Data for 2-butyl-4,4-dimethyl-6-nitro-1,1-dioxo-1,4-dihydro-2H-1λ6-benzo-[e][1,2]-
thiazin-3-one 366. IR (CH2Cl2) mixture νmax: 2960, 2361, 1722, 1527, 1385, 1269, 1124,
1070, 885 cm-1. 1H NMR (300MHz, CDCl3, δ): 7.95 (app. d, J = 8.0, 1H, ArCH), 7.64
(app. s, 1H, ArCH), 7.31 (d, J = 8.0, 1H, ArCH), 3.75 (t, J = 7.0, 2H, CH2), 1.71-1.61
(m, 2H, CH2), 1.43-1.30 (m, 8H, CH2 + (CH3)2), 0.95 (t, J = 7.0, 3H, CH3). 13C NMR
(75.5MHz, CDCl3,δ) 179.5 (s, C=O), 166.0 (s, C-NO2), 142.0 (s, C-SO2-), 130.5 (s, C-
C(CH3)2), 124.1 (d, ArCH), 117.4 (d, ArCH), 102.16 (d, ArCH), 43.3 (s, C(CH3)2), 38.9
(t, CH2), 28.4 (t, CH2), 23.1 (2 x q, C(CH3)2), 19.5 (t, CH2), 13.7 (q, CH3). LRMS (EI+)
m/z: data for 409 (M+ + 81BrH = 64%), 327 (MH+ = 80), 285 ( 35), 241 (17), 215 (33),
206 (83), 186 (100), 121 (75).
Data for 1-butyl-3,3-dimethyl-6-nitro-1,3-dihydro-indol-2-one 361
1H NMR (300MHz, CDCl3, δ): 8.23 (app. d, J = 8.5, 1H, ArCH), 8.08 (app. s, 1H,
ArCH), 6.90 (d, J = 8.5, 1H, ArCH), 3.76 (t, J = 7.0, 2H, CH2), 1.73-1.63 (m, 2H, CH2),
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1.45-1.35 (m, 8H, CH2 + ((CH3)2), 0.81 (t, J = 7.0, 3H, CH3). 13C NMR (75.5MHz,
CDCl3, δ): 181.0 (s, C=O), 166.0 (s, C-NO2), 142.0 (s, C-N-), 130.5 (s, C-(C(CH3)2),
124.1 (d, ArCH), 117.4 (d, ArCH), 106.8 (d, ArCH), 43.3 (s, C(CH3)2), 39.0 (t, CH2),
28.7 (t, CH2), 23.1 (2 x q, C(CH3)2), 19.5 (t, CH2), 13.7 (q, CH3). m/z 264 (M+ = 40% ),
154 (100), 137 (65). HRMS (LSIMS-FAB+) m/z: (MH+) Calcd for 263.1396,
C14H19N2O3; Found, 263.1399. Elemental Analysis (WAS): C, 55.7; H, 7.7; N, 6.6; S,
6.3 requires C, 51.5; H, 5.6; N 8.5; S, 9.82. S analysis for 366 (67%) S = 6.6. HRMS
(LSIMS) m/z: (M+-SO2) calcd for C14H18N2O5S, 263.1396; found, 263.1399.
N-Butyl-(4-nitrobenzene)-sulphonamide 283j 280
S
O2N
H
NO
O
Purification by flash chromatography (petrol ether/ethyl acetate 6:1) from radical
reaction furnished N-butyl-(4-nitrobenzene)-sulphonamide as a pale yellow crystalline
solid 283j. 1H NMR (300MHz, CDCl3,δ): 8.34 (app. d, J = 9.0, 2H, ArCH), 8.06 (app d,
J = 9.0, 2H, ArCH), 4.96 (bs, 1H, NH), 3.03 (app. q, J = 7.0, 2H, CH2), 1.52-1.43 (app.
quin., J = 7.0, 2H, CH2), 1.37-1.25 (app. sxt, J = 7.0, 2H, CH2), 0.83 (t, J = 7.0, 3H,
CH3).
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N-Butyl-2-(4-trifluoromethylphenyl)isobutyramide 280k
Discernible data:
F
F
F
O
NH
Purification by column (petrol ether/ethyl acetate 4:1) furnished 2-(4-trifluoromethyl-
phenyl)-n-butyl-isobutyramide 280k as transparent spherical crystals (0.02g 9%). IR
(CDCl3) νmax: 3332, 2962, 1643, 1328, 1125 and 840 cm-1. 1H NMR (400MHz, CDCl3,
δ) 7.60 (d, J = 8.0, 2H, ArCH), 7.48 (d, J = 8.0, 2H, ArCH), 5.16 (bs, 1H, NH), 3.18 (q,
J = 7.0, 2H, CH2), 1.58 (s, 6H, C(CH3)2), 1.43-1.35 (app. quin., J = 7.0, 2H, CH2), 1.28-
1.18 (app. sxt, J = 7.0, 2H, CH2), 0.87 (t, J = 7.0, 3H, CH3); 13C NMR (100MHz,
CDCl3, δ) 176.6 (s, C=O), 149.9 (s, C-C(CH3)2), 129.9-129.4 (s, J = 44, C(CF3), 126.7
(2 x d, ArCH), 125.6 (2 x d, ArCH), 125.3-122.5 (s, J = 277, C(CF3), 47.1 (s, C(CH3)2),
39.6 (t, CH2), 31.5 (t, CH2), 27.0 (2 x q, C(CH3)2), 20.0 (t, CH2), 14.7 (q, CH3).
(LSIMS) m/z: 273 (M+ = 6%), 154 (100), 136 (70), 120 (14).
N-Butyl-2-(3,5-bis-trifluoromethyl-phenyl)-isobutyramide 280l
H
N
O
F
F
F
F
F
F
Purification by column chromatography furnished N-butyl-2-(3,5-bis-trifluoromethyl-
phenyl)-isobutyramide 280l. As a clear crystalline solid (0.01g, 26%). IR (CH2Cl2) νmax:
3301, 2933, 1644, 1281, 1130, 896 cm-1. 1H NMR (400MHz, CDCl3, δ): 7.81 (s, 2H,
ArCH), 7.79 (s, 1H, ArCH), 5.42 (bs, 1H, NH), 3.23 (q, J = 7.0, 2H, CH2), 1.62 (s, 6H,
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(CH3)2), 1.46-1.39 (app. quin., J = 7.0, 2H, CH2), 1.29-1.20 (app. sxt, J = 7.0, 2H, CH2),
0.88 (t, J = 7.0, 3H, CH3). 13C NMR (125MHz, CDCl3,δ): 175.1 (s, C=O), 148.3 (s, C-
C(CH3)2), 132.0-131.8 (2 x s, J = 33.1, C(CF3), 126.5 (2 x d, ArCH), 124.3-122.2 (2 x
d, J = 271.5, C(CF3), 121.0 (d, ArCH), 47.1 (s, C(CH3)2), 39.7 (t, CH2), 31.5 (t, CH2),
27.0 (2 x q, (CH3)2), 20.0 (t, CH2), 13.6 (q, CH3). LRMS (LSIMS-FAB+) m/z: 355 (M+
= 10%), 220 (15), 154 (15), 147 (100), 136 (30) HRMS (LSIMS-FAB+) m/z: (MH+)
calcd for C16H20F6NO, 356.1449; found 356.1463.
8.0 Synthesis of cyclised and rearranged amides from radical precursors 369
N
O
R
O
HN R N
R
O
370 371 372
8.1 General method for copper-mediated radical reactions
To a stirred solution of the radical precursor 369 (1.0 eq.) in dichloromethane (DCM)
was added of tris-[(2-pyridyl)methyl]-amine (1.1 eq.) 279 and copper bromide (1.1 eq.).
The reaction was stirred under nitrogen at 37 °C, and monitored by TLC until the
disappearance of starting material. Filtering the crude product through a silica plug with
ethyl acetate quenched the reaction mixture. The solvent was evaporated in vacuo to
yield an emerald green crude product. Purification by flash chromatography led to an
isolation of both the cyclised and rearranged products. Reactions done in toluene were
performed under inert atmosphere at reflux temperature unless otherwise stated.
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Authentic synthesis of N-ethyl-2-tolyl-isobutyramide 370a 222
O
HN
General method: To a single-necked RB flask was added the gem-acid chloride 351
(0.02g) in diethyl ether (2 mL). Ethylamine 373a (0.01g, 3.0 eq.) was added dropwise,
and a turbid solution was observed. The reaction mixture was stirred for 48h. The
reaction was quenched with water (3 x 5 mL) followed by diethyl ether (5 x 5 mL). The
organic layer was dried over anhydrous magnesium sulfate, and the solvent removed in-
vacuo to furnish a yellow viscous solid (0.012g) as N-ethyl-2-p-tolyl-isobutyramide
370a. IR (CH2Cl2) νmax: 3370, 2971, 1706, 1513, 1130, 820 cm-1. 1H NMR (400MHz,
CDCl3,δ): 7.24 (d, J = 8.0, 2H, ArCH), 7.16 (d, J = 8.0, 2H, ArCH), 5.14 (bs, 1H, NH),
3.20 (quin., J = 7.0, 2H, CH), 2.34 (s, 3H, ArCH3), 1.54 (s, 6H, (CH3)2), 1.02 (t, J = 7.0,
3H, CH3). 13C NMR (100MHz, CDCl3,δ) 177.6 (s, C═O), 142.3 (s, C-Me), 136.6 (s, C-
C(CH3)2), 129.4 (2 x d, ArCH), 126.4 (2 x d, ArCH), 46.6 (s, C-C(CH3)2), 34.6 (t,
CH2), 27.2 (2 x q, C(CH3)2), 21.0 (q, ArCH3), 13.0 (q, CH3). LRMS (LSIMS-FAB+)
m/z: 206 (M+ = 57%), 204 (100), 154 (87), 136 (62), 124 (10). HRMS (LSIMS-FAB+)
m/z: (MH+) calcd for C13H20NO, 206.1545; found, 206.1552.
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1-Ethyl-3,3,5-trimethyl-1,3-dihydro-indol-2-one 372a, N-ethyl-2-p-tolyl-
isobutyramide 370a
N
O
HN
O
Purification by flash chromatography (petrol ether/ethyl acetate 6:1) furnished an
inseparable mixture (3:1) of 1-ethyl-3,3,5-trimethyl-1,3-dihydro-indol-2-one 372a and
N-ethyl-2-p-tolyl-isobutyramide 370a as a yellow oil (0.57g). Data for 372a. IR
(CH2Cl2) νmax: 2968, 1646, 1515, 1462, 1352, 1169, 819 cm-1. 1H NMR (400MHz,
CDCl3, δ): 6.97 (d, J = 7.0, 1H, ArCH), 6.74 (d, J = 7.0, 1H, ArCH), 6.60 (s, 1H,
ArCH), 3.63 (q, J = 7.0, 2H, CH2), 2.28 (s, 3H, ArCH3), 1.21 (s, 6H, (CH3)2), 1.15 (t, J
= 7.0, 3H, CH3). 13C NMR (100MHz, CDCl3,δ): 181.2 (s, C═O), 141.7 (s, C-N-), 136.4
(s, C-Me), 133.0 (s, C-(CH3)2), 122.7 (d, ArCH), 122.2 (d, ArCH), 109.1 (d, ArCH),
43.8 (s, C-(CH3)2), 41.9 (t, CH), 24.4 (2 x q, CH3)2), 21.0 (q, ArCH3), 13.5 (q, CH3).
LRMS (LSIMS-FAB+) m/z: 270 (M+ + SO2) 206 (M+- SO2 = 57%), 188 (15), 154 (86),
139 (55), 133 (35).
Data for N-ethyl-2-p-tolyl-isobutyramide 370a. IR (CH2Cl2) νmax: 3370, 2971, 1706,
1513, 1130, 820 cm-1. 1H NMR (400MHz, CDCl3,δ): 7.14 (d, J = 8.0, 2H, ArCH), 7.04
(d, J = 8.0, 2H, ArCH), 5.23 (bs, 1H, NH), 3.09 (quin., J = 7.0, 2H, CH), 2.23 (s, 3H,
ArCH3), 1.44 (s, 6H, (CH3)2), 1.13 (t, J = 7.0, 3H, CH3). 13C NMR (100MHz, CDCl3,
δ): 177.8 (s, C═O), 143.3 (s, C-Me), 136.1 (s, C-(CH3)2), 129.3 (2 x d, ArCH), 126.3 (2
x d, ArCH), 47.2 (s, C-(CH3)2), 34.6 (t, CH), 27.1 (2 x q, C(CH3)2), 21.8 (q, ArCH3),
13.3 (q, CH3). LRMS (LSIMS-FAB+) m/z: 203 (M+ = 30%), 154 (100), 136 (70), 120
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(10). HRMS (LSIMS) m/z: for 370a (MH+) calcd for C13H20NO 206.1545; found,
206.1552.
N-Propyl-2-p-tolyl-isobutyramide 370b
HN
O
Data for N-propyl-2-p-tolyl-isobutyramide 370b furnished as a partially separated
mixture with 3,3,5-trimethyl-1-propyl-1,3-dihydroindol-2-one 372b (4:1) as a colourless
oil, 0.13g. Data for 370b. IR (CH2Cl2) νmax: 3351, 2924, 2360, 1644, 1512 and 816 cm-1.
1H NMR (300MHz, CDCl3,δ) 7.25 (d, J = 8.0, 2H, ArCH), 7.15 (d, J = 8.0, 2H, ArCH),
5.20 (bs, 1H, NH), 3.11 (q, J = 7.0, 2H, CH2), 2.38 (s, 3H, ArCH3), 1.55 (s, 6H, (CH3)2),
1.44-1.36 (quin., J = 7.0, 2H, CH2), 0.81 (t, J = 7.0, 3H, CH3). 13C NMR (125MHz,
CDCl3,δ) 178.0 (s, C═O), 142.7 (s, C-Me), 137.0 (s, C-C(CH3)2), 129.7 (2 x d, ArCH),
126.8 (2 x d, ArCH), 47.1 (s, C-(CH3)2), 41.7 (t, CH2), 28.4 (2 x q, C(CH3)2), 23.1 (t,
CH2), 21.3 (q, ArCH3), 11.6 (q, CH3); LRMS (LSIMS) m/z 220 (MH+ = 15%), 154
(100), 138 (38), 137 (64), 136 (70), 120 (15); HRMS (LSIMS) m/z: (MH+) calcd for
C14H22NO; 220.1701, found, 220.1708.
3,3,5-Trimethyl-1-propyl-1,3-dihydroindol-2-one 372b
N
O
Purification by flash chromatography furnished 3,3,5-trimethyl-1-propyl-1,3-
dihydroindol-2-one 372b and a minor tentatively assigned reduced product 375b (7:1) as
a mixture (yellow oil, 0.19g); Data for 372b IR (CH2Cl2) νmax: 2966, 1720, 1618, 1457,
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1384, 1360, 1131, 810 cm-1; 1H NMR (400MHz, CDCl3,δ) 7.08 (d, J = 7.5, 1H, ArCH),
6.85 (d, J = 7.5, 1H, ArCH), 6.68 (s, 1H, ArCH), 3.66 (t, J = 7.0, 2H, CH2), 2.38 (s, 3H,
ArCH3), 1.76-1.66 (sxt. J = 7.0, 2H, CH2), 1.34 (s, 6H, CH3)2), 0.95 (t, J = 7.0, 3H,
CH3); 13C NMR (100MHz, CDCl3,δ) 182.0 (s, C═O), 142.2 (s, C-N-), 137.6 (s, C-Me),
133.1 (s, C-C(CH3)2), 122.6 (d, ArCH), 122.1 (d, ArCH), 109.2 (d, ArCH), 48.2 (s,
C(CH3)2), 41.3 (t, CH2), 24.6 (2 x q, C(CH3)2), 21.8 (q, ArCH3), 20.5 (t, CH2), 11.0 (q,
CH3). LRMS (LSIMS-FAB+) m/z 218 (MH+ = 100%), 217 (M+ = 75), 154 (55), 149
(78), 136 (45). HRMS (LSIMS-FAB+) m/z: (MH+) calcd. for C14H19NO2, 218.1467,
found 217.1472.
N-Pentyl-2-p-tolyl-isobutramide 370c
Discernible data:
HN
O
Purification from flash chromatography (petrol ether/ethyl acetate 6:1) furnished N-
pentyl-2-p-tolyl-isobutramide 370c as a colourless globular film (0.14g, 57%). IR (neat)
νmax: 3354, 2928, 1620, 1513, 1161 and 816 cm-1. 1H NMR (400MHz, CDCl3, δ) 7.25
(d, J = 8.0, 2H, ArCH), 7.15 (d, J = 8.0, 2H, ArCH), 5.20 (bs, 1H, NH), 3.13 (q, J = 7.0,
2H, CH2), 2.34 (s, 3H, ArCH3), 1.54 (s, 6H, (CH3)2), 1.40-1.33 (app. quin., J = 7.0, 2H,
CH2), 1.28-1.22 (app. sxt, J = 7.0, 2H, CH2), 1.19-1.13 (app. quin., J = 7.0, 2H, CH2),
0.84 (t, J = 7.0, 3H, CH3). 13C NMR (100MHz, CDCl3,δ) 177.6 (s, C=O), 142.3 (s, C-
Me), 136.5 (s, C-C(CH3)2), 129.4 (2 x d, ArCH), 126.4 (2 x d, ArCH), 46.6 (s,
C(CH3)2), 39.6 (t, CH2), 29.1 (t, CH2), 28.9 (t, CH2 ), 27.1 (2 x q, C(CH3)2), 22.3 (t,
CH2), 20.9 (q, ArCH3), 14.7 (q, CH3).
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N-Hexyl-2-p-tolyl-isobutyramide 370d
HN
O
Data for N-hexyl-2-p-tolyl-isobutyramide 370d as a colourless oil (0.14g, 57%). IR
(neat) νmax: 3344, 2926, 1620, 1513 and 815 cm-1. 1H NMR (400MHz, CDCl3,δ) 7.25 (d,
J = 8.0, 2H, ArCH), 7.15 (d, J = 8.0, 2H, ArCH), 5.19 (bs, 1H, NH), 3.13 (q, J = 7.0,
2H, CH2), 2.34 (s, 3H, ArCH3), 1.54 (s, 6H, (CH3)2), 1.39-1.32 (app. quin., J = 7.0, 2H,
CH2), 1.28-1.14 (m, 6H, 3 x CH2), 0.85 (t, J = 7.0, 3H, ArCH3). 13C NMR (100MHz,
CDCl3,δ) 177.5 (s, C═O), 142.3 (s, C-Me), 136.5 (s, C-C(CH3)2), 129.3 (2 x d, ArCH),
126.3 (2 x d, ArCH), 46.6 (s, C(CH3)2), 39.7 (t, CH2), 31.4 (t, CH2), 29.4 (t, CH2), 27.1
(2 x q, C(CH3)2), 26.4 (t, CH2), 22.5 (t, CH2), 20.9 (q, CH3), 14.0 (q, CH3). LRMS
(LSIMS-FAB+) m/z 262 (MH+ = 100%), 154 (18), 136 (10), 134 (18), 133 (60). HRMS
(LSIMS-FAB+) m/z: (MH+) calcd for C17H28NO; 262.2171, found 262.2161.
Authentic synthesis of N-hexyl-2-p-tolyl-isobutyramide 370d
O
HN
General method: To a single-necked RB flask was added the acid chloride 351 (0.02g) in
diethyl ether (2 mL). Hexylamine (0.01g, 3.0 eq,) 374d was added dropwise, and a
turbid solution was observed. The reaction mixture was stirred for 48h. The reaction was
quenched with water (3 x 5 mL) followed by diethyl ether (5 x 5 mL). The organic layer
was dried over anhydrous magnesium sulfate, and the solvent removed in-vacuo to
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furnish a yellow viscous solid (0.015g) as N-hexyl-2-p-tolyl-isobutyramide 370d; 1H
NMR (400MHz, CDCl3, δ) 7.25 (d, J = 8.0, 2H, ArCH), 7.15 (d, J = 8.0, 2H, ArCH),
5.12 (bs, 1H, NH), 3.13 (q, J = 7.0Hz, 2H, CH2), 2.34 (s, 3H, ArCH3), 1.55 (s, 6H, 2 x
CH3), 1.39-1.30 (quin., J = 7.0Hz, 2H, CH2), 1.26-1.15 (m, 6H, 3 x CH2), 0.85 (t, J =
7.0Hz, 3H, CH3); 13C NMR (100MHz, CDCl3, δ) 177.5 (s, C═O), 142.3 (s, C-Me),
136.6 (s, C-C(CH3)2), 129.6 (2 x d, ArCH), 126.4 (2 x d, ArCH), 46.7 (s, C(CH3)2),
39.4 (t, CH2), 31.4 (t, CH2), 29.4 (t, CH2), 27.1 (2 x q, C(CH3)2), 26.4 (t, CH2), 22.5 (t,
CH2), 21.0 (q, CH3), 14.8 (q, CH3); LRMS (LSIMS-FAB+) m/z: 262 (MH+ = 20%), 155
(100), 137 (72). HRMS (LSIMS) m/z: (MH+) calcd for C17H28NO; 262.2171, found,
262.2161.
1-Hexyl-3,3,5-trimethyl-1,3-dihydroindole-2-one 372d
N
O
Purification by flash chromatography furnished 1-hexyl-3,3,5-trimethyl-1,3-
dihydroindole-2-one 372d as a colourless oil (8%); IR (CH2Cl2) νmax: 2928, 1720, 1620,
1458, 1384, 1132 and 809 cm-1. 1H-NMR (400MHz, CDCl3, δ) 7.08 (d, J =7.0, 1H,
ArCH), 6.85 (d, J = 7.0, 1H, ArCH), 6.67 (s, 1H, ArCH), 3.68 (t, J = 7.0, 2H, CH2),
2.38 (s, 3H, ArCH3), 1.68-1.64 (m, 2H, CH2), 1.37-1.21 (m, 12H, 3 x CH2 and 2 x CH3),
0.87 (t, J = 7.0, 3H, CH3). 13C NMR (100MHz, CDCl3, δ) 182.0 (s, C═O), 142.2 (s, C-
N-), 137.6 (s, C-Me), 133.2 (s, C-C(CH3)2), 122.6 (d, ArCH), 122.1 (d, ArCH), 109.2
(d, ArCH), 43.8 (s, C(CH3)2), 39.8 (t, CH2), 31.5 (t, CH2), 27.4 (t, CH2), 24.5 (2 x q,
C(CH3)2), 22.6 (t, CH), 21.8 (q, (CH3), 22.5 (t, CH2), 14.7 (q, CH3). LRMS (LSIMS-
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FAB+) m/z 260 (MH+ = 100%), 259 (M = 75), 160 (20), 154 (35), 136 (25). HRMS
(LSIMS-FAB+) m/z: calcd 259.1936 for C17H25NO, found 259.1933.
N-Dodecyl-2-p-tolyl-isobutyramide 370e
HN
O
Data for N-dodecyl-2-p-tolyl-isobutyramide 370 as colourless globular oil (0.55g, 79%).
IR (neat) νmax: 3351, 2900, 1644, 1514, 1465 and 816 cm-1. 1H NMR (400MHz, CDCl3,
δ) 7.24 (d.t, J = 8.0 and 2.0, 2H, ArCH), 7.14 (d, J = 8.0, 2H, ArCH), 5.20 (s, 1H, NH),
3.13 (t, J = 7.0, 2H, CH2), 2.03 (s, 3H, ArCH3), 1.54 (s, 6H, (CH3)2), 1.39-1.12 (m, 20H,
10 x CH2), 0.90-0.82 (m, 3H, CH3). 13C NMR (100MHz, CDCl3, δ) 172.3 (s, C═O),
144.6 (s, C-Me), 140.9 (s, C-C(CH3)2), 129.5 (2 x d, ArCH), 122.6 (2 x d, ArCH), 43.8
(s, C-(CH3)2), 39.7 (t, CH2), 31.9 (t, CH2), 29.6 (t, CH2), 29.5 (t, CH2), 29.5 (t, CH2),
29.3 (t, CH2), 27.3 (2 x t, CH2), 27.0 (t, CH2), 27.0 (t, CH2), 24.9 (2 x q, C(CH3)2), 23.0
(t, CH2), 22.5 (q, ArCH3), 14.7 (q, CH3). LRMS (LSIMS-FAB+) m/z 346 (MH+ =
100%), 344 (10), 226 (10), 136 (10), 133 (92), 119 (12). HRMS (LSIMS-FAB+) m/z:
(MH+) calcd. for C23H40NO; 346.3110, found 346.3104.
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Authentic synthesis of N-isobutyl-2-p-tolyl-isobutyramide222 370g
O
HN
General method: To a single-necked RB flask was added the acid chloride 351 (0.02g) in
diethyl ether (2 mL). Iso-butylamine 374g (0.01g, 3.0 eq,) was added dropwise, and a
turbid solution was observed. The reaction mixture was stirred for 48h. The reaction was
quenched with water (3 x 5 mL) followed by diethyl ether (5 x 5 mL). The organic layer
was dried over anhydrous magnesium sulfate, and the solvent removed in-vacuo to
furnish a yellow viscous solid (0.016g) as N-isobutyl-2-p-tolyl-isobutyramide 370g. 1H
NMR (400MHz, CDCl3, δ) 7.19 (d.t, J = 8.0 and 3.0, 2H, ArCH), 7.09 (d, J = 8.0, 2H,
ArCH), 5.10 (bs, 1H, NH), 2.90 (t, J = 7.0, 2H, CH2), 2.27 (s, 3H, ArCH3), 1.61-1.52
(spt., J = 7.0, 1H, CH), 1.48 (s, 6H, (CH3)2), 0.70 (d, J = 7.0, 6H, (CH3)2); 13C NMR
(100MHz, CDCl3,δ) 177.9 (s, C═O), 142.5 (s, C-Me), 136.9 (s, C-C(CH3)2), 129.9 (2 x
d, ArCH), 126.7 (2 x d, ArCH), “not observed” (C(CH3)2), 47.2 (t, CH2), 28.7 (s, CH),
27.4 (2 x q, C(CH3)2), 20.2 (q, ArCH3), 19.5 (2 x q, CH3): LRMS (LSIMS-FAB+) m/z
233 (M+ = 100%), 154 (100), 137 (74), 120 (12); HRMS (LSIMS-FAB+) Calc for
234.1858 (MH+) calc for C15H23NO Found 234.1858.
9.0 Synthesis of radical precursors 396, 407, 408, 406 and 413
9.1 N-butyllithium method:
To a stirred solution of N-alkyl-4-methylbenzenesulfonamide 284e (1.0 eq.) in dry
dichloromethane was added n-butyllithium (1.1M) (1.0 eq.) and acid halide (1.0 eq/) at -
78 °C (dry ice/acetone) overnight. The reaction was quenched with saturated ammonium
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chloride (10 mL), and the product extracted with dichloromethane (200 mL), followed
by saturated sodium bicarbonate (200 mL). The aqueous phase was washed with
dichloromethane (2 x 200 mL) and the combined organic fractions were washed with
saturated sodium chloride. The organic phase was dried with magnesium sulfate, and the
solvent evaporated in-vacuo to yield a crude product. Purification of the crude product
(petrol ether/ EtOAc) gave the radical precursor.
N-Ethyl-4-methyl-N-trichloromethylbenzenesulfonamide 396
S
O
O
N
O
Cl Cl
Cl
Flash chromatography (6:1 petrol ether/ethyl acetate) furnished N-ethyl-4-methyl-N-
trichloromethylbenzenesulfonamide 396 as a white crystallised solid (2.5g, 84%).
1H NMR (400MHz, CDCl3, δ) 7.91 (d.t, J = 8.0 and 2.0, 2H, ArCH), 7.33 (d, J = 8.0,
2H, ArCH), 4.33 (q, J = 7.0, 2H, CH2), 2.45 (s, 3H, ArCH3), 1.55 (t, J = 7.0, 3H, CH3).
13C NMR (100MHz, CDCl3, δ) 158.8 (s, C═O), 145.6 (s, C-Me), 134.9 (s, C-SO2-),
129.5 (2 x d, ArCH), 129.1 (2 x d, ArCH), 92.5 (s, CCl3) 44.8 (t, CH2), 21.7 (q,
ArCH3), 15.5 (q, CH3); LRMS (LSIMS-FAB+) m/z 343 (M+ = 10%), 155 (100), 137
(72), 136 (66), 120 (13). HRMS (LSIMS-FAB+) m/z: (M+) calcd for C11H12Cl3NO3S;
343.9681, found 343.9671.
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N-Butyl-2,2,2-trichloro-N-tolyl-acetamide 407
Discernible data:
N
O
Cl
Cl Cl
Flash chromatography (6:1 petrol ether/ethyl acetate) furnished N-butyl-2,2,2-trichloro-
N-tolyl-acetamide 407 as a dark yellow oil (1.56g, 82%). 1H NMR (300MHz, CDCl3,δ)
7.12 (s, 4H, ArCH), 3.67 (bs, 2H, CH2), 2.31 (s, 3H, ArCH3), 1.57-1.46 (quin. J = 7.0,
2H, CH2), 1.31-1.17 (sxt, J = 7.0, 2H, CH2), 0.83 (t, J = 7.0, 3H, CH3). LRMS (LSIMS-
FAB+) m/z 310 (81Br MH+ = 39%), 308 (79Br MH+ = 49%), 155 (26), 155 (100), 139
(13), 138 (30), 137 (63), 136 (70), 120 (10). HRMS (LSIMS-FAB+) m/z: (MH+) calcd
for C13H17Cl3NO 308.0376, found 308.0363.
2-Bromo-N-butyl-N-p-tolyl-acetamide 408
N
O
H
H Br
Flash chromatography (6:1 petrol ether:EtOAc) furnished 2-bromo-N-butyl-N-p-tolyl-
acetamide 408 as a yellow oil (3.08g, 31%). 1H NMR (300MHz, CDCl3,δ) 7.15 (d, J =
8.0, 2H, ArCH), 7.05 (d.t, J = 8.0 and 2.0, 2H, ArCH), 3.59 (t, J = 7.0, 2H, CH2), 3.53
(s, 2H, CH2), 2.30 (s, 3H, ArCH3), 1.45-1.35 (quin., J = 7.0, 2H, CH2), 1.28-1.15 (sxt., J
= 7.0, 2H, CH2), 0.79 (t, J = 7.0, 3H, CH3). 13C NMR (100MHz, CDCl3, δ) 165.9 (s,
C═O), 138.6 (s, C-N-), 138.3 (s, C-Me, 130.2 (2 x d, ArCH), 127.5 (2 x d, ArCH), 51.5
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(t, CH2), 29.2 (t, CH2), 27.3 (t, CH2), 20.8 (q, ArCH3), 19.6 (t, CH2), 13.5 (q, CH3). m/z
(LSIMS) 286 (81Br MH+ = 98%), 284 (79Br MH+ = 100), 204 (24), 154 (54), 136 (41),
120 (26). HRMS (LSIMS) m/z: (MH+) calcd for C13H19BrNO, 284.0650; found
284.0652.
N-Butyl-2,2-dichloro-N-p-tolyl acetamide 406 and 2,2-dichloro-N-p-tolyl-acetamide
413
N
O
HCl
Cl
H
N
O
H Cl
Cl
Purification by flash chromatography (6:1 petrol ether:ethyl acetate) furnished N-butyl-
2,2-dichloro-N-p-tolyl acetamide 409 as a yellow oil (0.78g, 46%); IR νmax (neat) 2960,
1728, 1385, 1269, 1124, 1070 and 744 cm-1. 1H NMR (400MHz, CDCl3,δ) 7.28 (d, J =
8.0, 2H, ArCH), 7.12 (app. d, J = 8.0, 2H, ArCH), 5.83 (s, 1H, CH), 3.70 (app. t. J =
7.0, 2H, CH2), 2.42 (s, 3H, ArCH3), 1.56-1.49 (app. quin., J = 7.0, 2H, CH2), 1.38-1.26
(app. sxt., J = 7.0, 2H, CH2), 0.90 (t, J = 7.0, 3H, ArCH3). 13C NMR (100MHz, CDCl3,
δ) 164.0 (s, C=O), 139.4 (s, C-N-), 137.5 (s, C-Me), 130.8 (2 x d, ArCH), 127.7 (2 x d,
ArCH), 64.0 (d, CH), 50.3 (t, CH2), 29.3 (t, CH2), 21.1 (q, ArCH3), 20.0 (t, CH2), 19.5
(q, CH3). LRMS (EI) m/z: 274 (M+ = 15%), 134 (100), 106 (80).
Purification by flash chromatography (6:1 petrol ether:ethyl acetate) furnished 2,2-
dichloro-N-p-tolyl-acetamide 413 as a yellow-orange viscous solid (0.04g, 3%); IR νmax
(neat) 2961, 1707, 1645, 1508, 1229, 1164 and 833 cm-1. 1H NMR (400MHz, CDCl3,δ)
8.24 (s, 1H, NH), 7.45 (app. d, J = 8.0, 2H, ArCH), 7.17 (d, J = 8.0, 2H, ArCH), 6.08 (s,
1H, CH), 2.34 (s, 3H, ArCH3). 13C NMR (100MHz, CDCl3,δ) 161.1 (s, C=O), 135.0 (s,
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C-N-), 133.9 (s, C-Me), 129.7 (2 x d, ArCH), 120.3 (2 x d, ArCH), 67.0 (d, CH), 21.0
(q, ArCH). LRMS (EI+) m/z: 217 (M+ = 70), 202 (12), 146 (15), 134 (100), 106 (78).
5.10 General reactions
N-Butyl-N-(2-methylacryloyl)-benzenesulfonamide 286a
S
N
O
O
O
To a stirred solution of N-butyl benzenesulfonamide 283a (0.21g, 0.97 mmol) in
anhydrous dichloromethane (DCM) (10 mL) was added via syringe methacryloyl
chloride 285 0.09 mL, 0.94 mmol) followed by triethylamine (TEA) (0.13 mL, 0.94%).
The solution became turbid and was stirred at room temperature under nitrogen for 3h.
The crude mixture was quenched with water (50 mL) followed by extraction of the
product with diethyl ether (3 x 50 mL). The organic layer was dried over anhydrous
magnesium sulfate and the solvent removed in-vacuo, to furnish a yelow oil. Purification
via flash chromatography (petrol ether:ethyl acetate 6:1) furnished N-butyl-N-(2-
methylacryloyl)-benzenesulfonamide 286a as a colourless oil (0.08g, 79%).
IR (neat) νmax 2959, 1686, 1353, 1168, 1026 and 686 cm-1. 1H NMR (300MHz, CDCl3,
δ) 7.89 (d, J = 7.0, 2H, ArCH), 7.61 (app. t, J = 7.0, 1H, ArCH), 7.52 (t, J = 7.0, 2H,
ArCH), 5.26 (brs, 1H, C=CHH), 5.09 (s, 1H, C=CHH), 3.74 (t, J = 7.0, 2H, CH2), 1.92
(s, 3H, CH3), 1.69-1.59 (quin. J = 7.0, 2H, CH2), 1.36-1.24 (sxt., J = 7.0, 2H, CH2),
0.90 (t, J = 7.0, 3H, CH3). 13C NMR (100MHz, CDCl3, δ) 172.7 (s, C═O), 141.2 (s, C-
SO2-), 139.8 (s, C═CH2), 134.0 (d, ArCH), 129.3 (2 x d, ArCH), 128.5 (2 x d, ArCH),
119.5 (t, C═CH2), 47.7 (t, CH2), 32.2 (t, CH2), 20.3 (t, CH2), 20.0 (q, ArCH3), 14.0 (q,
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CH3). LRMS (LSIMS) m/z: 282 (MH+ = 100%), 165 (12), 154 (91), 136 (100), 115 (20).
HRMS (LSIMS-FAB+) m/z: (MH+) calcd for C14H20NO3S; 282.1164, found 282.1166.
Tris-(2-pyridylmethyl)-amine162 279
N
N
N
N
To a three necked RB flask was added 2-picoloyl chloride HCl (38.97g, 234 mmol, 2.0
eq.) and 2-picoloylamine (12.98g, 12.37 mL, 117 mmol, 1.0 eq.), the reaction mixture
became a turbid dark red solution and slightly exothermic. To the mixture was added
sodium hydroxide (10M, 24g, 60 mL water) at a rate of one drop per minute. The
reaction was stirred magnetically for 2 hr at room temperature. The crude product was
extracted with chloroform (3 x 150 mL), and the organic phase was dried over
anhydrous sodium sulfate. The solvent was removed in-vacuo to furnish dark red oil
(35.71g). To the crude product was added hot diethyl ether, the resulting blood red
solution was decanted leaving a black viscous oil residue. The solvent was removed in-
vacuo to furnish a bright orange red crystalline solid (32.02g). Recrystallisation with hot
diethyl ether and rapid cooling lead to beautiful golden crystals tris-(2-pyridylmethyl)-
amine 279 (12.68g, 71%). IR (neat) νmax: 2823, 1589, 1433, 1366, 1147 and 766 cm-1.
1H NMR (300MHz, CDCl3,δ) 8.54 (s, 3H, ArH), 7.68-7.57 (m, 6H, ArH), 7.15 (m, 3H,
ArH), 3.89 (s, 6H, (CH3)2). 13C NMR (100MHz, CDCl3,δ) 159.4 (3 x s, C-py), 149.1 (3
x d, ArCH), 136.4 (3 x d, ArCH), 123.0 (3 x d, ArCH), 122.0 (3 x d, ArCH), 60.1 (3 x
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t, CH2); LRMS (EI+) m/z: 291 (MH+ = 100%), 198 (100 ), HRMS (EI+) Calc. 290.1531
for C18H18N Found 290.1525.
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